Yaya tsawon lokacin da waɗannan alamun suka kasance?
kuma duk wani ciwon kirji ya kamata a bi da shi ta wannan hanyar musamman dangane da shekarunka
kuma tare da zazzabin cizon sauro
kuma ana bukatar a yi gwajin maganin rigakafi don sanin hawan jini
kuma kana da zazzabin cizon sauro a yanzu?
kuma ka ji ciwon zuciya yanzu?
kuma kana da matsalar numfashi
kuma za ku iya gaya mani wasu alamun da kuke da su banda waɗannan?
kuma menene zafin zafin da zazzabi
kuma ina girbi da girbi
kuma ina da ɗan sanyi da kuma rashin lafiya
kuma ina da ciwo mai zafi a cikin kirji a yau
kuma wannan shine lokacin da za ku sami canji na jiki na dogon lokaci
kuma akwai ciwon kirji
kuma ina ganin ina da zazzabin cizon sauro
kuma ina so ka bayyana min inda kake jin zafi
kuma suna da zazzabin cizon sauro
da kuma tarihin ciwon sukari
kuma ka san abin da sauti kamar na kirji da yake faruwa
kuma ka san cewa mutane suna yi mini ba'a koyaushe
kuma a yi maka rauni a ƙirjinka
kuma ka ce wannan matsin lamba ne a kirjinka
wani a cikin iyalinku yana da ciwon zuciya ko ciwon zuciya ko kuma ciwon zuciya da kuma yawan kitse a cikin zuciya
Shin akwai wasu alamun ko matsaloli da ke tattare da ciwon haɗin gwiwa?
Shin akwai wasu a cikin iyalinku da ke da irin wannan bayyanar cututtuka?
kuna da wasu alamun cutar?
kana da matsalar yin barci?
ciwon kirji
domin lokacin sanyi ne
amma kuma kada a bar mu a baya a kan tushen ciwon zuciya da ke haifar da rashin jin daɗi
amma babban matsalar yanzu shine ciwon kirji
amma ina da matsala numfashi
amma na san mutane da yawa da suke yi mini ba'a
amma dole ne mu kula da duk wani ciwon kirji da karfi
amma yanzu kana jin daɗin numfashi?
saboda ciwon kirji na manta da shi
yana kama da wani ya rungume shi
har yanzu ina jin zafin
suna gunaguni game da rashin lafiya da kuma bayyanar cututtuka?
Shin kana da wata cuta mai tsanani kamar hawan jini ko kuma wani irin cuta?
kana da wasu cututtuka masu tsanani ko kuma matsalar lafiya kamar ciwon sukari?
ciwon kirji yana sa ka yi ta kuka?
hawan jini mai yawa?
Shin kana jin kunya don haka?
kana da irin waɗannan alamun?
ka ga wannan hoton?
sha da yawa a yau
amma na yi gwajin ciwon sukari
amma yana da alamun da suka yi kama da nawa
har yaushe?
Yaya hawan jini naka yake?
idan zazzabin zazzabin cizon sauro ya ci gaba da damun ka
idan kana da zazzabin cizon sauro na 120 zuwa sama
idan ka ga cewa kana bukatar ƙarin bincike
na kamu da zazzabin cizon sauro jiya
na samu zazzabin cizon sauro
na kamu da zazzabin cizon sauro jiya
Ina da ciwo mai zafi a nan a kirjina
Ina da matsalar numfashi
zan aiko muku da hoto
da ciwon kirji a yau
Ina da ciwon kai da zazzabin cizon sauro a yau
a cikin tunani na cewa ba shi da sanyi
a cikin tunani na wannan ne kadan sanyi
kamar wani abu mai nauyi da ke wuyanka?
ya fara da ciwon kai da zazzabin cizon sauro a lokaci guda
a tsakiya na kirji
ciwon kirji mai tsanani
yana cikin kirjina
yana cikin kirji a tsakiyar
a cikin tsakiyar kirji
ciwon kirji
wannan ciwon na zuciya yana damun
Ina so ka bayyana min wannan ciwon kirji
hawan jini ko ciwon sukari
a tsakiyar kirji
yanzu idan kana da zazzabin zazzabin za ka iya haɗiye wani irin sukari na tachipirina
yanzu Mary yaushe kake da alamun
yanzu ka ce ka ji ciwon kirji
wani lokaci na ji ciwon kirji
yanzu kana da wasu alamun cutarwa ban da ciwo
ko kuma ka ji kamar wani yana rungume ka?
daidai yake da zazzabin cizon sauro da kuma ciwon kai da kuma ciwon tsoka
tsakiya na kirji
zan nuna maka inda kake jin zafi
idan kana da zazzabin cizon sauro
yanzu kana ganin wasu daga cikin wadannan alamun suna da nasaba da ciki?
yaranka suna da irin waɗannan alamun?
ina wa'azi game da ciwon kirji
zazzabin cizon sauro yana ƙaruwa da dare
zazzabin zazzabin da na yi kwanaki biyu
zazzabin ya karu a daren jiya
Wannan Dr. Porter ne daga dakin gaggawa a wurin da ake yin gwaji
yanzu za ku iya bayyana mini game da ciwon kirji da kuke ji?
yanzu ina jin zafi a gaban jikina a nan cikin kirji
yanzu ina jin zafi sosai a kirjina
yanzu da nake fama da wannan ciwon a kirji
wane irin ciwo ne kake ji a kirji?
a wane lokaci ne aka soma wahalar da shi?
ciwon zuciya?
ciwon kirji da ya fi sa ka baƙin ciki
kana jin kamar ƙirjinka ya yi tsit
ka san ina da ciwon sukari da dai sauransu
ka ce kana da wannan ciwo a kirji
Halin da ake ciki na kamuwa da cutar korona (COVID-19) a Tarayyar Turai/Yankin Tattalin Arzikin Turai da kuma Burtaniya, daga 1 ga Janairu zuwa 15 ga Maris 2020
Adadin mutanen da suka kamu da cutar coronavirus (COVID-19) ya nuna irin halin da kasashen Tarayyar Turai/Abokan Cinikayya da Burtaniya ke ciki, wanda ke nuna cewa, duk da cewa annobar COVID-19 tana da matakai daban-daban a kasashe daban-daban, tana karuwa a cikin sauri a duk duniya.
Dangane da yanayin Italiya, jihohi, asibitoci da dakunan jinya masu matukar wahala dole ne su kara kasancewa cikin shiri saboda karuwar adadin masu cutar COVID-19 da ke buƙatar kulawa, musamman kulawa mai mahimmanci.
A ranar 31 ga Disamba, 2019, an gano wasu marasa lafiya da ke dauke da cutar huhu a Wuhan, lardin Hubei, China.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cutar Sin ta ba da rahoton cewa cutar ta samo asali ne daga kwayar cutar coronavirus da ba a san asalinsa ba, wanda yanzu aka sani da cutar coronavirus 2 (SARS-CoV-2).
Tun daga wannan lokacin, cutar da ke haifar da kwayar cutar SARS-CoV-2 an kira ta cutar coronavirus (COVID-19).
Binciken ya nuna cewa kusan kashi 80% na mutanen da ke dauke da COVID-19 suna da ƙananan cututtuka, wato, kamuwa da cuta ta hanyar numfashi tare da ko ba tare da kumburi ba, kuma mafi yawan sun warke.
A kusan kashi 14 cikin ɗari na yankuna, COVID-19 ya zama babban cuta da ke buƙatar asibiti kuma kashi 6 cikin ɗari na mutane suna da mummunan cuta da ke buƙatar kulawa mai mahimmanci.
Kasuwancin COVID-19 da suka mutu sun kai kashi 4 cikin dari.
A cikin wannan binciken, mun bincika karuwar cutar COVID-19 a kowace ƙasa a Tarayyar Turai/Yankin Tattalin Arzikin Turai (EU/EEA) da Turai (UK) kuma mun kwatanta shi da lardin Hubei, China.
Mun kuma kwatanta adadin masu kamuwa da cutar COVID-19 a yanzu a cikin EU/EEA da UK da Italiya a ranar 31 ga Janairu zuwa 15 ga Maris 2020.
Al'ummar EU/EEA da Birtaniya sun kamu da cutar COVID-19
Bayan kasar Sin, COVID-19 ya bazu zuwa wasu yankuna kuma yanayin barkewar COVID-19 a wasu sassan duniya ya bi na kasar.
A ranar 11 ga watan Maris na shekarar 2020, Babban Jami'in Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba ta duniya.
A cikin wani rahoto na Eurosurveillance 2020 na 5 ga watan Agusta, Spiteri da abokan aikinsa sun bayyana farkon cutar COVID-19 a Turai bisa ga ma'anar WHO.
A EU/EEA, an gano cutar ta farko a Faransa a ranar 24 ga Janairu 2020 a Wuhan, lardin Hubei, China.
A ranar 15 ga watan Maris na 2020, an riga an gano cutar COVID-19 a cikin ƙasashe 30 na EU/EEA da Burtaniya, wanda a cikin wannan tsakanin 31 ga Disamba, 2019, akwai masu kamuwa da cutar 39,768 da mutuwar 1,727, tare da kamuwa da cutar 17,750 da mutuwar 1,441 daga Italiya kadai.
Samun adadin masu kamuwa da cutar COVID-19 da kuma mutanen da ke kamuwa da cutar COVID-19 a matsayin ci gaba
Cibiyar Kula da Cututtuka ta Turai (ECDC), ta bayyana adadin mutanen da suka kamu da cutar COVID-19 a kowace kasa a duniya, daga cibiyoyin sadarwa na kasa da kasa, kamar ma'aikatar lafiya, da kuma cibiyoyin kiwon lafiya na WHO, da kuma cibiyoyin sadarwa, ana sabunta su a kowace rana da karfe 2:00 na safe.
An yi amfani da wannan bayanin don nazarin yanayin COVID-19 a EU/EEA da Burtaniya, kuma an kwatanta shi da na Italiya.
A matsayin tsarin kididdigar adadin masu cutar COVID-19 da ke kan magani, mun lissafa adadin mutanen da suka kamu da cutar COVID-19 da aka gano a cikin kwanaki 14, a kowace ƙasa ta EU/EEA da Burtaniya, a tsakanin 1 ga Janairu zuwa 15 ga Maris, 2020.
Mun kuma nuna adadin wadanda suka kamu da cutar a kowace kasa kamar yadda ya karu a ranar 15 ga watan Agusta 2020 da karfe 2:00 na safe idan aka kwatanta da Italiya a lokacin 31 ga watan Janairu zuwa 15 ga watan Maris.
Halin COVID-19 a cikin EU/EEA da UK
Matsakaicin adadin mutanen da suka kamu da cutar COVID-19 da aka samu a cikin kwanaki 14 a cikin EU/EEA da Burtaniya gabaɗaya sun bi na lardin Hubei (China) (Hoto 1).
A cikin EU/EEA da kuma Burtaniya gabaɗaya, adadin mutanen da suka kamu da COVID-19 ya fara ƙaruwa a ranar 21 ga Fabrairu kuma ya ƙaru sosai a ranar 28 ga Fabrairu, 2020 (Litinin).
Wannan ya kasance saboda saurin karuwar adadin daga Italiya, amma duk sauran ƙasashen EU/EEA da Burtaniya sun sami karuwar adadin masu kamuwa da cutar COVID-19 (Hotspot).
Hoto na 2 ya nuna yawan mutanen da suka kamu da cutar COVID-19, a cikin EU/EEA da UK idan aka kwatanta da Italiya a ranar 31 ga Janairu zuwa 15 ga Maris 2020.
Ya nuna cewa, a ranar 15 ga watan Maris da karfe 2:00 na safe, sauran kasashe 15 na EU/EEA da kuma Birtaniya suna da adadin masu kamuwa da cutar da ya yi daidai da na Italiya a makonni 3 da suka gabata ko kasa da haka.
Bayananmu sun nuna cewa adadin masu kamuwa da cutar COVID-19 na karuwa sosai a EU/EEA da kuma Burtaniya.
Yanayin da aka samu a yawan mutanen da ke kamuwa da COVID-19 ya nuna cewa cutar tana ƙaruwa a cikin matakan da suka dace a duk ƙasashe.
Wannan ya kasance duk da cewa ƙasashe suna da matakan kulawa daban-daban, da kuma ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar.
A farkon watan Maris na 2020, likitoci a yankunan da cutar ta shafa a Italiya sun bayyana cewa kashi 10% na masu fama da cutar COVID-19 suna bukatar kulawa mai tsanani kuma labarai sun nuna cewa asibitoci da dakunan kulawa mai tsanani a yankunan sun cika.
Adadin marasa lafiya na COVID-19 da ke kwance a asibiti da / ko ɗakunan kulawa mai mahimmanci waɗanda aka ƙayyade a matakin EU / EEA sun kai kashi 6% da 1%, (ba a ba da wannan bayanin ba).
Maimakon haka, dole ne a tattara su a cikin tsari mai kyau wanda ya dace da bayanan da aka nuna game da adadin masu cutar da mutuwar.
Wani bincike da aka yi a 2010/11 ya nuna bambancin da ke tsakanin asibitocin gaggawa da asibitocin da ke kula da marasa lafiya a Turai, inda Jamus ke da asibitoci 29.2 da kuma Portugal tana da asibitoci 4.2 ga kowane mutum 100,000.
Wannan yana nufin cewa akwai ƙasashe da ke da mafi ko ƙasa da Italiya (kwakwalwa 12.5 na asibiti na gaggawa da kuma asibiti na kwantar da hankali ga mutane 100,000 a 2010).
Sakamakon da za a iya samu dangane da wadatar kayayyakin kiwon lafiya, bisa la'akari da adadin marasa lafiya da ke kwance da cutar COVID-19 a kowace kasa ta EU/EEA da Burtaniya da kuma matsalar da ake fuskanta idan bukatar asibitocin gaggawa ta wuce kashi 90%, an nuna a cikin rahoton ECDC na shida na saurin kimanta hadarin COVID-19.
Tun da yake har yanzu akwai wasu cututtuka a wasu ƙasashe na EU/EEA da kuma Birtaniya, kuma asibitoci da dakunan jinya na gaggawa suna ba da sabis ga mutanen da ke cikin yankuna da aka sani, za a samu bayanai game da marasa lafiya da kuma dakunan jinya a cikin tsarin Nomenclature of territorial units for statistics 2 (NUTS-2).
Abubuwan da ke faruwa a Italiya da sauran ƙasashe sun nuna cewa rikicin COVID-19 yana ƙaruwa a cikin EU / EEA da Burtaniya.
Saboda haka, asibitoci da dakunan kula da gaggawa dole ne su kasance cikin shiri don yaduwar SARS-CoV-2 a cikin al'ummomin yankin da kuma karuwar adadin marasa lafiya na COVID-19 da ke buƙatar kulawa, musamman kulawa mai tsanani, zuwa matakin da aka samu a yankunan Italiya da abin ya shafa.
Kamar yadda aka nuna a cikin binciken ECDC na gaggawa, ingantaccen shiri na gaggawa yana da mahimmanci wajen hana yaduwar SARS-COV-2, duk da sauyawa daga hana yaduwa zuwa warkarwa, saboda karuwar gaggawa a cikin adadin masu cutar da ake tsammani a cikin iko ba zai ba hukumomi da asibitoci damar samun isasshen lokaci don fahimta, yarda da aiwatar da matakan tsaro idan ba a aiwatar da su ba da wuri.
Binciken da aka yi a baya ya nuna hanyoyin kiwon lafiya da za a bi don magance matsalar.
Akwai wasu kasafai da kasa ke da damar da za ta iya kara karfinta wajen rage yaduwar cutar SARS-CoV-2 da kuma rage matsin lamba kan harkokin kiwon lafiya.
Idan wannan bai yi nasara ba, ana sa ran cewa za a sami matsalar kiwon lafiya a wasu ƙasashen EU/EEA saboda yawan marasa lafiya da ke buƙatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
Cutar Coronavirus ta 2019 (COVID-19), wacce ke haifar da cutar coronavirus 2 (SARS-CoV-2), ta kashe mutane sama da 3,000 kuma sama da mutane 80,000 sun kamu da cutar a China da sauran ƙasashe, wanda ya haifar da bala'in bala'i.
Kamar yadda cutar SARS-CoV, wadda ta haifar da cutar SARS a dubban mutane a 2003, SARS-CoV-2 na iya yaduwa ta hanyar huhu kuma yana haifar da alamun cutar.
A gefe guda, COVID-19 ba shi da ƙarfi kamar SARS kuma yana kashe mutane kaɗan amma yana da yaduwar yaduwa kuma yana shafar tsofaffi da maza fiye da matasa da mata.
Domin a amsa tambayoyin da aka yi game da wannan sabon ciwo, wannan talifin ya yi niyyar nuna cikakken bincike na wannan sabon ciwo.
Za mu tattauna abubuwa na asali game da cuta, abin da ke haddasa ta, ƙwayoyin cuta, ganewa, magani, hasashen nan gaba, da kuma guje wa su.
Ko da yake akwai tambayoyi da yawa da za a amsa, muna fatan wannan bincike zai taimaka wajen fahimtar da kuma magance wannan cuta da ke damun mutane.
Bikin bazara na ranar 25 ga Janairu, 2020 ya zama abin tunawa ga Sinawa waɗanda aka nemi su zauna a gidajensu a duk lokacin hutu da makonni masu zuwa saboda barkewar cutar da kwayar cutar ba a san ta ba.
Kwayar cutar ta yi kama da kwayar cutar coronavirus (CoV) da ta haifar da cutar sankarar numfashi (SARS) a 2003; saboda haka, Hukumar Lafiya ta Duniya (WHO) ta sanya sunan SARS-CoV-2 a ranar 11 ga Fabrairu 2020, kuma an sake sanya sunan cutar da ke haifar da cutar CoV Disease-19 (COVID-19).
Cutar ta fara ne a Wuhan, China, kuma nan da nan ta bazu zuwa kasar da kuma wasu kasashe 50 a duniya.
Ya zuwa ranar 2 ga watan Maris, 2020, cutar ta riga ta haifar da mutane sama da 80,000 da aka tabbatar da cutar COVID-19, sama da 40,000 sun warke kuma sama da 3,000 sun mutu.
WHO ta yi gargadin cewa COVID-19 shine abokin gaba na mutum na 1 kuma yana iya zama mai haɗari fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin kasa da watanni biyu, an buga takardu sama da 200 kan COVID-19 wanda ya hada da bayanai game da kwayar cutar, cuta, sanadin cutar, bincike da magani tun daga rahoton farko a ranar 7 ga Janairu, 2020 wanda ya gano kwayar cutar da aka ware daga marasa lafiya daban-daban.
Wannan binciken na nufin ci gaba da bincike a wannan sabon filin wasa mai saurin gudu.
A cikin wannan labarin, za mu gwada COVID-19 da SARS da kuma wani cutar da ke haifar da CoV, cutar numfashi ta Gabas ta Tsakiya (MERS, wanda ya ɓarke a shekarar 2012).
Za mu kuma tattauna abubuwan da muka koya game da yadda za mu guji wannan cuta da kuma wasu ra'ayoyi da kuma tambayoyi masu muhimmanci da ba a amsa ba.
CoVs an ɗauka cewa sun fi cutar mutum rauni, suna haifar da kashi 15% na kamuwa da cutar ta kowacce cuta 4.
A maimakon haka, a wannan karni, mun sami CoVs masu haɗari biyu ga ɗan adam, wato SARS-CoV da MERS-CoV, waɗanda suka fara kamuwa da cutar a China a 2003 da Saudi Arabia a 2012, nan da nan suka bazu zuwa wasu ƙasashe kuma suka kamu da cutar tare da kashe mutane da yawa.
Saboda haka, COVID-19 na yanzu shine CoV na uku da ya bayyana a tarihin ɗan adam.
Kamar yadda aka nuna a Hoto.Hoto.1,1, an fara bayar da rahoton cutar zazzabin cizon sauro a Wuhan a ranar 31 ga Disamba, 2019 ga Hukumar Lafiya ta Kasa ta China.
Bayan kwana bakwai, an fitar da kwayar cutar CoV.
A ranar 15 ga Janairu, 2020 an bayar da rahoton kamuwa da cutar ta farko daga Wuhan.
A halin yanzu, cutar ta bazu cikin hanzari zuwa garuruwan da ke kewaye da ita, da kuma ƙasashe.
A ranar 20 ga watan Janairu, an sanar da cewa akwai wata cuta da ke sa mutane kamuwa da ita.
A ranar 23 ga watan Janairu, an rufe birnin Wuhan kuma an dakatar da zirga-zirgar jama'a.
A ranar 24 ga watan Janairu, binciken farko na asibiti ya nuna cewa daga cikin mutane 41 da aka tabbatar da cutar, 21 ne kawai suka kai hari kai tsaye a kasuwar kifi ta Wuhan, inda ake ganin cutar ta samo asali ne daga wani dabba.
A ranar 30 ga watan Janairu, Hukumar Lafiya ta Duniya ta bayyana cutar a matsayin gaggawa ta duniya.
A lokacin da ake rubuta wannan rahoto, cutar ta riga ta yaɗu a ƙasar Sin da kuma ƙasashe 50 a dukan duniya (Hoto (Hoto.2).2).
Yayin da yanayi ke canzawa, sakamakon da kuma girman matsalar har yanzu ba a sani ba.
A ranar 11 ga watan Fabrairu, 2020, binciken da aka gudanar a wurare daban-daban kan mutane 8,866 da suka tabbatar da kamuwa da cutar COVID-19 ya samar da sabon ma'anar cutar (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 na shafar mutane a duk shekaru, amma sama da shekaru 30-65.
Kusan rabin (47.7%) na waɗanda suka kamu da cutar sun haura shekaru 50, kaɗan ne a ƙarƙashin shekaru 20, kuma marasa lafiya 14 ne kawai ke ƙasa da shekaru 10.
SARS-CoV-2 ya fi yawa a cikin maza (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ya fi yawa a cikin al'umma fiye da yadda ya faru a Hubei da kewaye.
COVID-19 ya ɗauki kimanin kwanaki 5 (2-9) daga lokacin da ya fara zuwa lokacin da aka gano shi.
A lokacin da aka fara nuna alamun cutar, ya kai kwanaki 4.8 (3.0-7.2).
Lokaci daga lokacin da aka gano shi zuwa lokacin da ya mutu kwanaki 9.5 ne (4.8-13).
A cikin marasa lafiya, yawan haihuwa na asali (R0) ya kai 3.77 (CI 95%: 3.51-4.05), yayin da R0 da aka gyara ya kai 2.23-4.82.
Adadin masu kamuwa da cutar ya yi tashin gwauron zabi kafin 23 ga watan Janairu, 2020, sakamakon yawan masu zirga-zirga kafin bikin bazara na kasar Sin.
Yawan mutuwar marasa lafiya ya kai 1.44% (95% CI: 1.10-1.86%), yayin da adadin marasa lafiya da aka gyara ya kai 3.06% (95% CI: 2.02-4.59%).
Abubuwa uku masu saurin kamuwa da cutar COVID-19 sune jima'i (maza), shekaru (≥60), da kuma ciwon hauka.
CoVs suna cikin kwayar cuta mai girma da ke kewaye da kwayar cuta mai ƙwayoyin cuta tare da RNA mai layi ɗaya.
Ana iya rarraba su zuwa nau'i hudu, wato alpha, beta, gamma, da delta, wanda a cikin su ne aka san cewa alpha da beta-CoVs suna cutar da mutane.
(S) glycoprotein ya shafi rashin daidaituwa na enzyme na angiotensin-converting 2 (ACE2) da dipeptidyl peptidase 4 (DPP4) a cikin SARS-CoV da MERS-CoV, a cikin kwayar halitta, wanda ke haifar da haɗuwa da ƙwayoyin cuta guda biyu.
Ana aika kwayar RNA mai kamuwa da cuta zuwa cikin kwayar; bayan kwayar ta ninka, RNA mai kama da glycoproteins da nucleocapsid sunadaran sun hada da kwayar cutar, wanda ke haɗuwa da kwayar cutar don fitar da kwayar cutar.
An gano kwayar cutar SARS-CoV-2 ta farko a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 a matsayin sabon nau'in beta-CoV wanda ya yi kama da kwayoyin halitta wanda kashi 99.98% na samfuran 10 da aka bincika an cire su daga wurin da cutar ta fara, Kasuwar Abinci na teku ta Huanan a Wuhan.
SARS-CoV-2 ya fi kama da SARS-CoV a tsarin kwayoyin halitta fiye da MERS-CoV.
Ta hanyar amfani da na'urorin daukar hoto, an gano SARS-CoV-2 a cikin hanyoyin jirgin kasa.
An gano enzymes na ACE2 suna haifar da SARS-CoV-2 tare da SARS-CoV.
A maimakon haka, kwayar S ta SARS-CoV-2 tana ɗaure da enzymes na ACE2 amma ba ta da ƙarfi kamar yadda yake a SARS-CoV, wanda ya danganta da gaskiyar cewa SARS-CoV-2 yana da ƙananan haɗari ga mutane idan aka kwatanta da SARS-CoV.
SARS-CoV-2 kuma yana iya samar da wani gajeren furotin da ba a taɓa gani ba wanda za a iya kira orf3b da kuma furotin da aka samar wanda za a iya kira orf8.
orf3b na SARS-CoV-2 na iya zama mai alhakin kamuwa da cutar a cikin mutane da kuma hana bayyanar IFNβ; duk da haka, orf8 ba shi da wani abu mai aiki.
A ranar 18 ga Fabrairu, 2020, Zhou, da abokan aikinsa sun gano cikakken tsarin cryo-EM na enzyme ACE2 a cikin bayani na 2.9 Å a cikin kwayar amino acid B0AT1.
Sun gano cewa wannan mahaɗin, wanda ya ƙunshi atom biyu, an tsara shi azaman kwayar atomatik kuma ACE2-B0AT1 ya iya haɗuwa da sunadarai na S, yana nuna alamar gano CoV da mai cutar.
B0AT1 na iya zama abin da ake niyya don maganin cutar SARS-CoV-2.
Tushen da ake samun wannan
An san cewa SARS-CoV da MERS-CoV sun samo asali ne daga kwari kuma sun yadu ga mutane ta hanyar naman alade da raƙuma, a cikin wannan kwayar.
Idan aka kwatanta SARS-CoV-2 da sauran CoVs, ana ganin cewa cutar bat-CoV tana da tasiri sosai wajen yaduwar SARS-CoV-2 saboda kwayar cutar ta yi daidai da kashi 96% na wasu nau'ikan CoVs guda biyu masu kama da SARS da ke cikin bat-CoVZX45 da bat-CoV-SLZX21.
Amma, ba a san dabbar da ta yi amfani da shi ba don ta tsallake shinge ta kai ga mutane ba, kuma ba a san hanyar da ta bi ba tukuna.
Ji da abokan aikinsa sun yi imanin cewa macizai sun fitar da kwayar cutar daga cikin naman sa zuwa ga mutane ta hanyar musayar sunadarin S protein.
A cewar wani bincike, masu bincike a Guangzhou, China, sun gano cewa pangolin - wani dabba mai cin kwari mai bakin ciki da ake amfani da shi a maganin gargajiya na kasar Sin - na iya zama mai watsa SARS-CoV-2 zuwa ga mutane bisa ga kamannin kwayoyin halitta kashi 99% na CoV da aka gano a cikin pangolin da SARS-CoV-2.
Maimakon haka, bambancin kashi ɗaya cikin ɗari tsakanin kwayoyin halittar biyu yana da girma; saboda haka, ba a samu tabbaci na gaske ba tukuna (Fig. (Hoto 33).
Ba a san yawancin abubuwan da ke tattare da cutar SARS-CoV-2 ba.
Kwayoyin cutar SARS-CoV da MERS-CoV na iya rayuwa a cikin gilashi na tsawon sa'o'i 48 a bushe da kuma tsawon kwanaki 5 a yanayin zafi na 20 °C da 40%-50%.
SARS-CoV-2 na iya zama mai ƙarancin yanayi.
An nuna cewa kwayar SARS-CoV-2 ba ta da kariya ga hasken rana (ultraviolet rays) da zafin jiki har zuwa 56 °C na tsawon minti 30; a kashi 75%, maganin da ke dauke da chlorine, peracetic acid, calcium, da sauran sinadarai masu ƙanshi, amma ba chlorhexidine ba, yana kashe kwayar cutar sosai.
Yawancin mutane ba su da rigakafin cutar SARS-CoV-2 kuma saboda haka suna iya kamuwa da cutar.
A halin yanzu, babu wani bincike da ya nuna cewa cutar SARS-CoV-2 tana da illa.
Saboda haka, za mu iya dogara ne kawai a kan binciken da aka yi a baya game da CoVs, musamman SARS-CoV da MERS-CoV (Hoto (Hoto 4).4).
A yadda aka saba, idan kwayar cutar ta kai hari ga dabba mai motsi, ana fara gano kwayar cutar ta hanyar masu karɓar tsarin (PRRs) waɗanda suka haɗa da masu karɓar lectin irin C-type (TLR), mai karɓar Toll-like (TLR), mai karɓar NOD-like (NLR), da mai karɓar RIG-I-like (RLR).
Ta hanyar hanyoyi daban-daban, kwayar cutar tana haifar da tsire-tsire, haɓakar ƙwayoyin dendritic, da kuma samar da nau'in interferons I (IFNs) wanda ke hana yaduwar kwayar cutar kuma yana ƙara ƙarfin macrophage don yaƙi da kwayar cutar.
Maimakon haka, kwayar N na SARS-CoV na iya taimakawa wajen tserewa daga cikin kwayar cutar.
Nan da nan, maganin rigakafin da aka samu ya shiga cikin yaƙi da kwayar cutar.
Kwayoyin T da suka ƙunshi CD4+ da CD8+ T suna da muhimmiyar rawa wajen yaƙi da ƙwayoyin cuta.
Kwayoyin CD4+ T suna motsa ƙwayoyin B su zama masu yaƙi da ƙwayoyin cuta, kuma ƙwayoyin CD8+ T suna kashe ƙwayoyin cuta kai tsaye.
Kwayoyin T masu taimakawa suna samar da sinadarin cytokines masu hana kumburi don taimakawa wajen kare rigakafi.
Maimakon haka, kwayar cutar CoV tana iya hana aikin T cell ta hanyar kashe T cells.
Tsarin rigakafin jiki na jiki, gami da sunadarai kamar C3a da C5a da kuma kwayoyin cutar, suna da muhimmanci wajen yaki da cutar.
Misali, kwayoyin cutar da aka cire daga mai cutar da suka warke sun kashe cutar MERS-CoV.
A wani ɓangare kuma, yawan aiki na jijiyoyin jiki yana sa a fitar da kwayoyin da ke saurin zama a waje, wanda hakan yana sa a yi wa huhu da sauran gaɓoɓin jiki lahani, wani lokaci kuma yana sa gaɓoɓin jiki su kasa aiki, kuma wani lokaci ma ya sa su mutu.
Kwayar cutar SARS-CoV-2, wacce aka gano a cikin mutanen farko, ta fi shafar tsofaffi da ke da wasu cututtuka da mata masu juna biyu.
A al'ada, mutane da ke da ƙwayoyin cuta ko kuma waɗanda ba su da ƙwayoyin cuta da yawa suna iya kamuwa da cuta fiye da wasu.
Lokacin da kwayar SARS-CoV-2 ke ɗaukar don nuna alamun cutar shine kwanaki 1-14, mafi yawan kwanaki 3-7 bisa ga binciken da aka yi kan marasa lafiya 425 na farko a Wuhan.
Maimakon haka, binciken da aka yi a kan marasa lafiya 1,099 ya nuna cewa cutar tana ɗaukan kwanaki 3 kafin a nuna alamun cutar kuma a matsakaici, kwanaki 0 zuwa 24.
Wani bincike da aka yi kwanan nan, da aka ambata a sama, ya nuna cewa tsawon lokacin da ake yi shi ne kwanaki 4.8 (3.0-7.2) a kan marasa lafiya 8,866.
Yana da muhimmanci ma'aikatan kiwon lafiya su sanya kwanakin keɓewa bisa ga lokacin da cutar ta fara bayyana, don kauce wa kamuwa da cutar daga mutanen da ba su da alamun cutar.
A al'ada, waɗanda suke zama a cikin yanayin da ke da cutar ko kuma waɗanda ke da cutar suna bukatar su keɓe kansu na kwanaki 14.
Shin ana bukatar a ƙara wa mutane kwanaki 24 ne kawai?
Malaria yawanci ita ce farkon bayyanar cutar ta COVID-19, wanda ba za a iya biye da shi ba tare da wasu alamun cututtuka kamar su bushewar hanci, wahalar numfashi, ciwon jijiya, kumburi, ciwon kai, ciwon wuya, kumburi, ciwon kirji, gudu, kumburi, da kuma amai.
Wasu marasa lafiya sun sami wahalar numfashi da kuma/ko rashin iskar oxygen a cikin mako guda bayan kamuwa da cutar.
A cikin yanayi mai tsanani, marasa lafiya sun yi saurin samun matsalar samun ruwa a cikin huhu, hawan jini (septic shock), asidosis na metabolism, da kuma coagulopathy.
Marasa lafiya da ke da zazzabin cizon sauro da/ko alamun cututtukan numfashi na zazzabin sauro, ko da ba su da cutar huhu, ya kamata a yi musu gwajin cutar a farkon lokaci.
Binciken da aka yi a watan Disamba na shekarar 2019 ya nuna cewa kashi 98% na alamun cutar sun kasance saboda tari, kashi 76% na bushewar hanci, kashi 55% na wahalar numfashi, da kuma kashi 3% na rashin nutsuwa; kashi 8% na marasa lafiya suna buƙatar taimakon numfashi.
An samu irin wannan sakamako a cikin bincike guda biyu da aka yi a kan marasa lafiya da ke cikin iyali daya da kuma marasa lafiya da aka yi musu allurar rigakafi.
Idan aka kwatanta, binciken da aka yi a shekarar 2012 ya nuna cewa masu fama da cutar MERS-CoV suna da zazzabin cizon sauro (98%), tari mai bushe (47%), da kuma wahalar numfashi (55%) a matsayin manyan alamun cutar.
Maimakon haka, kashi 80% na su na bukatar kayan numfashi, musamman ga marasa lafiya na COVID-19 kuma wannan ya yi daidai da gaskiyar cewa MERS ya fi cutar COVID-19 haɗari.
An kuma lura da ciwon wuya (26%) da kuma ciwon wuya (21%) a cikin marasa lafiya da ke dauke da cutar MERS.
A cikin marasa lafiya da cutar SARS, an nuna cewa zazzabin cizon sauro (99%-100%), tari mai bushe (29%-75%), wahalar numfashi (40%-42%), kumburi (20-25%), da kumburi a cikin wuyansa (13-25%) sune manyan alamun cutar kuma ana buƙatar kayan aikin numfashi a cikin kusan 14%-20%.
A ranar 14 ga watan Fabrairu, adadin sabbin mutanen da suka mutu daga COVID-19 ya kai kashi 2 cikin dari yayin da aka tabbatar da cewa akwai mutane 66,576 a duniya.
A kwatankwacin haka, mutuwar SARS a watan Nuwamba 2002 sun kai kashi 10 cikin 100 na mutane 8,096 da aka tabbatar da cutar.
A watan Yuni na shekara ta 2012, an yi bincike a kan cutar MERS kuma an gano cewa kashi 37 cikin 100 na mutane 2,494 ne suka mutu.
Binciken da aka yi a baya ya nuna cewa R0 na SARS-CoV-2 ya yi sama da 6.47 yayin da ƙimar amincewa (CI) ya kai kashi 95% na 5.71-7.23, yayin da R0 na SARS-CoV ya kasance tsakanin 2 zuwa 4 kawai.
An nuna kwatancen SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da alamomin, alamomin, da kuma R0 a cikin Table 1.1.
Wadannan ƙididdigar sun nuna cewa SARS-CoV-2 yana da damar yaɗuwa fiye da MERS-CoV da SARS-CoV, amma ba shi da haɗari kamar sauran biyun.
Saboda haka, yana da wuya a daidaita cutar SARS-CoV-2 fiye da na MERS-CoV da SARS-CoV.
Mutane da yawa suna zama a gida ɗaya ko kuma a cikin mota ɗaya.
Wadanda suka kamu da cutar sun yi tafiya ko sun zauna a Wuhan ko wasu wuraren da cutar ta bulla ko kuma sun kasance tare da mutanen da ke dauke da cutar ko kuma wadanda suka kamu da cutar makonni biyu kafin kamuwa da cutar.
A maimakon haka, an lura cewa mutane na iya kamuwa da cutar ba tare da nuna alamun cutar ba har tsawon makonni biyu kuma masu warkewa da aka sallama daga asibiti na iya sake kamuwa da cutar, wanda ke nuna bukatar tsawaita lokacin keɓewa.
Marasa lafiya suna da ƙarancin ƙwayoyin jini a cikin jini (salla a cikin jini) (musamman lymphocytes) a farkon lokaci.
Misali, an gano cutar lymphopenia tare da ƙididdigar ƙwayoyin jini &lt; 4×109/L ciki har da ƙididdigar ƙwayoyin lymphocyte &lt; 1×109/L, da aspartate aminotransferase da kuma viremia a cikin marasa lafiya 1,099 na COVID-19.
An gano adadin sinadarin hanta da myoglobin a cikin jinin wasu marasa lafiya, kuma an gano cewa C-reactive protein da kuma erythrocyte sedimentation sun tashi a cikin jinin yawancin marasa lafiya.
A cikin marasa lafiya masu tsanani, yawan D-dimer, wanda shine samfurin lalacewar fibrin a cikin jini, ya ƙaru, kuma yawan lymphocyte ya ragu.
Akwai wasu matsaloli a cikin kirji a cikin yawancin marasa lafiya na COVID-19 kuma wannan yana tare da matsalolin huhu (duhu biyu na filashi ko gilashin gilashi).
Marasa lafiya sukan sha wahala daga ciwon huhu, ciwon huhu, da kuma matsalar numfashi mai tsanani (ARDS).
Lokacin da ARDS ya faru, akwai yawan ruwa da kuma ruwa, kuma nama yana rufe raunuka wanda ke haifar da matsala a cikin iska.
Kwayoyin huhu na nau'i na I da na II (nau'in-I da nau'in-II pneumocytes) suna rage yawan surfactant kuma suna ƙara matsin lamba, wanda ke rage ikon huhu don fadada kuma yana ƙara yiwuwar gazawar huhu.
Saboda haka, sakamakon gwajin da ya fi muni a cikin ƙwayar cuta sau da yawa yana da alaƙa da yanayin da ya fi muni.
A ranar 18 ga Fabrairu, 2020, gwajin farko na COVID-19 ya nuna ƙaruwa na ƙwayar huhu, samar da ƙwayoyin hyaline, ƙwayoyin cuta, da ƙwayoyin syncytial multinucleated a cikin huhu na mai cutar da ya mutu, wanda yayi kama da gwajin marasa lafiya tare da ARDS kuma yayi kama da na SARS da MERS.
An yi amfani da gano SARS-CoV-2 RNA ta hanyar reverse-transcriptase polymerase chain reaction (RT-PCR) a matsayin babban hanyar gano COVID-19.
A maimakon haka, saboda yawan mutanen da suka kamu da cutar da suka kamu da cutar, wanda zai iya kawo cikas ga matsalar, an fara amfani da alamun lafiyar a cikin gwaji (ba bisa ga RT-PCR kawai) a China a ranar 13 ga Fabrairu, 2020.
Haka kuma yanayin gwajin SARS.
Saboda haka, tattara bayanan cutar, alamun cutar, gwajin asibiti, da kuma daukar hoto yana da mahimmanci kuma dole ne a yi shi don gano cutar.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana yadda ake amfani da fasahar CRISPR-based SHERLOCK don gano SARS-CoV-2, wanda ke gano SARS-CoV-2 RNA a 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (kwafi 10-100 a kowace microliter ana gwadawa) ta amfani da dipstick a cikin ƙasa da minti talatin ba tare da buƙatar ƙarin gwaji ba.
Ana sa ran cewa wannan sabon tsarin zai taimaka wajen yin bincike idan aka yi amfani da shi a gwaje-gwaje na ƙarshe.
Saboda rashin ilimin kwayar cutar CoV da ba a sani ba, likitoci na iya kula da kula da marasa lafiya na COVID-19, yayin da suke gwada magungunan da aka yi amfani da su ko kuma aka tsara su a baya don magance wasu ƙwayoyin cuta na CoV kamar SARS-CoV da MERS-CoV da sauran cututtukan ƙwayoyin cuta (Taswira (Taswira2).2).
Ana amfani da maganin zamani na maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuk
An kuma yi amfani da ruwan jini daga mutanen da suka warke a matsayin magani.
Kamfanonin samar da magunguna suna aiki tukuru don samar da kwayoyin cutar da magungunan rigakafin cutar.
SARS-CoV-2 ya fara kaiwa ga huhu kuma yana iya kaiwa ga sauran kwayoyin da ke dauke da ACE2, ciki har da tsarin gastrointestinal da kuma ƙwayoyin cuta.
Duk da haka, matsalar numfashi ita ce matsalar da ta fi kowacce ciwo da kuma sanadin mutuwa.
Saboda haka, na'urorin numfashi suna da mahimmanci wajen magance matsalolin numfashi da ceton rai wanda ya hada da maganin iskar oxygen na gaba daya, iskar oxygen mai saurin gudu, iska mai gujewa, da kuma iska mai gujewa ta hanyar inji dangane da yanayin cutar.
Ya kamata a yi amfani da maganin oxygenation na membrane na waje (ECMO) ga marasa lafiya da ke fama da matsalar numfashi, wanda shine maganin da ake amfani da shi wajen magance rashin numfashi wanda zai iya haifar da mutuwa.
Bugu da ƙari, kiyaye matakan lantarki, hanawa da kuma kula da wasu ƙwayoyin cuta da ke iya kaiwa ga mai cutar da kuma yaduwar jiki, da kuma kiyaye gabobin jiki da kuma ci gaba da hulɗa suna da mahimmanci a cikin marasa lafiya na SARS-CoV-2.
An gano cewa, cutar cytokine tana haifar da yawan halayen jikin mutum a cikin marasa lafiya da ke dauke da cutar SARS da MERS.
Cytokine storm shine amsawar jiki wanda ya ƙunshi samar da cytokines daban-daban ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Cytokines suna sa tsarin rigakafi ya samar da kwayoyin da ke haifar da ARDS da kuma rashin aiki na jiki.
Rage ƙwayar cuta yana da muhimmanci wajen magance guguwar cytokine, musamman ma a marasa lafiya masu tsanani.
An yi amfani da maganin corticosteroids da tocilizumab, wanda shine maganin anti-IL6 monoclonal antibody, don magance cutar cytokine.
Sauran maganin cytokine storm wanda ke rage yawan kwayar cuta sun hada da inganta T cell-directed immune response; hana IFN-γ, IL-1, da TNF; JAK inhibition; blinatumomab; suppressor of cytokine signaling 4; da kuma masu hana HDAC.
Ana amfani da maganin steroid, wanda ake amfani da shi wajen rage yawan kumburi, a maganin SARS don rage lalacewar tsokoki.
Amma, shan steroids a manyan allurai bai taimaka wajen rage cutar da ke saurin kamuwa da cutar SARS da COVID-19 ba.
Ƙari ga haka, za su iya jawo sakamako masu tsanani, musamman ma osteonecrosis na jijiyoyin jini, wanda zai iya shafan sakamakon da ake tsammani.
Duk da haka, an ba da shawarar yin amfani da maganin corticosteroids a cikin marasa lafiya na COVID-19 waɗanda suka kamu da cutar a ƙananan allurai.
A lokacin rubuta wannan labarin, babu wani magani da aka tabbatar da warkar da cutar.
Maimakon haka, an gano cewa maganin remdesivir da aka yi wa allurar, wanda yake kwatancen nucleotide, ya yi tasiri a kan wani mara lafiyar Amurkawa da ke dauke da COVID-19.
Remdesivir sabon magani ne da Gilead ta ƙera da aka yi amfani da shi a dā wajen magance cututtukan da ƙwayoyin cuta na Ebola da Marlburg suka jawo.
Daga baya, an gano cewa remdesivir yana da tasiri wajen magance wasu ƙwayoyin cuta masu dauke da kwayar RNA guda ɗaya, ciki har da MERS da SARS.
Bisa ga wannan, Gilead ta ba da maganin zuwa China don gwaji a kan mutanen da ke dauke da cutar SARS-CoV-2, kuma ana jiran sakamakon da aka samu.
An kuma gabatar da baricitinb, interferon-α, lopinavir/ritonavir, da ribavirin a matsayin magunguna masu amfani da su wajen magance marasa lafiya da ke fama da matsalar numfashi.
Ciki, kumburi, amai, ciwon hanta, da sauran matsaloli masu tsanani na iya faruwa idan aka hada lopinavir/ritonavir da wasu magunguna.
Ya kamata a lura da yadda wannan magani yake da alaƙa da sauran magunguna da ake amfani da su a kan marasa lafiya.
Plasma daga marasa lafiya da suka warke sun samar da rigakafi
Ana amfani da jini daga waɗanda suka warke don a yi wa marasa lafiya da ke da cututtuka da yawa magani ko kuma a ceci rayukan mutane daga kamuwa da cututtuka.
Hakika, mutane da suka warke daga cuta sau da yawa suna da ƙwayoyin cuta da yawa a cikin jininsu da suke kāre su daga cutar.
Kwayoyin rigakafi sune kwayoyin da B lymphocytes ke samarwa don yaki da kwayoyin cuta da sauran kwayoyin da ba su da kyau a cikin jiki kuma suna hana kwayoyin halitta daban-daban daga kwayoyin cuta kuma suna lalata su kai tsaye.
Bisa ga wannan, an cire sinadarin jini daga jinin wani rukuni na marasa lafiya da suka warke daga COVID-19 kuma an gwada su a cikin marasa lafiya 10 da suka fi muni.
Yanayinsu ya inganta cikin awanni 24, kuma tsufa ya ragu, yawan kamuwa da cuta ya ragu, kuma yawan iska a cikin jini ya ragu.
Maimakon haka, dole ne a sami tabbaci da haske don aiwatar da duk wani tsari da za a yi amfani da shi ga mutane da yawa kafin a ci gaba da wannan tsari.
Bugu da ƙari, saboda sakamakon maganin, dole ne a fara bincika abubuwan da ke da nasaba da jini.
Alal misali, ƙwayoyin cuta na iya sa ƙwayoyin cuta su yi yawa sosai kuma su sa a samu ciwon cytokine, wanda ke haifar da guba mai tsanani.
Kwayoyin rigakafi da ke cikin jini ba su da yawa, kuma ana bukatar ruwan jini sosai don a kula da marasa lafiya masu tsanani.
Yana da wahala a samar da maganin rigakafi da sauri don magance matsalar cutar a duniya.
Saboda haka, za mu iya ware ƙwayoyin B daga mutanen da suka warke kuma mu gano ainihin ƙwayoyin da ke da ƙwayoyin cuta ko kuma mu gwada su don gano ainihin ƙwayoyin cuta da ke da ƙwayoyin cuta.
Ta wannan hanyar, za mu iya ƙara yawan ƙwayoyin da ke hana ƙwayoyin cuta.
An yi amfani da TCM wajen magance cututtuka da dama a kasar Sin na dubban shekaru.
Maimakon haka, ingancinsa ya dogara ne da haɗuwa da abubuwa daban-daban a cikin magani wanda ke canzawa bisa ga abin da aka gano game da cutar bisa ga ka'idar TCM.
Yawancin abubuwan da ke cikinsa ba a san su ba ko kuma ba a fahimci su sosai ba domin yana da wuya a bincika su kuma a tabbatar da su ko kuma wanda ke yin su.
A halin yanzu, saboda babu wani magani da aka sani don maganin COVID-19, TCM yana ɗaya daga cikin magungunan da aka fi amfani da su don kula da marasa lafiya masu saurin bayyanar cututtuka ko waɗanda suka warke daga matakan da suka dace.
Misali, an gano cewa Shu Feng Jie Du da Lian Hua Qing Wen sun yi tasiri sosai wajen maganin COVID-19.
Yawancin masu cutar sun warke daga COVID-19 a larduna da dama na kasar Sin tare da maganin TCM a kashi 87% na yankunan da suka kamu da cutar, ciki har da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da a lardin Hubei, wanda ya yi amfani da TCM a kusan kashi 30% na masu cutar COVID-19, wanda ya sami mafi ƙarancin dawowa (13%).
Amma, wannan kwatancen ba daidai ba ne domin akwai wasu dalilai da yawa kamar yawan marasa lafiya da kuma yanayin da ya kamata a yi la'akari da su.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun buga sakamakon binciken da ya kwatanta maganin gargajiya na yammaci kawai da maganin gargajiya da TCM.
Sun gano cewa lokacin da ake bukata don dawo da zafin jiki, bayyanar cututtuka, da kuma kwanciya a cikin ƙungiyar maganin cutar kansa + TCM sun fi gajeren lokacin da aka yi a cikin ƙungiyar maganin kansa kawai.
Abin sha'awa, yawan cututtukan cututtuka (daga ƙanƙanta zuwa mai tsanani) sun kasance ƙasa da ƙasa a cikin rukunin maganin +TCM fiye da rukunin maganin kawai (7.4% vs 46.2%) kuma mutuwar ta kasance ƙasa da ƙasa a cikin rukunin maganin +TCM fiye da rukunin maganin kawai (8.8% vs 39%).
Duk da haka, ana bukatar a gwada inganci da kuma ingancin TCM a kan marasa lafiya da kuma wurare masu yawa.
Zai kuma kasance da kyau a yi bayani game da yadda ake yin maganin TCM ko kuma a yi bayani game da yadda ake yinsa idan ya yiwu.
Masu cutar da ake zargi ko kuma waɗanda aka tabbatar da cewa suna da COVID-19 suna da matukar damuwa game da wannan cutar mai haɗari, kuma waɗanda ke keɓewa suna jin kadaici, ɓacin rai, da fushi.
Bugu da ƙari, alamun rashin lafiya kamar zazzabin cizon sauro, rashin isasshen isasshen iska, da kuma rashin jin daɗi da kuma matsalolin rashin barci da ke tattare da maganin corticosteroids na iya ƙara damuwa da ciwon kai.
A farkon lokacin da cutar ta SARS ta bulla, akwai cututtukan da suka shafi ciwon kai da dama da suka hada da rashin damuwa, damuwa, fargabar tsoro, tashin hankali, tunanin banza, rashin kulawa, da kuma kashe kansa.
Binciken da ke tattare da cutar da ke tattare da cutar da ke tattare da cutar, wanda wani ɓangare ne na aikin COVID-19, na iya ƙara yawan damuwa da alhakin sakamakon cutar, keɓewa, da kuma nuna bambanci daga dangi da abokai.
Saboda haka, ya kamata a ba da kulawa ta musamman ga waɗanda ake zargi da cutar COVID-19, da waɗanda ke tare da su, da kuma waɗanda suke tare da su, da kuma duk waɗanda suke buƙatar kulawa.
Taimako na tunani ya kamata ya hada da kafa kungiyoyin likitoci a fannoni daban daban, sanar da jama'a a kan lokaci da kuma yadda ya kamata game da SARS-CoV-2 da kuma hanyoyin da za a bi da su da kuma amfani da na'urorin da ke hana kusanci.
Magungunan rigakafi suna da tasiri wajen hana yaduwar cutar daga dabbobi masu rai da mutane zuwa ga masu iya kaiwa, kuma suna aiki tare da maganin rigakafi wajen magance cututtukan da ke haifar da cutar.
An yi ƙoƙari don samar da allurar rigakafin S protein don samar da ƙwayoyin cuta masu ƙarfi da ƙarfi waɗanda ke kashewa da / ko kuma ƙwayoyin cuta a kan SARS-CoV.
An gwada maganin rigakafin cutar SARS a cikin dabbobi.
Amma, ana bukatar tabbatar da ingancin allurar a cikin tsofaffi da kuma a cikin ƙirar ƙalubale na kisa da kuma ingancinta a cikin ƙwayoyin cuta a cikin dabbobi kafin a gudanar da gwajin asibiti.
Wannan ya faru ne saboda cutar SARS ta mutu shekaru 17 da suka gabata kuma babu wanda ya sake samun cutar tun daga lokacin.
Akasin haka, akwai mutane da ke kamuwa da cutar MERS a Gabas ta Tsakiya kuma tana yaduwa zuwa wasu yankuna ta hanyar dabbobi masu zaman kansu da ke zaune a waɗannan yankuna.
An yi allurar rigakafin MERS ta amfani da kwayar cutar da ta lalace, DNA plasmids, masu ɗaukar kwayar cutar, nanoparticles, ƙwayoyin cuta masu kama da kwayar cuta da kuma ƙwayoyin sunadarai masu haɗuwa kuma an gwada su a cikin dabbobi.
Ana buƙatar ci gaba da allurar rigakafin SARS-CoV-2 a cikin ƙananan ƙwayoyin cuta da gaggawa don magance matsalar.
Maimakon haka, yana da ƙalubale a shawo kan wannan matsalar saboda tsawon lokacin da ake buƙata (kimanin watanni 18) don haɓaka da canza CoVs.
Saboda sabon kamuwa da cuta, an fara nuna halin COVID-19 a cikin dubban marasa lafiya.
A yawancin lokaci, marasa lafiya suna warkewa a hankali ba tare da sun nuna alamun cutar ba.
A maimakon haka, kamar yadda yake tare da SARS da MERS, masu cutar COVID-19 suna da saurin kamuwa da rashin lafiya da mutuwa.
Saboda haka, sanin matsalolin da za su iya tasowa yana da muhimmanci ga ma'aikatan kiwon lafiya su tsara hidimarsu, musamman ma a yankunan da ba a yawan zuwa.
Dangane da binciken da aka yi, wadannan abubuwan na iya zama masu alaƙa da matsalolin da ke tattare da cutar COVID-19 (Sashe na 33):
Matsayi: Matsayi shine babban mahimmin abu a cikin kimanta haɗarin cutar SARS, kuma wannan gaskiya ne ga COVID-19.
COVID-19 ya fi shafar mutanen da ke tsakanin shekaru 30-65 da kashi 47.7% na waɗanda suka kamu da cutar sun wuce shekaru 50 a cikin binciken mutane 8,866 kamar yadda aka ambata a sama.
Marasa lafiya da ke buƙatar kulawa mai tsanani sun fi waɗanda ke da cututtukan da suka riga sun kamu da su girma (kimanin shekaru 66 da 51), wanda ke nuna cewa shekaru suna da mahimmanci wajen kimanta haɗarin da ke tattare da COVID-19.
Nau'in: SARS-CoV-2 ya shafi maza fiye da mata (0.31/100,000 vs. 0.27/100,000), kamar yadda aka ambata a sama.
Cutar zuciya da kuma cututtuka: Marasa lafiya da ke da cutar COVID-19 da ke bukatar kulawa mai tsanani suna da damar kamuwa da raunin zuciya da kuma arrhythmia.
Cutar zuciya ita ce babbar hanyar mutuwar marasa lafiya da cutar SARS.
An gano cewa SARS-CoV-2 na iya yin rigakafi ga kwayoyin ACE2-positive cholangiocytes, wanda zai iya haifar da rashin aikin hanta a cikin marasa lafiya na COVID-19.
Yana da muhimmanci a fahimci cewa tsufa da ciwo suna da nasaba sosai kuma suna iya shafan juna.
Sakamakon gwaji na yau da kullun: Matsakaicin C-reactive protein (CRP) a cikin jini yana nuna damuwa na gina jiki ko lalacewar nama kuma an nuna shi azaman haɗarin da zai iya faruwa ga marasa lafiya, wanda ke faruwa yayin maganin, da kuma warkarwa.
An kuma yi magana game da alaƙar da ke tsakanin CRP da tashin hankali da kuma yiwuwar cutar COVID-19.
Ƙarin lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da kuma creatine kinase (CK) ma za su iya taimakawa wajen kimanta sakamakon.
Ana samun waɗannan sinadarai a wurare dabam dabam, musamman a zuciya da hanta, kuma ana fitar da su sa'ad da wani abu ya shafa.
Saboda haka, sau da yawa suna nuna ciwo na zuciya ko kuma hanta.
Alamomin asibiti na farko: Ana iya yin hotunan kirji da kuma lura da alamun cutar a lokaci mai tsawo tare da wasu dalilai don kimanta cutar COVID-19.
Amfani da steroids: Kamar yadda aka bayyana a sama, steroids suna da alaka da ƙwayoyin cuta kuma ana amfani da su sosai don taimakawa wajen magance cututtukan da ke haifar da cututtuka na jiki.
Saboda yawan maganin corticosteroids da aka yi amfani da su a cikin marasa lafiya masu cutar SARS, yawancin marasa lafiya da suka warke sun kamu da cutar osteonecrosis na jijiyoyin jiki kuma sun kasance marasa lafiya na dogon lokaci da kuma rashin ingancin rayuwa.
Saboda haka, idan ya zama dole, ya kamata a yi amfani da steroids a ƙananan allurai kuma na ɗan gajeren lokaci a cikin marasa lafiya na COVID-19.
Rashin lafiyar kwakwalwa: Kamar yadda aka bayyana a sama, a lokacin barkewar COVID-19 marasa lafiya da yawa sun sami mummunan rauni na kwakwalwa saboda yawan lokaci a keɓewa da rashin sanin abin da zai faru da kuma ganin danginsu da abokan aikin su sun mutu.
Wadannan marasa lafiya suna bukatar ta'aziyya da tallafi na ɗan lokaci don taimaka musu su shawo kan wannan damuwa kuma su koma rayuwarsu ta yau da kullun.
Bisa ga binciken da aka yi a kan mutane, COVID-19 yana da alamun bayyanar cututtuka daban-daban da SARS.
Baya ga yaduwar cutar a ƙananan ƙwayoyin cuta, SARS-CoV-2 na iya yaduwa cikin ƙwayoyin cuta a ƙananan ƙwayoyin cuta tare da ƙananan ko kuma rashin alamun bayyanar cututtuka a farkon lokacin kamuwa da cuta, kamar yadda yake tare da sauran ƙwayoyin cuta na cutar cuta.
Saboda haka, marasa lafiya a farkon ko kuma kafin cutar ta bulla na iya fitar da adadin ƙwayoyin cuta da yawa a cikin ayyukansu na yau da kullun, yana ƙuntata aikin yaki da cutar.
A maimakon haka, ana tunanin cewa SARS-CoV ya yadu ne a lokacin da ake samun ƙarancin kamuwa da cutar, kuma ba a yadu sosai a farkon lokacin.
Saboda haka, cutar COVID-19 ta yanzu ta fi ƙarfin SARS.
Ana ci gaba da wani gagarumin yunkuri a kasar Sin, wanda ya hada da kulle Wuhan da garuruwan da ke kewaye da shi da kuma sanya mutane a keɓe domin hana yaduwar cutar SARS-CoV-2.
Duk da cewa wadannan ayyukan sun yi tasiri sosai a kan tattalin arziki da sauran bangarorin kasar, yawan sabbin masu kamuwa da cutar na raguwa, wanda ke nuna cewa matsalar tana raguwa.
A ƙarshe, an yi hasashen cewa za a daina wannan matsalar a ranar Laraba kuma za a rage yawan cutar cikin watanni uku zuwa huɗu.
Amma, wasu masana ba su da irin wannan begen.
Paul Hunter, da abokan aikinsa sun yi hasashen cewa COVID-19, wanda ya fi SARS fama da cutar, ba zai kare ba har zuwa shekarar 2020.
Ira Longini, da abokan aikinsa, sun gano hanyar da za su iya hango sakamakon cutar kuma sun yi hasashen cewa SARS-CoV-2 na iya shafar kashi biyu bisa uku na yawan mutanen duniya.
Wata ƙungiyar Kanada ta gano cewa an gano SARS-CoV-2 a cikin marasa lafiya da suka warke kuma aka sallame su daga asibiti makonni 2 da suka gabata, wanda ke nuna cewa sabon kwayar cutar na iya dawowa a matsayin annoba.
Maimakon haka, an ga alamun fatan alheri a China dangane da raguwar sabbin masu kamuwa da cutar, wanda ke nuna cewa hanyoyin da ake bi na iya yin tasiri.
A dā, an ce cutar Ebola za ta iya kashe mutane miliyan ɗaya ko kuma dubu hamsin.
Maimakon haka, saboda bin ƙa'idodin keɓewa da keɓewa, an sami nasarar magance cutar.
Zai yiwu, kamar yadda ya faru da SARS-CoV, cewa cutar SARS-CoV-2 za ta iya raunana a cikin yanayin kamuwa da cutar sannan kuma ta ƙare ko kuma ta raunana ta zama mai dacewa da mutane.
Kwatantawar cutar COVID-19 da SARS da MERS an nuna a ƙasa (Hoto (Hoto 55).
SARS-CoV-2 ya fi yaduwa ta hanyar hanci ko hanci, kuma mai yiwuwa ta hanyar taɓawa da abubuwa masu cutar.
An kuma gano kwayar cutar a cikin naman alade, wanda ke nuna cewa yana yiwuwa a kamu da ita ta hanyar cin abinci.
Wani binciken da aka yi kwanan nan a kan marasa lafiya 138 ya nuna cewa kashi 41% na waɗanda ke da kwayar cutar sun fita daga asibiti, ciki har da marasa lafiya 17 da suka kamu da cutar da kuma likitoci 40.
Saboda haka, ya kamata a yi amfani da matakan kariya, musamman ma likitoci, masu kula da marasa lafiya, masu gida, ma'aikata, da kuma mutanen da ke tsaye kusa da marasa lafiya ko kuma mutanen da ke da cutar.
Hanyar farko da za a iya amfani da ita don rage haɗarin kamuwa da kwayar cuta ita ce sanya abin rufe fuska; yin amfani da kayan rufe fuska na N95 (jerin # 1860s) duka suna taimakawa rage yaduwar kwayar.
Maganin tsabtace jiki yana hana abubuwa kamar su fata na mutum da za su iya zama a cikin iska ko kuma a kan wasu abubuwa, inda za su iya kaiwa ga wasu mutane.
A maimakon haka, N95 (jerin # 1860s) shine kawai zai iya hana kwayar cutar 10 a 80 nm, wanda kashi 5% na kwayoyin cutar zasu iya wucewa; SARS-CoV-2 yayi kama da SARS-CoV a girma kuma tsawonsa 85 nm.
Saboda kwayar cutar na iya shiga cikin abin rufe fuska na tiyata, dole ne likitoci su sanya N95 (jerin # 1860s) maimakon abin rufe fuska na tiyata.
Bugu da ƙari ga abin rufe fuska, likitoci suna buƙatar saka takunkumi don rage haɗuwa da ƙwayoyin cuta.
Ƙwayoyin cuta suna iya kamuwa da mutum ta wurin wucewa.
A ranar 22 ga Janairu, 2020, likitan ya kamu da cutar SARS-CoV-2 duk da cewa yana sanye da kwayar cutar N95; cutar ta iya shiga jikinsa ta hanyar wucewa ta hanyar idanunsa.
Saboda haka, ya kamata likitoci su saka abin rufe fuska ko kuma tabarau sa'ad da suke kula da marasa lafiya.
Ga talakawa a yankunan da ke da cutar ko kuma wanda ke da yiwuwar kamuwa da ita, ya kamata kowa ya yi amfani da sabulu da wanke hannu fiye da yadda ya saba, ya yi ƙoƙarin kasancewa a cikin gida yayin da yake keɓe kansa kuma ya rage haɗuwa da mutanen da ke da yiwuwar kamuwa da cutar.
Ana ɗaukan tsawonsa na ƙafa uku a matsayin lokacin da ya dace don a yi kamar mutum yana da ciwo.
Wadannan ayyuka suna da tasiri wajen rage yiwuwar kamuwa da cutar da kuma yaduwar ta.
Ko da yake SARS-CoV-2 ya zo ne a matsayin sabon kwayar cutar ɗan adam, kamannin SARS-CoV da aka gano a ranar 7 ga Janairu, 2020 zai ba da darasi mai mahimmanci ga China dangane da abin da aka tuna game da barkewar cutar SARS a 2003.
A maimakon haka, har zuwa 19 ga Janairu, 2020, shugaban Cibiyar Kula da Cututtuka ta Wuhan ya ci gaba da tabbatar wa jama'a cewa ba a yadu da sabon kwayar cutar ba kuma ba a yadu da ita daga mutum zuwa mutum ba kuma cutar ba ta da wuyar rigakafi da yaki.
Wannan sakon ya yi matukar sanyaya muryar jama'a, musamman yayin da kasar ke shirin bikin bazara, kuma lokacin da ya dace don yaki da cutar ya yi nisa a Wuhan.
Ma'aikatun kula da cututtuka a kasar Sin na iya amfani da wannan darasi don yin gyare-gyare na gaba.
Misali, waɗannan hukumomin ya kamata (1) su kasance masu hankali sosai game da ma'anar jama'a saboda kowane kalma tana da ma'ana ga 'yan ƙasa kuma tana iya canza ra'ayinsu da yanke shawara; (2) su ƙara kulawa da amsawa ga saƙonnin da ba a saba gani ba daga asibitoci maimakon jiran rahotanni na hukuma daga likitoci ko jami'ai; (3) ƙara ƙarfin don magance cututtukan da ke iya zama masu haɗari da zarar sun bayyana maimakon ƙoƙarin kwantar da hankalin jama'a; da (4) ci gaba da aiki a kai a kai ta hanyar ƙara wayar da kan jama'a game da cututtukan da ke faruwa da kuma gwajin mutane tare da inganta yadda al'ummomin ke magance al'amuran a kowane lokaci.
Cutar COVID-19 da sabon kwayar cutar SARS-CoV-2 ta haifar ta fara ne a ƙarshen Disamba 2019.
A cikin kasa da watanni biyu, ya yaɗu ko'ina cikin ƙasar Sin da kuma ƙasashe 50 a duniya a lokacin da nake rubuta wannan.
Saboda irin kwayar cutar SARS-CoV da alamun cutar COVID-19 da SARS, cutar COVID-19 ta sa mutane su yi tunanin cewa SARS ta dawo.
Maimakon haka, waɗannan su ne manyan bambance-bambance tsakanin COVID-19 da SARS, waɗanda ke da mahimmanci wajen magance cutar da kuma kula da marasa lafiya.
COVID-19 ya fi rinjayar tsofaffi fiye da matasa da maza fiye da mata, kuma yawan tashin hankali da mutuwa ya fi girma a cikin tsofaffi fiye da matasa.
SARS ya fi COVID-19 kisa (10.91% idan aka kwatanta da 1.44%).
Masu cutar COVID-19 suna kamuwa da cutar ko da ba su da alamun cutar, yayin da masu cutar SARS ke kamuwa da cutar idan suka kamu da cutar, wanda hakan ya sa ya fi wahalar magance yaduwar cutar COVID-19 fiye da yadda SARS ke yi.
Wannan shine daya daga cikin dalilan da yasa SARS-CoV-2 ke yaduwa da sauri kuma ya kai nesa fiye da SARS-CoV.
Gwajin SARS-CoV-2 da RNA na iya nuna cewa ba shi da cutar a wasu marasa lafiya na COVID-19.
Ƙari ga haka, waɗanda suka warke za su iya sake kamuwa da cutar.
Wannan binciken ya kara wa cutar damar yaduwa.
Duk da cewa an yi bincike kan COVID-19 da wuri, har yanzu akwai wasu muhimman batutuwa da ba a bayyana ba, kamar su:
Daga ina SARS-CoV-2 ya fito?
Duk da cewa akwai kamanceceniya na kashi 96% tsakanin kwayar cutar SARS-CoV-2 da kwayar cutar Cov-CoV guda biyu, ba za mu iya tabbatar da cewa SARS-CoV-2 ta fito ne daga kwayar cutar ba.
Wane dabba ne ya ɗauki kwayar cutar daga dabba ta asali, wataƙila ƙuda, kuma ya kawo ta cikin mutane?
Idan ba mu san amsoshin 1 da 2 ba, ba za mu iya hana yaduwar cutar ba, kuma za ta sake tasowa a kowane lokaci.
Ko da yake tsarin samfurin kwayoyin halitta da kuma nazarin kwayoyin sun nuna cewa SARS-CoV-2 yana da alaƙa da ACE2, ta yaya kwayar cutar ta shiga cikin ƙwayoyin iska don haifar da cutar?
Shin cutar ta shafi rashin lafiyar ACE2 a wasu sassan jiki?
Idan ba mu sami amsoshi masu gamsarwa ga waɗannan tambayoyin ba, ba za mu iya gano magani da sauri ba.
Har yaushe za a ci gaba da wannan cuta?
Ta yaya kwayoyin halitta suke canja yayin da suke yaɗuwa?
Shin zai zama bala'i ne na duniya, zai ƙare kamar SARS ko kuma zai sake dawowa a matsayin annoba?
Yana da muhimmanci mu bincika amsoshin waɗannan tambayoyin da kuma wasu.
Maimakon haka, babu wani abu da za mu iya yi sai dai mu kawar da cutar nan da nan kuma mu koma rayuwarmu ta yau da kullum.
Kwayar cutar corona daga dabbobi
Canjin halittar kwayoyin halitta ya haifar da kwayar cutar corona (CoVs) da kuma bambancin da ke tsakanin dabbobi, ciki har da mutane, tsawon dubban shekaru.
Kafin 2003, an san nau'ikan CoVs na mutum (HCoVs) guda biyu suna haifar da cututtukan cututtuka, har zuwa mura.
Barkewar cututtukan cututtukan numfashi na gaggawa (SARS) da cututtukan numfashi na Gabas ta Tsakiya (MERS) sun canza yanayin kuma sun nuna yadda cutar HCoV za ta iya zama mai haɗari da kisa.
Barkewar cutar SARS-CoV-2 a tsakiyar kasar Sin a karshen shekarar 2019 ya sake dawo da kwayar cutar CoVs a cikin gidajen wanka kuma ya ba mu mamaki yadda ake kamuwa da cutar cikin sauri da kuma jinkirin kamuwa da cutar idan aka kwatanta da cutar SARS-CoV.
HCoVs sun samo asali ne daga dabbobi kuma fahimtar asalin HCoVs na dabbobi yana da matukar taimako.
Yawancin kwayar cutar HCoVs sun samo asali ne daga ƙwayoyin cuta na ƙwayoyin cuta, wanda ba shi da cutar.
An kuma gano wasu nau'o'in dabbobi da ke da HCoVs da suka fara tsinkayewa kafin su kai ga mutane.
Gano dabbobi masu cutarwa yana da matukar muhimmanci wajen yaki da cututtukan da ke cutar da mutane.
Binciken yadda dabbobi masu dauke da CoV ke hulɗa da juna na iya taimakawa wajen tantance hadarin CoV ga mutane.
A cikin wannan bita, mun taƙaita sabon binciken da aka yi game da kwayar cutar HCoVs guda bakwai, tare da mai da hankali kan tarihin ganowa da kuma asalinsa a cikin dabbobi da kuma yaduwar cutar tsakanin dabbobi daban-daban.
A cikin wannan, muna nuna kamance da bambance-bambance tsakanin nau'ikan HCoVs ta hanyar nazarin juyin halitta na kwayar cuta da kuma sake haɗuwa da kwayoyin halitta.
An yi magana a kan cutar CoV mai cutarwa ta 2019 (COVID-19) a cikin wannan labarin.
An kuma tattauna yadda dabbobi masu kamuwa da cutar ke canzawa da kuma yadda cutar ke nuna cewa cutar ta na da tsanani.
Kwayar cutar corona (CoVs) tana cikin kwayar cutar Coronaviridae, wanda ya ƙunshi nau'ikan ƙwayoyin cuta masu ƙyalli, kowane positive-sensed, kuma yana da RNA guda ɗaya.
An sanya sunayen kwayar cutar CoVs saboda irin nau'in da take kama da kambi da aka gano a cikin yisti.
A cikin masana'antu, CoVs suna da kwayoyin halitta da ba a cire su ba kuma suna tare.
Kusan kashi biyu bisa uku na kwayoyin halitta suna ɗauke da manyan abubuwa biyu masu kama da juna (ORF1a da ORF1b), waɗanda suke haifar da pp1a da pp1ab.
Bayan haka, sai aka yi amfani da sunadarai masu yawa don a yi wasu sunadarai 16 da ake kira nsp1~16.
Sauran bangaren kwayoyin halitta suna dauke da ORFs a kan sunadarai masu tsari, wadanda suka hada da spike (S), envelope (E), membrane (M) da nucleoprotein (N).
Yawancin sunadarai masu amfani da layin halitta (lineage-specific accessory proteins) suna cikin jerin nau'ikan CoVs.
Bisa ga bambancin tsarin sunadarai, an rarraba CoVs zuwa manyan nau'ikan guda hudu (alpha-CoV, beta-CoV, gamma-CoV da delta-CoV), wanda a cikinsu beta-CoV ne ke da mafi yawan kwayar cutar HCoVs kuma an rarraba shi zuwa layi huɗu (A, B, C da D).
Sakamakon binciken ya nuna cewa namomin kaza da namomin kaza sune tushen alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune tushen gamma-CoVs da delta-CoVs.
Shekaru dubbai, CoVs sun kasance suna rarrabuwa daga dabbobi kuma wasu sun zama tushen cututtukan ɗan adam.
Ya zuwa yanzu, an gano kwayar cutar CoVs guda bakwai na mutum (HCoVs).
Daga cikin wadannan, HCoV-229E da HCoV-NL63 na cikin jerin alpha-CoVs.
Wasu beta-CoVs guda biyar sun hada da HCoV-OC43, HCoV-HKU1, cutar coronavirus mai saurin numfashi (SARS-CoV), cutar coronavirus mai saurin numfashi ta Gabas ta Tsakiya (MERS-CoV) da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 suna haifar da cututtuka masu saurin kamuwa da cuta, kamar su mura da kuma/ko zazzaɓi.
Akasin haka, SARS-CoV, MERS-CoV da SARS-CoV-2 da aka gano suna da cututtuka masu yawa, suna shafar ƙananan ƙananan ƙwayoyin cuta a cikin yawancin marasa lafiya kuma akwai yiwuwar haɗarin cututtukan numfashi mai tsanani (ARDS) da kuma bayyanar waje na huhu (extrapulmonary manifestations).
An gano kwayar cutar HCoV-229E ta farko, B814, a cikin kwayar cutar da aka gano a cikin tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin bincike ta hanyar binciken da aka yi kan HCoV-229E da HCoV-OC43, dukansu suna haifar da alamun cutar da ke iyakance kanta.
A gaskiya ma, an yi imani da cewa kamuwa da kwayar HCoVs ba shi da haɗari har sai da barkewar cutar SARS.
SARS ya barke a 2003 kuma ya kasance daya daga cikin mafi munin cututtuka a tarihin kwanan nan, inda ya shafi mutane sama da 8,000 tare da kashi 10% na mutuwar da ake tsammani.
Shekara goma bayan haka, cutar MERS ta kai ga barkewar annobar a yankin Arabiya ta Tsakiya, kuma ta yaɗu zuwa sauran ƙasashe.
Sabuwar cutar HCoV (2019-nCoV) ta 2019, daga baya aka sake masa suna SARS-CoV-2, ita ce ke haifar da cutar coronavirus ta 2019 (COVID-19), wacce ta kashe mutane sama da 3,120 kuma ta kamu da mutane sama da 91,000 har zuwa 3 ga Maris, 2020.
An yi kararrawa kuma duniya na bukatar ta shirya don barkewar cutar SARS-CoV-2 a duniya.
Dukkanin kwayar cutar HCoVs bakwai sun samo asali ne daga naman gwari, tsutsotsi ko kuma dabbobi masu kiwo.
Yawancin hujjoji sun tabbatar da cewa dukkanin HCoVs sun fito ne daga ƙwayoyin cuta, wanda ke da ƙwayoyin cuta masu lafiya da marasa cutarwa amma suna da jerin kwayoyin halitta daban-daban.
Cutar COVID-19 ta haifar da kalubale masu yawa a fannin kiwon lafiya, kimiyya, zamantakewa da halayyar jama'a ga kasar Sin da kuma duniya baki daya.
Binciken asalin HCoVs a cikin dabbobi yana ba mu damar fahimtar tarihin, abubuwan da ke haifar da kuma hana kwayar cutar daga wasu dabbobi zuwa wasu.
Wannan kuma zai iya taimakawa wajen hanzarta aikin gano kwayar cutar SARS-CoV-2 daga kwayar halitta zuwa mutum, wanda hakan zai taimaka wajen hana sake barkewar cutar.
A cikin wannan binciken, mun gano asalin HCoVs a cikin dabbobi, yadda suka yadu a cikin dabbobi daban-daban da kuma cututtukan da ke haifar da su.
Musamman, muna nunawa da kuma tattauna batun cewa kwayar cutar HCoVs ba ta da haɗari a cikin dabba amma tana da haɗari idan ta shiga cikin dabba.
Mun kuma bincika yadda kwayar HCoV ke canzawa yayin da aka yi amfani da ita kuma yawanci yana rage haɗarin kamuwa da cuta.
Sakamakon barkewar cutar SARS-CoV-2 na yanzu an kuma tattauna shi a cikin wannan labarin.
An san CoVs na dabbobi tun daga ƙarshen shekarun 1930.
Kafin a gano kwayar cutar HCoV-229E mai suna B814 a cikin kwayoyin cutar da suka kamu da cutar, an gano CoVs da yawa a cikin dabbobi masu kamuwa da cutar, ciki har da namomin kaza, kwari, shanu, aladu, dabbobin gida da karnuka.
A cikin ƙarni da suka gabata, an gano nau'ikan HCoVs guda bakwai.
Taƙaitaccen tarihin gano HCoV a cikin tsarin halittar sa (Table 1) zai ba da darasi.
An gano kwayar HCoV-229E a cikin kwayar cutar marasa lafiya da ke fama da raunin ƙwayar cuta a shekarar 1966, kuma an gano cewa tana girma a cikin layin kwayar cutar huhu WI-38.
Marasa lafiya da ke dauke da HCoV-229E suna da alamun cutar da aka saba da su, ciki har da ciwon kai, tari, ciwon hanci da ciwon wuya, da zazzabin cizon sauro da kuma tari a kashi 10 zuwa 20 cikin dari na marasa lafiya.
Daga baya, a cikin 1967, an gano HCoV-OC43 a cikin al'adun gabobin jiki sannan kuma a cikin hanyar wucewa ta hanyar kwakwalwa.
Alamomin asibiti da HCoV-OC43 ke nunawa suna kama da na HCoV-229E, wanda ba ya bambanta da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuk
HCoV-229E da HCoV-OC43 suna yawo a duk duniya, kuma suna yawan tafiya a lokacin sanyi a yanayin yanayi mai sanyi.
A matsakaici, cutar tana ɗaukan fiye da mako guda kafin a nuna alamun cutar, sai kuma a yi kusan makonni biyu kafin a kamu da ita.
Bisa ga binciken da aka yi a kan masu ba da gudummawa, mutanen da ke da lafiya da ke dauke da HCoV-229E sun kamu da cutar a cikin ƙananan ƙananan ƙwayoyin cuta.
Wasu marasa lafiya da ke da ƙananan ƙwayoyin cuta sun sami rauni mai tsanani a ƙananan ƙwayoyin cuta.
SARS, wanda aka fi sani da cutar huhu, shine farkon cutar da aka fara rubutawa a cikin tarihin ɗan adam wanda ke haifar da HCoV, kuma cutar SARS-CoV ce ta uku da aka gano.
An samu mutum na farko da cutar SARS a ƙarshen shekara ta 2002 a lardin Guangdong na kasar Sin.
Cutar SARS ta kama mutane 8,096 kuma ta kashe mutane 774, ta bazu zuwa kasashe da nahiyoyi da dama.
Baya ga masu yaduwar cutar, an kiyasta cewa kowane mai cutar zai iya kamuwa da mutane biyu, tare da bayyanar cututtuka a cikin kwanaki 4 zuwa 7 tare da ƙaruwar ƙwayar cutar a cikin mutum a ranar 10 na kamuwa da cutar.
Masu cutar SARS-CoV da farko suna fama da ciwon tsoka, ciwon kai, zazzabin cizon sauro, ciwon kumburi da kuma tari, sannan kuma suna fuskantar wahalar numfashi, narkewa da kuma samun ruwa a cikin huhu.
Lymphopenia, gwajin aikin hanta, da kuma yawan creatine kinase sune wasu daga cikin matsalolin SARS da aka gano a gwajin gwaji.
An kuma lura da lalacewar alveolar, yaduwar kwayar epithelial da kuma karuwar macrophage a cikin marasa lafiya na SARS.
Kimanin kashi 20-30% na marasa lafiya suna buƙatar kulawa mai tsanani da kayan aikin numfashi.
Baya ga ƙananan ƙwayar cuta, yawancin ɓangarorin ciki, hanta da ƙwayoyin cuta na iya samun rauni a cikin waɗannan yanayi masu tsanani, wanda yawanci yana tare da guguwar cytokine, wanda zai iya haifar da mutuwa musamman a cikin marasa lafiya masu ƙarancin ƙwayar cuta.
An fara gano kwayar cutar ne a cikin wani kwayar cutar da aka cire daga huhu na wani dan uwan da aka fara gano cutar wanda ya yi tafiya zuwa Hong Kong daga Guangzhou.
Tun daga wannan lokacin, an yi ƙoƙari sosai wajen binciken HCoV.
An gano HCoV-NL63 a cikin jariri mai wata 7 daga Netherlands a ƙarshen 2004.
A baya an gano cewa cutar ta fi yawa a cikin yara, tsofaffi da kuma marasa lafiya da ke da ƙananan ƙwayar cuta da kuma cututtukan da suka shafi ciwon huhu.
Cutar coryza, cutar sankara, zazzabin cizon sauro, da kuma cutar sankarar huhu sun fi yawa a cikin cututtukan da HCoV-NL63 ke haifarwa.
Wani bincike kuma ya gano kwayar cutar a cikin hanci na wani yaro mai wata takwas da ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi a Netherlands, ya yaɗu a dukan duniya.
An kiyasta cewa HCoV-NL63 yana haifar da kashi 4.7% na cututtukan numfashi na yau da kullun, kuma ya fi yawa a farkon bazara, bazara da hunturu.
HCoV-NL63 yana da alaƙa da cutar laryngitis na toshewa (coup).
A wannan shekarar, an gano HCoV-HKU1 a cikin wani mutum mai shekaru 71 da aka kwantar da shi saboda cutar sankarar bargo da kumburi a Hong Kong.
Baya ga ciwon huhu da kumburi, an kuma gano HCoV-HKU1 yana da alaƙa da mummunar cutar asma.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, an gano HCoV-HKU1 a duk duniya, wanda ke haifar da cututtukan numfashi masu saurin kamuwa da cuta.
Dukkanin wadannan nau'o'in HCoVs guda hudu an san su sosai kuma ba a sa ran sauya su zuwa cututtuka masu saurin faruwa, duk da cewa an samu hadari da dama saboda wasu dalilai da ba a gano su ba, kamar nau'in HCoV-NL63 mai saurin faruwa, wanda kwanan nan aka gano cewa ya haifar da mummunan rauni a yankin yankin China.
Gabaɗaya, HCoVs suna samun damar yin yawo da zama cikin mutane, kuma suna samun ƙarancin haɗari.
An fara gano kwayar cutar MERS-CoV a shekarar 2012 a cikin huhu na wani mutum mai shekaru 60 da ke fama da cutar sankarar bargo da kuma rashin aikin koda a Saudi Arabia.
Duk da cewa dukkan wadanda aka tabbatar da cutar sun fito ne daga Gabas ta Tsakiya, an gano wasu masu kamuwa da cutar daga kasashen waje da kuma daga kasashen Turai da Tunisia.
Wani sabon fashewar cutar a Koriya ta Kudu a shekarar 2015 inda aka samu mutum 186 da suka kamu da cutar.
Alamar asibiti na MERS tana kama da na SARS, wanda ya ƙunshi ciwon huhu mai saurin ci gaba.
Ba kamar SARS ba, yawancin masu cutar MERS sun kuma sami rashin aikin koda, wanda a halin yanzu MERS ne kawai ke haifar da cutar HCoV.
Fiye da kashi 30% na marasa lafiya suna da matsaloli a cikin hanji, kamar su tari da kuma amai.
A ranar 14 ga watan Fabrairu, 2020, sama da mutane 2500 da aka tabbatar da cutar sun mutu a kashi 34.4 cikin dari, wanda ya sanya MERS-CoV daya daga cikin cututtukan da suka fi kowa cutar.
A tsakiyar da ƙarshen Disamba 2019, an gano wasu marasa lafiya da cutar zazzabin cizon sauro da aka sani da cutar SARS-CoV-2 a Wuhan, lardin Hubei, China.
Hukumar Lafiya ta Duniya ta ayyana cutar SARS-CoV-2 a matsayin gaggawa ta duniya da ake kira COVID-19.
A ranar 3 ga watan Maris, 2020, an tabbatar da mutane 90,053 a duniya, tare da kashi 3.4% na mutuwar.
Abin lura, yawan mutanen da suka kamu da cutar a Hubei, China ya kai kashi 4.2%, yayin da na kasashen waje ya kai kashi 1.2%.
SARS-CoV-2 yana haifar da mummunan rauni a cikin jijiyoyin jiki kamar SARS-CoV da MERS-CoV, wanda ke haifar da zazzaɓi, kumburi da wahalar numfashi.
Ana kuma samun maganin rigakafi a wasu marasa lafiya.
Cutar kumburi na daya daga cikin alamun da suka fi tsanani kuma zai iya fadada cikin sauri kuma ya haifar da matsala a hanyar jirgin kasa.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya ta hanyar kamanceceniya ta kwayoyin halitta (high nucleotide sequence homology) na kusan kashi 82%, sun faɗi a rassan daban na itacen phylogenetic.
SARS-CoV-2 ba shi da haɗari sosai amma yana da saurin yaduwa idan aka kwatanta da SARS-CoV da MERS-CoV.
An gano wasu cututtuka na SARS-CoV-2 da ba su nuna alamun cutar ba kuma suna iya taimakawa wajen hanzarta yaduwar cutar a duniya.
Kwatanta SARS-CoV-2 da sauran HCoVs shida sun nuna kamance da bambance-bambancen da za a iya ganowa.
Na farko, lokacin bayyanar cututtuka da tsawon lokacin kamuwa da cutar HCoV suna da kamanceceniya sosai.
A wannan hanyar, SARS-CoV-2 yana bin tsarin hali na sauran kwayoyin HCoVs shida.
Na biyu, cutar COVID-19 tana da matukar damuwa tsakanin SARS-CoV da kuma nau'ikan HCoVs guda huɗu (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, mutum mai dauke da SARS-CoV-2 yana da alamun cutar da aka saba gani a cikin mutum mai dauke da HCoVs, wanda ya kunshi rashin bayyanar cututtuka, rashin ƙarfi ko rashin bayyanar cututtuka.
A gefe guda, ana iya gano ƙananan ƙwayoyin COVID-19 a cikin yanayin da ke kama da na SARS-CoV, kodayake ba su da yawa.
Na uku, cutar SARS-CoV-2 tana nuna yanayin da ke tattare da cutar HCoVs da SARS-CoV.
A gefe guda, yaduwar SARS-CoV-2 tana da ƙarfi kamar yadda yake tare da HCoVs.
A gefe guda, ba a tabbatar da ko cutar SARS-CoV-2 ta ragu ba bayan kamuwa da cutar a cikin mutane kamar yadda yake a SARS-CoV da MERS-CoV.
A ƙarshe, kamar yadda yake tare da sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfurori masu cutarwa.
Ko za a iya kamuwa da cutar SARS-CoV-2 ta hanyar cutar SARS-CoV a wasu lokuta har yanzu ana ci gaba da tabbatar da hakan a cikin binciken da za a yi nan gaba.
Hakanan yana da mahimmanci a ga ko SARS-CoV-2 na iya samun lokacin da ya dace da HCoVs.
Duk da haka, bayanan SARS-CoV-2 da ke tattare da yadda cutar ta kamu da ita, da kuma yadda ta ci gaba da kamuwa da ita a cikin mutane na iya zama da mahimmanci ga sakamakon cutar COVID-19 ta yanzu.
Duk wani rashin jin daɗi da HCoVs ke haifarwa ya kasance mai kyau ga mutane.
Idan aka duba shi ta wata hanyar, zai iya zama gaskiya cewa mutane sun sami damar kare HCoVs.
A wasu kalmomi, duka biyu na iya zama masu tsira daga cutar HCoV mai cutarwa.
Kwayoyin HCoVs da ke haifar da cututtuka masu saurin kamuwa da cutar a cikin mutane da kuma mutanen da ke da cutar HCoV mai tsanani sun mutu.
Don haka, HCoVs dole ne su ninka a cikin mutane sau da yawa don su iya jurewa da tasirin da ke tattare da su.
A wannan yanayin, yayin da SARS-CoV-2 ke raguwa kuma ya rage yawan kamuwa da cutar, damar da yake da ita na kamuwa da cutar ta ƙaru.
Idan ya daidaita, yana da wuya a hana yaduwar cutar a cikin al'umma ta hanyar kulle ko wasu hanyoyin hana yaduwar cutar.
A cikin shekaru da dama, nau'ikan CoVs guda hudu sun yadu a cikin mutane suna haifar da mura a cikin mutanen da ke da rigakafi.
Ba a bukatar ƙwayoyin cuta su ɓoye a cikin dabba.
Idan aka kwatanta, kwayar cutar SARS-CoV da MERS-CoV ba su da kyau sosai ga mutane kuma ba za a iya samun yaduwar cutar a cikin mutane ba.
Dole ne su kasance a wurin kuma su nemi zarafi su taɓa mutane marasa ƙarfi, wataƙila ta wurin mutum ɗaya ko fiye da haka da suke da rauni.
Kwayar cutar SARS-CoV-2 tana da alamun kama da SARS-CoV/MERS-CoV da kuma wasu ƙwayoyin cuta guda huɗu da ke da alaƙa da mazauna ƙasa da ake kira HCoVs.
Yana da yaduwar cutar kamar HCoVs, aƙalla a matsayin sananne a halin yanzu.
A maimakon haka, yana da cutar fiye da HCoVs na mutum kuma ba shi da cutar kamar SARS-CoV ko MERS-CoV.
Har ila, ana bukatar a bincika ko ya saba da mutane sosai kuma ya yaɗu daga mutane zuwa wasu da ba su da cuta ko kuma ya kasance a kan dabba da ba ta da cuta.
Kafin mu tattauna game da asalin HCoVs na dabbobi, zai taimaka mana mu tattauna ma'anar da alamun waɗannan kalmomin, yanayin, yanayin, watsawa, mai watsawa da mai watsa HCoVs.
Dabbobi suna iya zama masu rarraba HCoVs idan suna da kwayar cutar da ke kama da kwayar cutar ta kwayar halitta ta hanyar rarraba kwayoyin halittar su a matakin kwayar halitta.
Kwayar cuta tana iya zama a inda take kuma ba ta iya cutar da inda take.
Hakazalika, kwayar cutar HCoV tana da wuri a cikin jiki na tsawon lokaci.
A kowane hali, kwayar cutar ta kamu da cutar kuma ita ce kwayar cutar HCoV ko kuma kwayar cutar.
Akasin haka, idan aka sanya kwayar HCoV a jikin kwayar cutar kafin ko kuma a lokacin da aka sanya ta cikin mutane, ba ta saba da kwayar cutar ba kuma tana iya yada cututtuka.
Kwayar cuta mai guba na iya zama tushen cutar a cikin mutane kuma tana taka rawar da kwayar cutar ke takawa ta hanyar ba da izinin kwayar cutar ta sake haifuwa kuma ta kamu da mutane kuma ta yada cutar a cikin mutane.
HCoV ba zai iya yaduwa ba idan ba zai iya rayuwa a kan kwayar cutar ba.
A wasu kalmomi, HCoVs na iya daidaitawa da kwayar cutar da ba ta yaduwa kuma ta kasance mai cutarwa na dogon lokaci.
A wannan hanyar, kwayar cuta da ba ta haihu ba tana iya kamuwa da cuta ta halitta.
Bayanai na annoba sun nuna cewa cutar SARS ta shafi dabbobi.
Binciken da aka yi a rijiyar ya nuna cewa masu sayar da dabbobi suna da kwayoyin cutar SARS-CoV IgG da yawa a jikinsu idan aka kwatanta da sauran mutane.
An gano cewa kumfa (Paguma larvata) da kuma wani kare da ake kira racoon na Asiya suna dauke da kwayar cutar SARS-CoV mai kama da SARS-CoV.
Wannan ya kara da cewa bayan kashe dabbobi a duk wuraren sayar da kayayyaki, ba a sake samun cutar SARS ba.
A maimakon haka, dabbobin daji ko dabbobin da ke cikin gonar kafin a sayar da su ba su da cutar SARS-CoV, wanda ke nufin cewa dabbobi masu rai suna iya zama masu cutar amma ba su yadu ba amma ba su da alamun cutar SARS-CoV.
A halin yanzu, saboda kashi 80% na dabbobi a kasuwar Guangzhou suna da maganin rigakafin SARS-CoV, ba za a iya yin watsi da yiwuwar cewa ƙananan dabbobi na iya yin aiki a matsayin mai watsa SARS-CoV ba.
Dukkanin waɗannan sun kasance suna da cutar SARS-CoV amma ba su yadu ba.
Sakamakon haka, wani kwayar halitta da ke dauke da cutar SARS-CoV ta nuna cewa tana da kama da kwayar cutar CoV, SARS Rhinolophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), wanda ke zaune a cikin barkon dawakai na kasar Sin.
Wannan kwayar tana dauke da kwayar cutar SARS-CoV da kuma kwayar cutar BatCoV HKU3.
Wannan kuma wani nau'in kwayar cutar CoV mai saurin kamuwa da cuta ne wanda ke raba kashi 88-92% na kwayar cutar tare da SARS-CoV.
Wannan bincike ya kafa sabon tushe na fahimtar cewa ƙudaje suna ɗauke da sababbin cututtuka da ke shafar mutane.
An gano wasu ƙwayoyin cuta masu kama da SARS CoVs (SL-CoVs) a cikin ƙwayoyin cuta amma babu wanda ya bambanta da WIV1 a matsayin kwayar cuta mai rai.
An gano wani abu mai suna angiotensin converting enzyme 2 (ACE2) a matsayin mai karɓar SARS-CoV.
WIV1 ya fito ne daga samfurori na cutar ta wuka kuma an nuna shi ta hanyar amfani da wuka, taliya da ACE2 a cikin mutane a matsayin mai karɓar rigakafin cutar.
Abin sha'awa, cutar SARS a cikin marasa lafiya da suka warke ta iya haifar da cutar WIV1.
Duk da haka, WIV1 yana wakiltar dangi mafi kusa da SARS-CoV a cikin kumburin, wanda ke raba kashi 95% na kwayar halitta.
Duk da kamanceceniya tsakanin kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar.
Binciken kwayoyin halittar mutum ya sanya MERS-CoV a cikin rukuni ɗaya tare da CoV-HKU4 da CoV-HKU5.
Kwayoyin cutar CoV-HKU4 da MERS-CoV suna amfani da kwayar cutar guda ɗaya, dipeptidyl peptidase 4 (DPP4), don shigar da kwayar cutar.
Kwayar RNA ta MERS-CoV tana kama da wanda aka gano a beta-CoVs da aka gano a Turai da Afirka.
Duk da haka, ba a iya gano kwayar cutar MERS-CoV mai rai a cikin naman gwari ba.
MERS-CoV da kwayar cutar CoV-HKU25 sun raba kashi 87% na kwayoyin halitta.
A wannan yanayin, ƙwayoyin cuta na iya zama ba su da saurin kamuwa da cutar MERS-CoV.
A gefe guda kuma, binciken da aka yi a kasashen Gabas ta Tsakiya ya nuna cewa raƙuma sun kamu da cutar MERS-CoV a cikin tsarin rigakafin jiki, kamar yadda ya faru a cikin raƙuman Afirka da suka fito daga Gabas ta Tsakiya.
An gano kwayar cutar MERS-CoV mai kama da kwayar cutar da ke kamuwa da mutane daga madarar raƙumi, wanda ya nuna cewa raƙuma suna da tasirin cutar MERS-CoV.
Abin lura shi ne cewa an gano wasu ƙananan alamun cutar a cikin raƙuman da ke dauke da cutar MERS-CoV.
Ka lura, raƙuma marasa lafiya ba kawai suna da ƙwayoyin cuta ba, amma suna da ƙwayoyin cuta masu yawa da suka ɓace a cikin kwari.
A maimakon haka, akwai tambayoyi da yawa saboda waɗanda aka tabbatar da cutar MERS ba su da alaƙa da dabbobi da raƙuma da alamun cutar, wanda zai iya zama cutar mutum-zuwa-mutum ko kuma hanyar watsawa ta hanyar da ba a sani ba wanda ke dauke da nau'in dabbobi da ke dauke da cutar MERS-CoV.
SARS-CoV-2 yana da kashi 96.2% na kwayoyin halitta tare da CoV RaTG13 wanda aka ware daga Rhinolophus affinis bats.
Kuma kamar yadda yake tare da SARS-CoV da MERS-CoV, bambancin dake tsakanin SARS-CoV-2 da RaTG13 yana da matukar muhimmanci da yake da wuya a gano alakar dake tsakanin kwayar cutar.
Wato, ba za a iya samun cutar SARS-CoV-2 a cikin kwayar cutar ba sai dai idan an gano kwayar cutar ta SARS-CoVs.
A ka'ida, dabba mai dauke da kwayar cutar da ba ta yada SARS-CoV-2 ba dole ne ta kasance daga cikin nau'ikan da ke cikin daji da ake sayar da su a kasuwar cin abincin teku ta Huanan, inda a farkon cutar ta COVID-19 da aka gano, akwai yiwuwar yaduwar cutar daga dabba zuwa mutum.
Bincike da yawa na baya-bayan nan bisa ga tsarin halittar kwayoyin halitta sun nuna cewa wani nau'in dabbobi masu hatsari na pangolins (Manis javanica) na iya samun kwayar cutar beta-CoVs mai kama da SARS-CoV-2.
Wannan kwayar Pangolin da ba a taɓa gani ba wacce ke dauke da kwayar cutar CoV tana da kashi 85-92% na SARS-CoV-2.
Maimakon haka, yana da kamanceceniya da RaTG13 a kusan kashi 90% na tsarin kwayoyin.
Sun rarraba ƙananan layuka 2 na kwayar cutar SARS-CoV-2 a cikin kwayar halitta wanda ɗayan ke da alaƙa da (RBD) SARS-CoV-2, tare da daidaiton kwayar halitta na 97.4%.
A cikin kwatancen da aka yi, aikin RBDs na SARS-CoV-2 da RaTG13 ya bambanta sosai amma an ji shi a cikin jigilar kwayar halittar kwayoyin.
Binciken farko kan pangolin da ke da cutar ya kuma nuna cewa kwayar cutar ta kamu da cutar a cikin samfurorin huhu da ke da alaƙa da SARS-CoV-2.
Wannan binciken ya yi amfani da hanyoyi daban-daban da suka hada da yin amfani da kwayoyin halitta don samun kwayar halitta mai dauke da kashi 86.3% na kwayar cutar.
Ba za mu iya kawar da yiwuwar cewa pangolin ne kawai dabba da ke da kwayar cutar da ba ta yada SARS-CoV-2 ba.
A halin yanzu, babu wani bayani na tabbatar da cutar SARS-CoV-2 na pangolin saboda bambancin da ke tsakanin SARS-CoV-2 da SARS-CoV-2 beta-CoVs na pangolin.
Hakazalika, tazarar tsakanin SARS-CoV-2 da RaTG13 ta fi tazarar tsakanin SARS-CoV-2 da SARS-CoV-2-related beta-CoVs na pangolin.
Har yanzu ba a san yadda SARS-CoV-2 ke yaduwa a cikin namomin kaza, pangolin da sauran dabbobi masu kama da mutane ba.
Duk da cewa an gano alaƙar kwayoyin halittar tsakanin RBDs da SARS-CoV-2 da pangolin, ƙwayoyin cuta masu kamuwa da cutar SARS-CoV-2 beta-CoVs, SARS-CoV-2 da RaTG13 suna raba wannan alamar.
Ana tsammanin cewa babban kamance tsakanin RBDs a cikin kwayar cutar pangolin SARS-CoV-2 beta-CoVs da SARS-CoV-2 ana sarrafa su ta hanyar bambancin kwayar halitta.
Wani bambancin da aka gabatar ya goyi bayan alaƙar da ke tsakanin kwayar cutar pangolin SARS-CoV-2 beta-CoV da RaTG13 a cikin jinsin dabbobi.
A matsayin abin motsawa na maye gurbin, rashin daidaituwa yana da mahimmanci a cikin beta-CoVs.
Har yanzu ba a yanke shawara kan kwayar cutar SARS-CoV-2 ba.
Baya ga kwayoyin cutar HCoVs, an kuma bincika asalin HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1 a cikin dabbobi.
Binciken binciken kwayoyin halitta ya nuna cewa HCoV-NL63 da HCoV-229E na iya samo asali ne daga CoVs a cikin ƙwayoyin cuta, yayin da aka gano kwayar cutar HCoV-OC43 da HCoV-HKU1 a cikin ƙwayoyin cuta.
An gano cewa an gano wani nau'in CoV mai suna ARCoV.2 (Appalachian Ridge CoV) a Arewacin Amurka a cikin nau'i uku kuma ya nuna cewa yana da kusanci da HCoV-NL63.
A wani bangare, HCoV-229E ya kamu da kwayar cutar CoV, mai suna Hipposideros/GhanaKwam/19/2008, wanda aka ruwaito a Ghana, kuma ana tsammanin raƙuma ma sun kamu da cutar.
Don ƙarin bayani, an ba da shawarar asalin dabbobi na HCoVs da aka sani a cikin Hoto na 1 da Table 2.
Binciken juyin halitta ya ba da tabbacin cewa HCoVS yana yaduwa a cikin nau'in dabbobi masu guba kamar yadda ya faru a tarihi.
Lokacin da HCoV-OC43 ya tashi daga wani nau'in zuwa ga mutane daga dabbobi masu kiwo a cikin 1890, an gano cutar da ke haifar da cutar kumburi.
Tarihin yaduwar bambance-bambancen HCoV-229E bai bayyana ba.
An gano alpha-CoVs na bat da ke da alaƙa da HCoV-229E.
Daga cikin su akwai alpha-CoV alpaca.
Saƙonni daban-daban da ke tallafawa yaduwar cutar sun bazu daga ƙwayoyin cuta zuwa mutane kai tsaye.
Na farko, mutane ne, ba alpacas ba, suke da alaƙa da ƙwari wajen rarraba wurin zama.
Maimakon haka, mutane suna da dangantaka ta kusa da alpacas.
Na biyu, HCoV-229E-related bat alpha-CoVs sun bambanta kuma ba su haifar da cutar a cikin kumburi ba, yayin da alpaca alpha-CoVs ke haifar da cutar a cikin kwayar cutar da ke cikin kwayar cutar.
A ƙarshe, ba a gano alpha-CoV alpaca a cikin dabbobin da suka koma daji ba.
A wannan yanayin, ba za a iya kawar da yiwuwar alpacas su zo da HCoV-229E-related alpha-CoV daga mutane ba.
A gaskiya ma, ƙwayoyin cuta da ke yada cututtuka a cikin mutane sun hada da kwayar cutar rabies, kwayar cutar Ebola, kwayar Nipah da kwayar cutar Hendra.
Ba abin mamaki ba ne cewa naman gwari na iya yada HCoV-229E kai tsaye zuwa ga mutane.
A wasu kalmomi, yayin da alpha-CoVs ke aiki a matsayin tushen kwayar halitta na HCoV-229E, alpacas da raƙuma (dromedary camels) na iya aiki a matsayin mai watsa kwayar cutar mai yaduwa a cikin mutane kamar yadda yake a cikin MERS-CoV.
MERS-CoV ya zama misali mai kyau na yaduwar kwayar cutar daga nau'in zuwa nau'in daga dromedary zuwa raƙuma da kuma daga raƙuma zuwa mutum.
An san asalin asalin MERS-CoV daga ƙwayoyin cuta tun daga farkon kuma an tabbatar da wannan ganewar asali a cikin binciken da aka yi.
A bayyane yake cewa ƙudaje suna da nau'o'in ƙwayoyin cuta da yawa waɗanda ke tafiya a cikin nau'ikan daban-daban waɗanda suka rarraba kansu zuwa nau'ikan daban-daban kuma suka bazu cikin nau'ikan daban-daban.
Tsawon rayuwa, yawan rukuni na batsa, kusanci da kuma iyawar tsallewa duk suna sanya batsa zama mai yaduwar ƙwayoyin cuta.
A gefe guda kuma, an gano cutar MERS-CoV a cikin raƙuman ruwa na tsawon lokaci.
Ta yi rayuwa mai kyau a cikin waɗannan raƙuman da suka canja daga kwayar cuta mai saurin yaduwa zuwa kwayar cuta mai saurin kamuwa.
MERS-CoV yana haifar da rashin lafiya da kuma ƙananan rikice-rikice a cikin waɗannan dabbobi.
An kiyasta cewa yaduwar cutar a cikin mutane ba zato ba tsammani ne kuma mutane suna ci gaba da kasancewa tare da MERS-CoV amma ba su yadu ba saboda ba a iya samun yaduwar cutar.
Idan aka kwatanta da aikin raƙuma wajen yaduwar MERS-CoV, aikin pangolins, idan aka ware, a yaduwar SARS-CoV-2 ya bambanta.
Mafi yawan cutar beta-CoVs na pangolin na haifar da cututtuka a cikin pangolins.
Zai iya zama mai amfani da kwayar cutar da ba ta watsa beta-CoVs masu alaƙa da SARS-CoV-2, kamar yadda yake a cikin maganin SARS-CoV.
Za a tabbatar ko a ƙaryata yiwuwar watsa SARS-CoV-2 a cikin nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau
Da farko, ana iya samun cutar SARS-CoV-2 a cikin kumburin kumburin da ke da kama da SARS-CoV-2.
Mutane za su iya kwatanta yadda ake samun abinci da kuma yadda ake narkar da shi.
Na biyu, pangolin na iya zama mai watsa kwayar cutar SARS-CoV-2 wanda aka sanya su.
Mutane suna kamuwa da cutar ta hanyar kashewa da cin naman kwari.
Akwai yiwuwar cewa dabbobi kamar mutane da suka hada da dabbobin gida na iya kamuwa da cutar SARS-CoV-2.
Ana bukatar bincike a kan dabbobi da ke cikin gida da kuma daji don gano rigakafin da ke cikin su.
Na uku, kamar yadda aka ambata a sama, kwayar cutar SARS-CoV-2 na iya kasancewa a cikin nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Binciken asalin SARS-CoV-2 a cikin dabbobi har yanzu yana gudana.
Baya ga nau'in dabbobi da suka kamu da cutar, abubuwa uku masu mahimmanci a kan kwayar cutar ma suna da mahimmanci a cikin sake fasalin CoVs don yanke shingen sauyawa zuwa wasu nau'ikan.
Na farko, ana ganin cewa yawan nau'in da suke haifa ya fi na RNA.
Idan aka kwatanta da sauran ƙwayoyin cuta masu amfani da RNA guda ɗaya, ana hasashen cewa yawan kwayar cutar ta kasance tsakanin wmusu da wmaɗaukaki tare da matsakaicin ƙimar ~10-4 a kowace shekara a kowane matsayi na 2, dangane da matakin daidaitawa na CoV da kuma ƙimar kwayar cutar da ba a sani ba.
CoVs suna iya yin amfani da exoribonuclease, kuma idan aka gano su, suna haifar da ƙarancin ƙarfi ko kuma wani lokacin ba su yiwu ba.
Abin sha'awa, an san analog na nucleotide Remdesivir da cewa yana hana kwayar cutar CoV ta hanyar hana kwayar halitta mai suna exoribonuclease (RNA) da ke dogara da RNA polymerase.
Remdesivir yana cikin magungunan da ke yaki da cutar SARS-CoV-2 da ake gwadawa a asibiti.
Baya ga wannan, yawan kamuwa da CoVs ya ninka na kamuwa da cutar sau miliyan.
Hakazalika, yawan kamuwa da cutar yana da yawa idan ba su san abin da ke kama su ba.
Idan aka kwatanta da SARS-CoV wanda ke da babban canji, yanayin canji na SARS-CoV-2 ya yi ƙasa, wanda ke nuna cewa yanzu ya daidaita da mutane.
Wataƙila ya riga ya saba da wani abu da ya yi kama da mutane.
Baya ga SARS-CoV-2, wannan yana shafar MERS-CoV, wanda ya saba da raƙuma.
A ka'ida, ana iya ganin cewa canjin kwayoyin halitta zai iya haifar da maganin rigakafin cutar SARS-CoV-2 da ba ya aiki da sauri.
Na biyu, babban kwayar RNA a cikin kwayar cutar CoVs tana hana kwayar halitta ta zama mai rarrabuwa, ta haka ne ta kara damar da kwayoyin ke da shi a cikin kwayar halitta, wanda hakan zai taimaka wajen haifar da kwayar cutar CoV da ba a sani ba idan yanayin ya daidaita.
Wannan yana da goyon bayan tsarin tsarin karatun na musamman na musamman da kuma gina jiki mai mahimmanci wanda ke cikin 3′ na genome.
Na uku, CoVs suna sauya fasalin kwayar halitta a lokacin haihuwar ta hanyar tsarin koppa-plonus.
A cikin kwayar cutar da ke kama da kwayar cutar, canji ya fi yawa a lokacin kwafin RNA na CoV.
Kwayoyin RNA masu kama da juna da kuma RNAs na subgenomic na iya haɗuwa don samar da wani nau'in CoV.
Bayanai na kwayar halitta sun nuna cewa an gano shi a cikin HCoV-HKU1 da HCoV-OC43, da kuma CoV na dabbobi kamar su SL-CoV da batCoV-HKU9.
Haɗin kai da kwayar cuta na iya zama hanyar yaduwar cuta
Baya ga abubuwan da suka shafi kamuwa da cuta guda uku da aka ambata a sama, kamuwa da cuta ta hanyar kwayar cuta ma wani muhimmin abu ne na yaduwar cututtuka a cikin nau'o'i daban-daban.
A cikin wannan takarda, ana daukar kwayar cutar SARS-CoV a matsayin sanannen misali na yadda ake samun bayanai a lokacin yaduwar cutar wanda ake kira da zabin mai kyau.
Dangane da nazarin tsakanin bayanan da aka gano na SARS-CoVs na mutum da na namomin kaza, ana ganin SARS-CoV yana da saurin daidaitawa ga kwayar cutar, musamman ta hanyar canzawa zuwa RDB a cikin furotin S.
Gabaɗaya, RBD a cikin furotin S na CoV yana da alaƙa da tsarin rigakafi kuma ana zaɓar shi ta hanyar rigakafin jiki a cikin kwayar cutar.
A cikin SARS-CoV, RBD yana cikin amino acid 318 zuwa 510 a kan sashin S1, wanda ke ɗaure zuwa ACE2 a cikin mutane da kuma masu amfani da kwayoyin.
RBD na SARS-CoV zai iya gano kwayoyin ACE2 a cikin dabbobi daban-daban, gami da ramuka, dabbobin daji, da karnuka, wanda ke ba da damar yaduwar cutar zuwa wasu nau'ikan.
A gaskiya ma, an gano 6 amino acid da suka rage daga mutane a cikin RBD kuma 4 daga cikinsu suna cikin kwayar cutar ta hanyar haɗuwa da kwayar cutar ACE2.
SARS-CoV wanda ya haifar da kwayar cutar ya haifar da sauyawar K479N da S487T RBD, wanda zai iya kara hadin gwiwar sinadarin spike da ACE2 wanda ya haifar da kwayar cutar a cikin mutane.
Wato, amino acid biyu da aka gāda suna iya zama da muhimmanci wajen daidaitawa da kamuwa da cuta.
Yana da muhimmanci a san cewa SARS-CoV-2 yana rarraba kwayar cutar da ke kama da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin matakin S1 na furotin S yana nuna cewa dangantakar S da ACE2 a cikin mutane na iya canzawa.
A zahiri, binciken cryo-EM ya nuna dangantaka mai ƙarfi tsakanin 10-in-20 a cikin wannan haɓakawa fiye da ACE2 a cikin mutane da kuma furotin SARS-CoV S.
Zai kuma zama da kyau a ga ko za a bukaci wani abu mai cutarwa don yada SARS-CoV-2.
Abin sha'awa, HCoV-NL63 kuma yana ƙarfafa ACE2 amma yana amfani da wani ɓangaren S.
Akwai wasu nau'ikan HCoV masu kama da juna, kamar su aminopeptidase N a kan HCoV-229E, da 9-O-acetylated sialic acid a kan HCoV-OC43.
Hakanan yana iya bayyana yadda kwayar cutar CoV ke daidaitawa cikin mutane bayan yaduwar ta zuwa wasu nau'ikan daga dabbobi.
Baya ga masu karɓar kwayar cutar, sakamakon HCoVs na yaduwa tsakanin nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan.
Bambancin furotin mai watsawa tsakanin mutane da halittu masu yada HCoVs kamar su kwari, raƙuma da masu tsutsa na iya zama abin toshewa wajen watsa cutar a cikin nau'ikan daban-daban.
HCoVs suna iya kawar da kwayar cutar kuma suna iya kauce wa shinge na kwayar cutar don inganta yaduwar cutar a cikin nau'ikan daban-daban.
Saboda haka, har yanzu ana bukatar a fahimci kuma a bayyana abin da ke sa ƙwayoyin halittar a wannan muhimmin wuri da ke da ƙwayoyin cuta.
Yin bincike na gaba daya na kwayar cutar SARS-CoV-2 tare da amfani da fasahar zamani na iya haifar da sakamako mai kyau.
Rashin sanannun cututtukan HCoVs: komawa baya
Bambancin CoVs na kwayar cutar yana haifar da babbar dama ga ɓarkewar HCoVs da ba a taɓa ganowa ba.
A wannan yanayin, CoV mai saurin zama yana aiki a matsayin tushen asalin HCoVs.
Bugu da ƙari, sauyawa da kuma haɗuwa da kwayoyin halitta suna sarrafa kwayar HCoV kuma suna aiki a matsayin matakai biyu na asali a cikin kwayar halitta.
Alal misali, samun ko rasa wasu kwayoyin da ba a san su ba na iya canja kamannin kwayar cutar.
A cikin sunadarai masu amfani da SARS-CoV, ana ganin ORF8 suna da mahimmanci wajen daidaitawa ga mutane, yayin da aka gano kwayar cutar SARS-CoV mai cutar da ƙwayar cuta amma kuma an gano cewa tana da sunadarai daban-daban na ORF8.
An gano kwayar cutar SARS-CoVs mai kwayar cuta mai kwayar cuta mai kwayar cuta 29-nucleotide a cikin kwayar cutar da aka gano a farkon barkewar cutar a cikin mutane.
Wannan rikici ya raba ORF8 daga ORF8a da ORF8b kuma ana tunanin cewa yana da wani nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Bugu da kari, SARS-CoV yana da tarihin iyawar haɗuwa da jerin alpha- da gamma-CoVs, wanda aka lura da ƙarancin haɗuwa a cikin ƙaramin tsari a cikin RNA mai dogara da RNA polymerase.
An gano wasu wuraren da ake samun rikici a cikin nsp9, mafi yawa a cikin nsp10, da kuma sassan nsp14.
Hakazalika, an gano cewa cutar MERS-CoV ta samo asali ne daga rikice-rikice tsakanin nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in.
Baya ga SARS-CoV da MERS-CoV, an kuma gano wasu nau'ikan HCoVs, waɗanda HCoVs ke haɗuwa da CoVs na dabbobi a cikin ƙwayoyin halittarsu da ake kira non-structural genes.
Ya kuma kamata a yi gargadin cewa bin diddigin mutane na iya haifar da canje-canje da ba a gano ba a cikin kwayoyin halitta na kwayar cutar, wanda ya fi yawa daga bambancin kwayar cutar zuwa matsi na bin diddigin, kamar su daga kwayar cutar.
Misali na wannan rikici shine asarar ORF4 mai tsanani a cikin kwayar HCoV-229E, wanda ya haifar da lalata nucleotide sau biyu.
Yayin da ORF4 mai canzawa zai iya ganowa a cikin ƙwayoyin cuta na HCoV-229E, alpaca alpha-CoV ya nuna ƙwayoyin nucleotide, daga tsarin.
A ƙarshe, ba a san yadda ake samun HCoVs ba kuma ana iya samun su ta hanyar rarraba su a cikin kwayar cutar.
An lura da rashin bayyanar cututtuka ko kuma rashin bayyanar cututtuka a matsayin cutar CoVs, wanda ke nuna daidaituwa tsakanin CoVs da cuta.
An gano cewa kwari sun san CoVs sosai a tsarin jikin mutum da kuma yanayin rayuwar yau da kullun.
Misali, rashin daidaito a cikin tsarin da ke faruwa a cikin kwayar halitta yana rage rashin daidaito da CoVs ke haifarwa.
Bugu da ƙari, an gano cewa mutuwar kwayar halitta a cikin ƙwayoyin cuta ta haifar da raguwar ƙwayoyin cuta na kwayar halitta na NKG2/CD94 da kuma ƙananan ƙwayoyin cuta na rukuni na I.
Duk da haka, nau'in oxygen (ROS) da ke fitowa daga tsarin abinci a cikin farji na iya hana kwayar cutar CoV da kuma hana tabbatar da exoribonuclease, wanda ke haifar da matsin lamba na zaɓi wanda ke haifar da nau'in kwayar cutar mai saurin kamuwa da cuta lokacin da aka sanya shi a cikin wani yanki na kwayar cuta.
Sauran CoVs ma za su iya girma ta hanyar haɗuwa, suna haifar da furotin da ba a taɓa ganowa ba ko kuma alamun furotin da ke ba da damar mai cutar ta saba da shi.
A wannan yanayin, ba zato ba tsammani cewa HCoVs da ba a gano ba sun sake bayyana a cikin shekaru biyu da suka gabata.
CoVs ba sa haifar da cuta ko kuma suna haifar da alamun rashin lafiya a cikin masu yaduwa kamar su ƙudaje da raƙuma.
Za su bambanta sosai kuma ba za su iya shafan mahaukaciyar cuta ba.
Wannan yana cikin asirin da ke sa mutane su kamu da cututtuka marasa lahani.
Alamun cutar sun fi yawa daga tashin ƙwayoyin cuta da kuma bayyanar cututtukan cututtukan cuta (cytokine storm) wanda ya sa yawan cutar da ke faruwa ya fi tsanani, kuma cutar da huhu ta fi tsanani.
Idan aka kwatanta da mutanen da ba su da alamun cutar, ana hana masu cutar cutar cutar ta CoV.
Wannan hanyar kawar da kwayar cutar na iya zama da amfani wajen maganin SARS-CoV-2.
Interferon yana da ƙarfi sosai a cikin hanci.
A wannan yanayin, yin amfani da nau'in interferon na I aƙalla lokacin da aka gano cutar SARS-CoV-2 a cikin mutane dole ne ya kasance mai tasiri.
Hakazalika, kunna NLRP3 inflammasome a cikin tsutsa ba shi da wani sakamako.
A wannan ma'anar, hana NLRP3 inflammasome tare da MCC950 na iya taimakawa wajen maganin COVID-19.
Cutar SARS-CoV-2 ta biyo bayan wani tsari na asali na SARS-CoV da MERS-CoV.
An gano cewa beta-CoV yana da kashi 95% na kwayar cutar SARS-CoV, yayin da kuma kwayar cutar CoV tana da kashi 96% na kwayar cutar SARS-CoV-2.
An gano cewa wasu kayan abinci da sauran dabbobi da ake sayar da su a kasuwa suna ɓoye kwayar cutar da ke kama da SARS-CoV, wanda ba a gano kwayar cutar da ke yada SARS-CoV-2 ba.
An gano beta-CoVs na pangolin da ke da kamanceceniya da SARS-CoV-2, wanda ke nuna cewa pangolin na iya zama mai amfani da kwayar cutar ko kuma beta-CoVs na pangolin na iya zama mai amfani da kwayar halitta da ke haifar da sabon nau'in SARS-CoV-2.
Duk da cewa har yanzu akwai tambayoyi, babu wani bayani da ya nuna cewa SARS-CoV-2 ya samo asali ne ta hanyar mutum ko kuma ba da gangan ba.
CoVs sun sake bayyanawa a cikin mutane saboda barkewar cutar SARS-CoV-2 da ta gabata.
Binciken CoVs a cikin naman gwari da sauran dabbobi ya sauya fahimtar muhimmancin kwayar cutar HCoVs a yaduwar cututtuka a cikin mutane.
Bayanai masu yawa sun nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga kuraje kuma ana yada su ga mutane ta hanyar kwayar cutar da ba ta yaduwa.
Saboda cutar SARS-CoV ta samo asali ne daga hulɗa tsakanin mutane da naman gwari a kasuwa, rufe wuraren sayar da kayan masarufi da kashe naman gwari zai taimaka wajen hana barkewar cutar SARS.
Hakazalika, dole ne a cire pangolins daga kasuwannin kayan masarufi don hana yaduwar cututtuka daga dabbobi zuwa mutane, tare da fatan gano bambance-bambancen beta-CoVs na pangolin da ke da matukar juriya ga SARS-CoV-2.
A maimakon haka, ko SARS-CoV-2 ya yadu ga mutane ta hanyar pangolins da sauran dabbobi masu kama da mutane da kuma yadda ake yaduwar cutar za a gano a cikin binciken da za a yi nan gaba.
A gefe guda kuma, cutar MERS-CoV ta kasance a cikin raƙumi na tsawon lokaci.
Rakuma suna da muhimmanci a sufuri kuma suna bukatar nama, madara, fata, da kuma ulu.
Ana samun su a Gabas ta Tsakiya da Afirka.
A halin yanzu, kashe dukkan raƙuma yana da wahala saboda rigakafin MERS, wanda ake gudanarwa a kasuwannin namun daji na kasar Sin don hana yaduwar SARS-CoV da SARS-CoV-2.
Don hana barkewar cutar MERS, dole ne a inganta tsarin cutar don samar da maganin rigakafin MERS-CoV na zamani, tare da sauran hanyoyin rigakafi.
Tun da ba za mu iya kawar da wannan kwayar cutar ba, za a iya haifar da wani nau'in kwayar cutar.
Wani nau'in CoV wanda ke yada cutar daga dabbobi zuwa mutane ya yadu a cikin daji.
Musamman, yana da nau'in CoV mai saurin kamuwa da cuta wanda ke iya yada cututtuka daga dabbobi zuwa mutane ta hanyoyi da yawa.
Akwai yiwuwar cewa CoV mai yaduwa daga dabbobi zuwa mutane ba zai iya haɗuwa ba saboda sabon fashewar CoV mai saurin yaduwa da / ko a cikin asalin ɗan adam.
Dole ne a yi watsi da cin naman daji a wasu yankuna na kasar Sin don rage hulɗa da ba dole ba tsakanin mutane da dabbobi.
A cikin wannan yanayi na SARS, MERS da COVID-19, ya kamata a sami kyakkyawan shiri da kuma tsarin da zai magance su.
Hakika, yawancin ƙwayoyin cuta sun daɗe suna wanzuwa a duniya.
Suna zama a inda suke har sai sun samu zarafin yin tafiya.
Ko da yake dabbobin daji suna da ayyuka da yawa da suke iya yada ƙwayoyin cuta, za a iya rage damar da mutane suke da shi na hulɗa da dabbobi dabbobin daji idan aka gaya wa mutane su guje su.
Ana buƙatar lura da hankali a cikin dabbobi kamar mutane don ƙarin fahimtar yanayin CoVs da kuma abubuwan da ke tattare da kwayoyin halitta waɗanda za su iya zama masu mahimmanci wajen hana yaduwar cututtuka daga dabbobi zuwa mutane da kuma cutar coronavirus a nan gaba.
A ƙarshe, hanya mafi kyau ta hana ƙwayoyin cuta daga dabbobi zuwa mutane ita ce mutane daga wuraren da ke da ƙwayoyin cuta da ke watsa cututtuka daga dabbobi zuwa mutane.
Akwai abubuwa da yawa da ba a san su ba game da asalin cutar SARS-CoV-2 daga dabbobi zuwa mutane.
Da farko, idan kwari ya yada kwayar cutar SARS-CoV-2 a cikin pangolin, yana da kyau a lura da yanayin da kwari da pangolin ke rarraba su a cikin yanayin da suke ciki.
Na biyu, idan kwari yana taka rawa wajen yada cututtuka kai tsaye tsakanin mutane, to, ya kamata a yi la'akari da yadda mutane ke hulɗa da kwari.
Na uku, idan dabba ta zama mai cutarwa, ya kamata a bayyana yadda ta dace da sauran nau'in, ciki har da mutane, dabbobin daji da pangolin.
A ƙarshe, saboda yawancin dabbobi kamar mutane ciki har da dabbobi masu gida suna iya kamuwa da cutar SARS-CoV-2, dole ne a yi sa ido da gwaji don gano cutar.
Idan akwai wani biri, wani pangolin ko wani dabba mai kama da mutum, ana iya samun SARS-CoV-2 ko wasu kwayoyin cutar da suka yi kama da su a cikin yanayin da kwayoyin suka fito.
Binciken da aka yi a baya-bayan nan zai bayyana yadda cutar SARS-CoV-2 ta kamu da cutar a cikin dabbobi, tare da fa'idodi masu mahimmanci a cikin rigakafin COVID-19 a cikin mutane.
Ana buƙatar daidaita tushen tabbatar da mai haƙuri  wanda ake zargi da  wanda aka tabbatar yana da COVID-19
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta fitar da sabbin matakai na gaggawa don ganowa da kuma kula da mutanen da ke da kwayar cutar coronavirus (2019-nCoV) ta 2019, kuma waɗannan matakai sun nuna kwarewarmu da kuma yadda za a magance cutar a duniya.
A maimakon haka, cutar coronavirus ta 2019 (COVID-19) sabuwar cuta ce, kuma iliminmu yana ƙaruwa bisa ga binciken da ake yi da kuma hanyoyin da ake bi don magance shi; saboda haka, ana yin canje-canje a cikin bincike da hanyoyin magani.
A cikin wannan wasikar, mun amsa tambayar da aka yi game da ka'idodinmu kuma mun ba da sabbin ka'idodin da aka ƙayyade  da  tabbatarwa bisa ga ka'idodin kwanan nan na Bincike da Kula da COVID-19 (na bakwai)) wanda Kwamitin Lafiya na Jiha na kasar Sin ya bayar.
A watan Disamba na shekarar 2019, kwayar cutar coronavirus (2019-nCoV) ta 2019 ta haifar da cutar, wacce yanzu aka sanya mata suna coronavirus disease 2019 (COVID-19) kuma aka sake kiranta da suna severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
A ranar 11 ga watan Maris na shekarar 2020, WHO ta ayyana COVID-19 a matsayin matsalar lafiya ta duniya.
Don yaki da cutar SARS-CoV-2, tawagarmu ta samar da takardar gaggawa da aka buga a shafin yanar gizon Military Medical Research a ranar 06 ga watan Fabrairu 2020.
An yi amfani da su sosai tun lokacin da aka buga su.
Amma ya kamata a lura cewa COVID-19 sabon cuta ne, iliminmu yana ƙaruwa bisa ga binciken da ake ci gaba da yi da kuma sakamakon magani; saboda haka, ana canza bincike da hanyoyin magani.
A cewar Bayanan Bincike da Kula da COVID-19 da Kwamitin Lafiya na Jamhuriyar Jama'ar Sin (http://www.nhc.gov.cn/), tsakanin 16 ga Janairu 2020 da 3 ga Maris 2020, ya fitar da jimillar fitowar bakwai tare da wasu canje-canje na yanayi.
An ba da labarin yadda Zhou da abokan aikinsa suka tsara wani tsari mai sauƙi na bincike bisa ga abin da suka gano a asibiti.
Aikin da suka yi ya ƙara tabbatar da ƙa'idodinmu kuma ya ba da bayani game da wannan matsalar ta duniya.
Muna godiya sosai ga irin aikin da suke yi.
Maimakon haka, aikin su ma yana buƙatar sabuntawa bisa ga sabon Tsarin Gwaji da Kulawa da COVID-19 (Sashe na Bakwai) da kuma sabon bincike.
A cewar fitowar ta bakwai (3 ga watan Maris 2020), tabbatar da wanda ake zargi da cutar na bukatar hada daya daga cikin bayanan bayanan asibiti da kuma bayanan asibiti guda biyu domin yanke hukunci na karshe, ko kuma ya zama dole a kammala bayanan asibiti guda uku idan babu bayanan bayanan asibiti da aka sani:
Tarihin rashin lafiya: (1) kasancewar mutum a Wuhan da kewaye, ko kuma wasu yankuna da aka gano cewa akwai masu cutar COVID-19 a cikin kwanaki 14 kafin bayyanar cututtuka; (2) kasancewar mutum yana tare da mutanen da ke dauke da cutar SARS-CoV-2 (ta hanyar gwajin nucleic acid mai kyau); (3) kasancewar mutum yana tare da masu cutar zazzabin cizon sauro ko masu fama da matsalar numfashi daga Wuhan da ke kewaye, ko kuma wasu yankuna da aka gano cewa akwai masu cutar COVID-19 a cikin kwanaki 14 kafin bayyanar cututtuka; (4) kasancewar mutum yana tare da masu cutar (ƙananan masu cutar zazzabin cizon sauro ≥ 2 da kuma/ko kuma waɗanda ke da wahalar isa a cikin makonni 2 da suka gabata, kamar su gidajen abinci, ofisoshi, makarantu, da sauransu).
Alamun asibiti sune: (1) zazzabin cizon sauro da/ko wahalar numfashi; (2) alamun rashin lafiyar jiki da ke nuna cutar COVID-19; (3) yawan kwayoyin jini (white blood cells) da ke nuna ƙimar lymphocyte mai kyau, ko kuma raguwa a farkon lokacin.
Ya kamata a tabbatar da mai haƙuri idan akwai alamun cutar ko gwajin ruwa kamar yadda aka nuna a ƙasa: (1) idan gwajin PCR na gaggawa ya nuna cewa mutum yana da cutar SARS-CoV-2; (2) idan tsarin kwayar cutar kwayar cutar ya nuna kamannin da ke tattare da sabon kwayar cutar corona; (3) idan gwajin ruwa ya nuna cewa mutum yana da kwayar IgM da kwayar IgG ta SARS-CoV-2; ko kuma idan canjin kwayar cutar ta SARS-CoV-2 daga mara kyau zuwa mai kyau, ko kuma idan titer ya tashi sama da kwanaki ≥4 a lokacin warkewa fiye da lokacin da aka nuna rashin lafiya.
Mun lura cewa an kara gwajin PCR na gaggawa don gano acid nucleic a cikin jini ko jini a fitowar ta biyu (18 Janairu 2020) da ta uku (22 Janairu 2020).
An ƙara gano cutar a cikin samfurin jini a fitowar ta huɗu (27 Janairu 2020) da kuma ta biyar (8 Fabrairu 2020); kuma an ƙara tabbacin gwajin ruwa na jiki a fitowar ta bakwai.
Wannan juyin ya dogara ne akan aikin bincike na gano wani abu wanda zai iya gano kwayar nucleic acid don gwajin gaggawa, tare da samfurin daga kwayar cutar da ke dauke da samfurin jini, wanda ya kara yawan yiwuwar samun gwajin daban, kuma ya goyi bayan samun kwayar cutar ta jiki a matsayin daya daga cikin tushen tabbatar da cutar.
Bugu da ƙari, akwai wasu tabbaci da yawa da za su iya tunasar da mu mu mai da hankali ga waɗanda suke da ciwo da kuma waɗanda ba su da alamun ciwo.
Saboda haka, ya kamata a sake duba takardar da Zhou da abokan aikinsa suka rubuta, domin sun nuna cewa mutum da ba shi da alamun cutar yana da ƙarancin haɗari.
Ana bukatar a tabbatar da wannan tsarin a wasu asibitoci da kuma a wasu bincike.
A taƙaice, muna sa rai cewa ƙarin tabbaci zai bayyana kuma muna gayyatar masu karatu su yi sharhi.
Sanin abin da aka yi tsammani da kuma tabbatar da shi, muna shirya don bi da bin umarnin da aka ba da na ƙasashenku.
Ƙungiyarmu za ta sabunta bayananmu don taimakawa.
Bangladesh ta sanar da karin mutane biyar da suka mutu sakamakon COVID-19, wanda shine mafi yawan mutuwar yau da kullun
Jiya, Bangladesh ta tabbatar da cewa karin mutane biyar sun mutu sakamakon COVID-19 a wannan ranar.
Wannan shi ne adadin mutane da suka mutu a rana daya saboda cutar.
Har zuwa jiya, Cibiyar Kula da Cututtuka ta Bangladesh (IEDCR) ta yi rajistar mutane 114 da suka kamu da cutar kuma 33 sun warke a gida.
Jimillar wadanda suka mutu ya kai 17.
A wani rahoto da aka fitar a yanar gizo, jami'in IEDCR, Dr Meerjady Sabrina Flora, ya ce wadanda suka mutu sun hada da maza hudu da mace daya.
A cewar Dr Meerjady, mutane biyu da suka mutu sun haura shekaru 60, biyu daga cikinsu suna tsakanin shekaru 51 zuwa 60, kuma daya daga cikinsu yana tsakanin shekaru 41 zuwa 50.
Ya kuma ce biyu daga cikinsu daga birnin Dhaka ne.
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba ta duniya.
Wani jami'in asibiti ya shaida wa kamfanin dillancin labarai na Anadolu cewa daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, wani jami'in hukumar yaki da cin hanci da rashawa ta Bengal, wanda ke jinya a asibitin Kuwait Maitree.
A ranar Asabar, Ministan Sufuri na Bangladesh Obaidul Quader ya sanar a cikin wani bidiyo cewa duk zirga-zirgar jiragen sama na kasa da kasa za a dakatar da su na tsawon lokaci fiye da yadda aka tsara, har zuwa Asabar mai zuwa.
An fara dakatar da zirga-zirgar jiragen sama a ranar 26 ga watan Maris kuma an shirya za a kawo karshen ranar 4 ga watan Afrilu.
An ƙyale a kai kayayyakin da ake bukata - magani, mai, da abinci.
An gano mutane na farko da suka kamu da cutar COVID-19 a Bangladesh a ranar 8 ga watan Agusta, wadanda suka hada da mutane biyu da suka dawo daga Italiya da kuma matar daya daga cikin mutanen.
A ranar 19 ga Maris, an warkar da su ukun.
SARS-CoV-2 ya kashe mutane miliyan daya a duniya
A ranar Alhamis, adadin masu kamuwa da cutar SARS-CoV-2 coronavirus ya zarce miliyan daya a duniya kamar yadda Jami'ar Johns Hopkins ta ruwaito.
Akalla mutane dubu 52 ne aka ce sun mutu sakamakon COVID-19, cutar da coronavirus ke haifarwa.
Wannan ya faru ne a ranar da Malawi ta samu mutum na farko da ya kamu da cutar kuma a daidai lokacin da Zambia ta samu mutum daya da ya mutu sakamakon cutar coronavirus.
Koriya ta Arewa ta ce a ranar Alhamis ta kasance daya daga cikin kasashen da suka rage da cutar coronavirus.
A ranar Talata ne Hukumar Lafiya ta Duniya ta sanar da cewa an samu mutum 1,051,635 da suka kamu da cutar ciki har da mutum 79,332 da suka kamu da cutar a cikin sa'o'i 24 da suka gabata a karfe 4 na safe, lokacin da aka saba da lokacin Turai ta Tsakiya (0800 UTC) a ranar 4 ga watan Afrilu.
A Amirka, an ba da rahoton fiye da mutane 244,000 da suka kamu da cutar kuma mutane 5,900 ne suka mutu.
CBS News ta nakalto jami'ar Johns Hopkins inda ta ce, a Amurka, sama da mutane 1,000 ne suka mutu a ranar Laraba sakamakon cutar coronavirus.
A duk duniya, al'ummai sun ba da sanarwar cewa dole ne a dauki matakai masu tsauri don hana yaduwar cutar.
A ranar Alhamis, magajin garin Moscow, Sergei Sobyanin, ya tsawaita dokar kulle birnin har zuwa ranar 1 ga watan Mayu.
A duk fadin kasar, Shugaba Vladimir Putin ya sanar da cewa za a biya 'yan kasar Rasha albashi duk da cewa ba za su je aiki ba har zuwa 30 ga watan Afrilu.
Majalisar dokokin Portugal ta kada kuri'ar ƙara wa'adin na kwanaki 15 da aka amince da shi, inda aka samu rinjaye 215 da suka goyi bayan, 10 suka ki, kuma 1 ya ki.
Saudi Arabia ta tsawaita lokacin shan kofi a biranen Makka da Madina har tsawon yini guda; a dā, ana shan kofi ne daga ƙarfe tara na yamma zuwa ƙarfe shida na safe.
Thailand ta shirya kofi tsakanin karfe 4 na dare zuwa karfe 10 na dare.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihar ta tsawaita dokar hana fita zuwa ranar 1 ga Mayu.
Shaguna a Ostiraliya sun ƙayyade adadin kwalaben da mutum zai iya saya a lokaci guda
A ranar Lahadi da Asabar da yamma, manyan kantunan Australiya, Woolworths da Coles sun sanya iyaka kan sayen kayan kwalliya idan mutum ya sayi guda biyu ko fiye a duk fadin kasar a cikin manyan kantunan.
ALDI ta kafa iyaka na 'yar'uwa guda a ranar Litinin.
An bayyana wannan dokar ne a cikin sanarwar da aka fitar a shafin Facebook na kamfanonin.
An shawarci masu sayen su kasance cikin shiri saboda tsoron COVID-19 yayin da ake buƙatar keɓewa.
A ranar Laraba, Woolworths ya rage yawan sayen kek da za a iya aikawa gida idan mutum ya samu guda daya a rana.
Wannan canjin ya biyo bayan takunkumin farko na kashi hudu na farashin da Woolworths da Coles suka gabatar a ranar 4 da 5 ga watan Maris a kan kamfanonin biyu a cikin yarjejeniyar.
A cikin wata sanarwa da Coles ta wallafa a ranar 8 ga watan Maris, ta ce "kasuwanci da dama sun kawar da takunkumin tallace-tallace a cikin sa'a daya da suka kawo", kuma ta ce ba a taba samun irin wannan bukatar ba, yayin da ALDI, a cikin wani sakon da ta wallafa a Facebook a ranar Talata, ta ce "ba a taba tsammanin hakan ba".
Kasuwanci sun yi tsalle sosai a makon da ya gabata a cewar mai magana da yawun Woolworths.
Wani shagon Costco da ke Canberra ya rage farashin 'yan'uwa biyu a makon da ya gabata.
Don rage rashi, Coles ya nemi masu aikawa da su kara yawan kayan da suka samar, Woolworths ya ba da umarnin kara yawan kayan da suka samar, kuma ALDI ta kawo wasu kamar yadda ta shirya a ranar Laraba ta musamman.
Russell Zimmerman, shugaban kungiyar 'yan kasuwar Australia, ya ce 'yan kasuwar suna kokarin kara yawan kayayyakin da suke sayarwa, amma takunkumin da hukumomi suka kafa kan yawan motocin da ake shigowa da su ya sa su cikin matsala.
Yana fatan ya kara yawan kudaden da ake kashewa, yayin da ma'aikata ke kokarin biyan bukatun da ake bukata da kuma iyakancewar kwanakin.
A ranar Talata, ALDI ta sanar da cewa bayan da aka fara sayar da kayayyakin da aka ajiye a cikin sauri, wasu shagunan ba za su iya yin wani abu ba sai ranar Laraba.
A wani rahoto da News.com.au ta wallafa, Dr Gary Mortimer, wani masanin sayar da kayayyaki daga jami'ar Queensland University of Technology, ya ce, kantuna suna kawo kayayyaki a kowane dare.
Ya ce, yawan ƙwai yana sa farashin kayayyakin ya yi kasa, kuma idan aka gama sayar da su, naman zai zama mai yawa kuma hakan zai sa a ji cewa akwai bukatar.
Russell Zimmerman ya gaya wa ABC News cewa "Coles da Woolworths sun yi tunanin [cewa] idan akwai abubuwa da yawa a cikin abincin, kayayyaki kamar su tukwane da kayan wanki [za a saya] kuma a samu su a yalwace, za a iya rage yawan cin hanci".
Wani ma'aikacin da ke kula da shan naman tumaki ya ce a ranar Laraba an gama shan naman.
Kimberly-Clark, wanda ke kera kayan kwalliya, da Solaris Paper wanda ke kera Sorbent, sun tabbatar da cewa suna aiki 24/7 don tabbatar da cewa suna gasa da bukatar, a cewar rahoton News.com.au.
Shafin yanar gizo na Domain.com, wanda ke sayar da dukiya, ya ce wasu 'yan kasuwa suna ba da kwalabe na kyauta ga wanda ya lashe gasar hammerball a Melbourne, tare da karancin tallace-tallace na hammerball saboda masu sayen suna da lokacin hutu a karshen mako wanda ya hada da ranar ma'aikata.
A cikin wata sanarwa da aka wallafa a ranar Alhamis a jaridar NT News da ke Darwin, an rubuta wani littafi mai ɗauke da takardu takwas da za a iya cirewa kuma a yi amfani da shi a matsayin abin da za a yi amfani da shi a matsayin abin da za a yi amfani da shi a matsayin abin da za a yi amfani da shi a matsayin abin da za a yi amfani da shi a matsayin abin da za a yi amfani da shi.
Shaguna sun fara hana sanya iyaka, a cewar rahoton ABC Australia a ranar 3 ga Maris inda suka ce ba su da shirin sanya iyaka kan sayayya.
Russell Zimmerman ya kara da cewa kayayyakin da ake sayarwa sun hada da kayan shafawa, kayan wanke hannu, abinci mai bushewa, sabulu da kuma gari.
Hakazalika, a waje da Ostiraliya, an ga cewa kantin sayar da kayayyaki na Ocado na kan layi a ranar Lahadi da yamma ya hana sayen 'yan kwalban Andres da suka kai 2 zuwa 12.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba ta duniya
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana barkewar cutar COVID-19  a matsayin cutar da ke haifar da kwayar cutar coronavirus SARS-CoV-2  a matsayin annoba ta duniya.
Ko da yake kalmar nan "tazarar duniya" tana nufin yadda cutar ta yadu, ba yadda wasu cututtuka suke da haɗari ba, WHO ta ba da shawarar cewa gwamnatoci su mai da hankali su yi aiki:
"Kowace ƙasa za ta iya canja yadda wannan matsalar ta duniya take yaɗuwa.
Idan ƙasashe suka yi bincike, su gwada, su yi magani, su rarraba, su sa ido, kuma su haɗa kan mutane a kan wannan batun", in ji Tedros Adhanom Ghebreyesus, Babban Daraktan WHO.
"Muna jin damuwarmu game da yadda cutar ke yaduwa da kuma yadda ake nuna rashin kulawa da kuma rashin kulawa".
Wani tsohon darektan Hukumar Kula da Cututtuka a Amirka, Dr. Tom Frieden ya ce wannan annoba "ba ta da kyau".
Ya ce, a cikin wata sanarwa da CNN ta bayar a ranar Talata, "ban da cutar korona, babu wani kwayar cutar da ta kamu da cutar numfashi da aka gano tun lokacin da ta bulla a duniya".
Ghebreyesus ya ba da irin wannan ra'ayi, yana mai cewa "ba mu taɓa ganin cutar coronavirus a duniya ba".
Ya daɗa cewa: "Ba mu taɓa ganin wata matsala da za a iya magance ta a dukan duniya ba".
Sabon matakin da aka dauka na rikicin na duniya ya zo ne bayan da Hukumar Lafiya ta Duniya (WHO) ta yanke shawarar a watan Janairu ta ayyana barkewar cutar a matsayin babbar matsalar lafiya ta duniya.
Daraktan Cibiyar Kula da Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar
A ranar Alhamis, kamfanin dillancin labarai na Associated Press ya ruwaito cewa akwai mutane 126,000 da suka kamu da cutar COVOID-19 a duniya, kuma mutane 4,600 ne suka mutu.
Cutar cutar coronavirus ta 2019/20 ita ce cutar COVID-19 mai ci gaba, wanda kwayar cutar coronavirus 2 (SARS-CoV-2) ke haifarwa.
An gano cutar a Wuhan, China, a watan Disamba na 2019, kuma an ayyana ta a matsayin babbar matsalar lafiya ta duniya a ranar 30 ga Janairu, 2020, sannan kuma a matsayin babbar cuta ta duniya a ranar 11 ga watan Agusta, 2020.
A ranar 10 ga watan Afrilu na 2020, an samu rahoton kamuwa da cutar COVID-19 miliyan 1.61 a kasashe 210 da yankuna, kuma kusan mutane 97,000 sun mutu.
Mutane 364,000 ne suka warke.
An kiyasta cewa yawan mutanen da suka kamu da cutar ya kai kashi 4 cikin 100 a kasar Sin, yayin da na duniya ya kai kashi 13.04% a Aljeriya da kuma kashi .08% a New Zealand.
Alamun cutar sun hada da zazzabin cizon sauro, tari da kuma numfashi.
Matsalar wannan cuta na iya haɗawa da ciwon huhu da kuma matsalolin numfashi.
Lokaci daga kamuwa da cutar zuwa bayyanar cututtuka yana da kimanin kwanaki biyar amma daga kwana biyu zuwa goma sha huɗu.
Babu maganin rigakafi ko magani na yau da kullum da ke hana cutar.
Maganin farko na maganin cutar shine maganin cututtuka da kuma taimako na farko. Shawarwarin da aka yi don gano cutar sun hada da, wanke hannu, rufe baki da kuma shafawa, nisantar da kai daga wasu, saka idanu da kuma ware kai idan kana zaton kana da cutar.
Hukumomi a dukan duniya sun amsa da hana mutane zuwa wurare dabam-dabam, da keɓe mutane, da hana yin amfani da kofi, da kuma hana yin aiki.
Wannan ya shafi lafiyar jama'a da tattalin arziki a duniya, ya kara ko soke wasanni, bukukuwan addini, al'amuran siyasa da al'adu, da kuma haifar da karancin kayayyaki da suka haifar da yawan sayayya.
Makarantu da jami'o'i sun rufe a matakin kasa ko yanki a kasashe 193, wanda ya shafi kusan kashi 99.4 na daliban duniya.
Bayanai na karya game da cutar sun bazu a yanar gizo kuma an sami hare-haren nuna kyama da nuna wariya ga Sinawa, wasu mutanen Gabas da Kudu maso Gabashin Asiya ko kuma wasu mutane masu kama da su daga yankunan da cutar ta fi yawa.
Ta hanyar rufe hanyoyin sufuri da manyan masana'antu, an sami raguwar gurbataccen yanayi da iskar carbon.
Jami'an kiwon lafiya a Wuhan, China (babban birnin lardin Hubei) sun ba da rahoton cewa akwai wasu mutane da suka kamu da cutar da ba a san su ba tun daga 31 ga Disamba, 2019, kuma an fara binciken a farkon Janairu, 2020.
An gano wadanda suka kamu da cutar ne a kasuwar sayar da abincin teku ta Huanan, inda ake ganin cutar ta samo asali ne daga dabbobi zuwa mutane.
Kwayar cutar da ta haifar da barkewar cutar ta SARS-CoV-2, sabuwar kwayar cutar da aka gano wacce ta yi kama da kwayar cutar bat coronaviruses, pangolin coronaviruses, da SARS-CoV. An gano mutum na farko da ya kamu da cutar a ranar 1 ga Disamba, 2019, kuma ba a gano cewa mutumin yana da alaƙa da sayar da kayan masarufi ba.
Daga cikin wadanda aka fara samun rahoto a watan Disamba na 2019, kashi biyu bisa uku na wadanda aka samu sun yi nasaba da wannan kasuwar.
A ranar 13 ga watan Maris na shekarar 2020, wani rahoto da ba a bayyana ba daga South China Morning Post ya nuna cewa wanda ya kamu da cutar a ranar 17 ga watan Nuwamba na shekarar 2019, mai shekaru 55 daga lardin Hubei, na iya zama wanda ya fara kamuwa da cutar. A ranar 26 ga watan Fabrairun 2020, WHO ta ba da rahoton cewa yayin da sabbin cututtuka suka ragu a China amma suka karu da sauri a Italiya, Iran, da Koriya ta Kudu, adadin sabbin masu kamuwa da cutar a wajen kasar Sin ya zarce sabon masu kamuwa da cutar a cikin kasar Sin a karon farko.
Wataƙila akwai wasu ƙididdigar marasa lafiya da ba a bayyana ba musamman waɗanda ba su da alamun cutar.
A ranar 26 ga watan Fabrairu, an samu karamin adadin mutane da suka kamu da cutar a tsakanin matasa masu shekaru 19 zuwa kasa da suka kai kashi 2.4% na wadanda suka kamu da cutar a duniya. Babban mai ba da shawara kan harkokin kimiyya na Burtaniya, Patrick Vallance, ya kiyasta cewa kashi 60% na yawan jama'ar Burtaniya na iya kamuwa da cutar kafin a samu kamuwa da cutar a cikin mutane.
Masu kamuwa da cutar sun nuna yawan mutanen da suka yi gwajin COVID-19, kuma sun tabbatar da cewa suna da cutar bisa ga bayanan hukuma.
A ranar 23 ga watan Maris, babu wata ƙasa da yawan jama'arta ya wuce kashi 3 cikin dari, kuma ƙasashe da yawa suna da tsarin gwajin marasa lafiya, kamar Italiya, Netherlands, Spain, da Switzerland.
Wani bincike da aka fitar a ranar 16 ga watan Maris ya nuna cewa a kasar Sin, har zuwa ranar 23 ga watan Janairu, kashi 86 cikin dari na masu kamuwa da cutar ba su riga sun yi allurar rigakafi ba, kuma wadanda ba a riga an yi musu allurar ba sun kai kashi 79 cikin dari na waɗanda aka yi wa allurar.
Binciken da aka fitar a ranar 30 ga watan Maris ya nuna cewa adadin masu kamuwa da cutar a Italiya ya fi na baya baya.
Hasashen farko na ƙididdigar ƙididdigar farko (R0) na COVID-19 ya kasance 1.4 zuwa 2.4.
Wani bincike da aka yi a Amirka da aka wallafa ta Cibiyar Kula da Cututtuka ya nuna cewa wannan adadin zai iya kaiwa 5.7.
Yawancin mutanen da ke kamuwa da COVID-19 suna warkewa.
A cikin waɗanda ba su tsira ba, tsawon lokacin da alamun cutar suka fara zuwa mutuwa ya kai kwanaki 6 zuwa 41, amma mafi yawan kwanaki 14 ne.
A ranar 10 ga Afrilu 2020, an bayar da rahoton mutuwar mutane 97,000 da suka kamu da cutar COVID-19.
A China, a ranar 5 ga watan Fabrairu, kashi 80% na mutanen da suka mutu sun kasance a cikin shekaru 60, kuma kashi 75% suna da wasu cututtuka ciki har da cututtukan zuciya da ciwon sukari.
Adadin ainihin mutuwar COVID-19 na iya zama mafi girma saboda ba za a iya samun mutane da ke mutuwa ba tare da an gwada su ba - a gida, a cikin gidajen kula da tsofaffi, da sauransu.
Wani rahoto na Italiya ya gano cewa adadin mutanen da suka mutu a lokacin annobar ya ninka na COVID sau 4-5 bisa na hukuma.
Wata mai magana da yawun cibiyar kula da cututtuka da rigakafin cutar ta Amurka (CDC) ta yarda cewa "Mun san cewa [adadin mutuwar] ba daidai ba ne", kuma mun tabbatar da hakan ne ta hanyar binciken da aka yi a Amurka. Rashin daidaito ya kasance a lokutan barkewar cutar kamar cutar mura ta alade ta 2009 H1N1.
Mutuwa ta farko da ta faru a waje da China ta faru ne a Philippines a ranar 1 ga watan Fabrairu, yayin da ta farko da ta faru a kasashen waje ta Asiya ta faru ne a Faransa a ranar 14 ga watan Fabrairu.
A ranar 28 ga Fabrairu, fiye da mutane 12 ne suka mutu a ƙasashen Iran, Koriya ta Kudu, da Italiya, ba tare da China ba.
A ranar 13 ga watan Maris, sama da kasashe 40 da yankuna sun bayar da rahoton mutuwar mutane a kusan dukkanin nahiyoyi sai dai Antarctica.
Wannan adadin yana canzawa a kowane yanki da lokaci kuma ya bambanta da yawan gwaje-gwaje, ingancin magani, maganin da ake samu, tsawon lokacin da cutar ta fara, da kuma yanayin jama'a kamar shekaru, jinsi, da kuma rayuwarsu gabaɗaya. Adadin mutuwar da mutuwar suna nuna yawan mutuwar da aka gwada a cikin lokaci.
A cewar bayanan Jami'ar Johns Hopkins, yawan mutuwar mutane da suka kamu da cutar ya kai 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu, 2020.
Adadin yana canjawa a ko'ina.
A kasar Sin, kimanta yawan mutuwar mutum dangane da kamuwa da cutar ya ragu daga kashi 17.3% (ga wadanda ke nuna alamun cutar a farkon ranar 10 ga Janairu 2020) zuwa kashi 0.7% (ga wadanda ke nuna alamun cutar a farkon ranar 1 ga Fabrairu 2020).
Waɗannan ƙididdigar ba su da iyaka a kan lokaci kuma suna bin wasu mutane tun daga lokacin da suka kamu da cutar har zuwa lokacin da aka yi musu allurar rigakafi.
Masu bincike sun yi ƙoƙari su ƙidaya yawan mutanen da suke raye a lokacin.
Cibiyar Kula da Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan mutanen da suka kamu da cutar AIDS a kullum ya kai kashi 0.1% zuwa 0.39%.
Babban kimantawa a wannan matakin ya yi daidai da sakamakon gwajin farko na COVID-19 a Jamus, kuma binciken da aka yi na ƙididdigar gwajin ya ba da shawarar ƙididdigar mutuwar.
Hukumar lafiya ta duniya WHO ta ce za a iya hana wannan cuta ta duniya.
Ba a san yadda cutar ke gudana ba kuma tsawon lokacin da za ta ci gaba ba kuma zai iya bambanta dangane da wuri.
Maciej Boni na Jami'ar Jihar Penn ya ce: "Idan ba a kula da cutar ba, za ta iya ƙaruwa kuma ta zama cuta mai yawa.
Amma ba shi yiwuwa a yi hasashen lokacin da hakan zai faru".
Babban mai ba da shawara ga gwamnatin China, Zhong Nanshan ya ce "za a iya kawo karshen cutar a karshen watan Yuni" idan an karfafa wa dukkan kasashe gwiwar bin shawarwari da ka'idojin WHO don dakatar da yaduwar cutar.
A ranar 17 ga watan Maris, Adam Kucharski na Makarantar Kiwon Lafiya da Magunguna ta London ya ce SARS-CoV-2 "zai iya yaduwa, mai yiwuwa a cikin shekara ɗaya ko biyu".
Bisa ga binciken Kwalejin Imperial da Neil Ferguson ya yi, ana bukatar a yi nesa da kuma ƙarin magani "har sai an samu rigakafin (wataƙila watanni 18 ko fiye da haka)".
"Ina tsammanin cewa cutar coronavirus ta hanyar yaduwar saurinta za ta iya zama wata cuta ta wucin gadi da ke sake faruwa a kowace shekara", in ji William Schaffner na Jami'ar Vanderbilt.
Tsakanin da zai dawo zai dogara ne akan yadda yake da alaka da kuma yadda yake da alaka da shi.
Alamun cutar COVID-19 na iya zama masu rikitarwa kuma waɗanda ke da cutar ba sa nuna alamun cutar.
Alamun da suka fi yawa sune zazzabin cizon sauro (88%) da kuma tari (68%).
Alamun da ba safai ba sun haɗa da rashin jin daɗi, yawan hawaye, rashin ƙamshi, rashin numfashi, ciwon tsoka, ciwon wuya, ciwon kai, jin iska/tsoro, amai, hawan jini (hemoptysis), ciwon jini, ko kuma cyanosis. WHO ta ce mutum ɗaya cikin shida yana rashin lafiya na dindindin kuma yana da wahalar numfashi.
Cibiyoyin Kula da Cututtuka na Amurka (CDC) sun ba da alamun farko kamar su numfashi mai tsanani, ciwon kirji, rashin jin daɗi, wahalar motsi, da kuma fuska ko lebe; ana buƙatar kulawa da gaggawa idan mutum ya sami alamun. Ciwon da ke ci gaba zai iya haifar da mummunan rauni, mutuwa ta hanyar numfashi mai tsanani (acute respiratory distress syndrome), sepsis, septic shock da sauransu.
Wasu marasa lafiya na iya zama marasa alamun cutar, amma idan an tabbatar da cutar, to masu bincike sun ba da shawarar cewa duk wanda ya sadu da waɗanda suka tabbatar da cutar ya kamata a kula da su sosai.
Kimanin kasar Sin na yawan alamun cutar ya kai kashi 44 cikin dari.
Lokacin bayyanar cututtuka (lokacin daga kamuwa da kwayar cutar zuwa bayyanar cututtuka) yawanci daga kwana ɗaya zuwa kwanaki 14; yawanci kwanaki biyar.
Har ila, ba a san yadda cututtuka suke yaɗuwa ba.
Ana zaton cewa cutar tana yaduwa ne a tsakanin mutanen da suka yi hulɗa da masu cutar tare da shan ruwan da ake yadawa ta hanyar tari, ɗagawa, ko magana; kuma wannan hulɗa tana tsakanin 1 zuwa 2 mita (3 zuwa 6 feet).
Bincike ya nuna cewa idan aka yi amfani da ruwa a kan ruwa, sai rijiyar ta yi nisa daga mita 4.5 zuwa 8.2.
Wasu sun ce za a iya yada kwayar cutar ta hanyar iska mai iska mai iska, wanda za a iya fitarwa ta hanyar magana. Za a iya fitar da ruwa daga numfashi ta hanyar numfashi ciki har da lokacin magana, ko da yake ba a yawanci cutar ta tashi ta iska.
Za a iya kai ƙanshin cikin hanci ko bakin mutane da ke kusa ko kuma a yi masa jijiya a cikin huhu.
Wasu hanyoyin magani kamar su yin amfani da maganin sauro da kuma aikin farfado da zuciya (CPR) na iya sa a samu wani rami a cikin jijiya, kuma a sa cutar ta yaɗu ta iska.
Za a iya yaɗawa ta wurin taɓa wani abu da ke da cutar, kamar fuska, jijiyoyi, ko kuma baki.
Ko da yake akwai tsoron cewa za ta iya yaɗuwa zuwa mugunta, an yi imanin cewa wannan haɗarin bai da yawa.
Gwamnatin kasar Sin ta yi watsi da yiwuwar yaduwar cutar SARS-CoV-2. Kwayar cutar ta fi yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, amma ana iya yaduwa kafin bayyanar cututtuka da kuma a cikin matakan ƙarshe na kamuwa da cutar.
An gano mutane da cutar kwanaki uku kafin bayyanar cututtuka da ke nuna yiwuwar yaduwar cutar ko da ba a nuna alamun cutar ba.
Rahotanni sun nuna cewa an sami wasu marasa lafiya da ba su da alamun cutar, amma an gano cewa ana iya samun cutar ta hanyar mutanen da ba su da alamun cutar a wasu ƙasashe ta hanyar lura da hulɗar da mutum da ke da cutar da sauran mutane.
Cibiyar hana yaduwar cututtuka ta Turai (ECDC) ta ce ba a san yadda cutar ke yaduwa ba, amma a halin yanzu mutum daya ne ke kamuwa da cutar daga mutane biyu zuwa uku. Kwayar cutar tana rayuwa a kan abubuwa na tsawon sa'o'i da kwanaki.
Musamman, an gano cewa kwayar cutar ta yi rayuwa har tsawon kwanaki uku a kan filastik (polypropylene) da kuma a kan 304-degree-gallon, rana ɗaya a kan kwali da kuma sa'o'i huɗu a kan takarda.
Maimakon haka, wannan ya bambanta dangane da tushen iska da yanayin zafi. An gwada dabbobin gida da dabbobi don COVID-19.
Babu rahoto da ya nuna cewa dabbobi suna iya yaɗawa mutane cutar, ko da yake hukumomi a Biritaniya sun ba da shawarar cewa mutane su wanke hannuwansu bayan sun taɓa dabbobi, kamar yadda suke yi da abin da ya shafi waɗanda ake zargi da cutar.
Kwayar cutar coronavirus 2 (SARS-CoV-2) kwayar cutar da ba a gano ba, wacce aka fara ganowa a cikin mutane uku da suka kamu da cutar da ta yi daidai da wacce ta kamu da cutar numfashi mai saurin kamuwa da cuta a Wuhan.
Duk wani kwayar cutar SARS-CoV-2 da ba a taɓa ganowa ba yana cikin kwayar cutar coronavirus mai kama da sauro. A waje da jikin mutum ana kashe kwayar cutar ta hanyar sabulu na gida, wanda ke kashe kwayar cutar. SARS-CoV-2 yayi kama da kwayar cutar SARS-CoV da aka fara ganowa.
Ana tsammanin cewa daga dabbobi ne ya zama mutum.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar coronavirus a cikin kwayoyinta ta kama da nau'in Betacoronavirus, a cikin nau'in Sarbecovirus (lineage B) tare da nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'in nau'ikan nau'ikan nau'ikan.
Yana da kusan kashi 96 cikin dari na kamanceceniya a matakin kwayoyin halitta da sauran kwayoyin cutar da ke cikin samfurori (BatCov RaTG13).
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai amino acid guda daya a wasu sassan jerin kwayoyin halitta tsakanin kwayoyin halittar pangolins da kuma kwayoyin halittar mutum.
Ya zuwa yanzu, mafi yawan kwatancen kwayoyin halitta sun gano cewa kashi 92% na kwayoyin halitta suna cikin bangolin coronavirus da SARS-CoV-2, wanda bai isa ya tabbatar da pangolin ba.
Ana iya gano kwayar cutar a farkon bayyanar cututtuka, amma ana tabbatar da ita ta hanyar jujjuyawar polymerase chain reaction (rRT-PCR) a cikin kwayoyin da aka shafa ko kuma a cikin hoto na kwamfuta (CT imaging).
Binciken da aka yi a Wuhan wanda ya kwatanta PCR da CT ya nuna cewa amfani da CT ya fi PCR, ko da yake ba a bayyana shi ba, kuma sassan hoton suna ɓacewa a cikin wani kwayar cuta da kuma wasu cututtuka.
A watan Maris na shekarar 2020, Kwalejin Kula da Maganin Radiology ta Amurka ta ba da shawarar cewa "Ya kamata a yi amfani da CT don tantance ko kuma a yi amfani da shi azaman gwajin farko don gano COVID-19".
WHO ta fitar da bayanan bincike na RNA na SARS-CoV-2, wanda aka fara fitarwa a ranar 17 ga Janairu.
Gwajin yana amfani da ainihin lokacin jujjuyawar polymerase chain reaction (rRT-PCR).
Ana iya yin gwajin ne ta hanyar samfurin iska ko jini.
A yawancin lokaci, ana ganin sakamakon bayan 'yan sa'o'i zuwa kwanaki.
A yadda aka saba, ana yin wannan gwajin ne a kan kwayar nasopharyngeal ko da yake ana iya amfani da kwayar fitsari. Yawancin gwaje-gwaje da kamfanoni suna haɓaka gwajin jini don gano rigakafin jiki.
Ya zuwa ranar 6 ga watan Afrilu, 2020, babu ɗayan waɗannan da aka tabbatar da ingancinsa ta hanyar kimiyya don tabbatar da amfani a ko'ina.
A Amurka, an amince da gwajin jini da Cellex ya samar don amfani da gaggawa a cikin gwaji na musamman.
Alamun da ke nunawa a kan radiographs da CT na mutane masu lura da alamun sun hada da asymmetric peripheral ground glass opacities da kuma rashin fitowar pleural.
Kamfanin Radiological na Italiya yana kan aikin samar da wani shafin yanar gizo na hotunan da aka samu daga mutanen da suka kamu da cutar.
Saboda haɗuwa da wasu cututtuka kamar adenovirus, yin hoto ba tare da tabbatar da PCR ba ba zai iya tabbatar da gano COVID-19 ba.
Wani babban bincike a kasar Sin ya kwatanta sakamakon CT na kirji da PCR kuma ya nuna cewa ko da daukar hoto ba zai iya tabbatar da cutar ba, yana nuna cewa ya kamata a yi amfani da hankali sosai wajen gano wuraren da cutar ta kama.
An tsara hanyoyin sadarwa na kwakwalwa na kwakwalwa na kwakwalwa na kwakwalwa don yin amfani da hotunan hoto ta hanyar amfani da radiographs da CT.
Hanyoyin hana yaduwar cutar sun hada da kiyaye tsabta a ko'ina, wanke hannu, guje wa taɓa fuska, hanci, ko baki ba tare da wanke hannu ba, da kuma shafa ko tsotsa a cikin takarda ko takarda sannan a jefa shi kai tsaye a cikin kwandon shara.
An shawarci wadanda ke da cutar su sanya abin rufe fuska a lokacin da suke tafiya daga gida.
Gwamnatoci da dama sun hana ko kuma sun shawarci mutane kada su yi tafiya sai dai idan ba zai yiwu ba su je ko kuma su bar wuraren da cutar ta yi tasiri.
A maimakon haka, cutar ta kai matakin da za ta iya yaduwa a yankuna da dama a duniya.
Wannan yana nufin cewa kwayar cutar tana yaduwa a cikin al'ummomi, kuma wasu mutane a cikin al'ummomin ba su san inda ko yadda aka kamu da su ba. Ana ba da shawara ga masu aikin jinya/likitoci da ke kula da wanda ke da cutar su yi taka tsantsan, su kasance cikin hulɗa da mai yiwuwa, da kuma rufe fuska. Kula da mutanen da suka sadu da su yana da mahimmanci ga ma'aikatan kiwon lafiya don gano wanda ya haifar da cutar kuma don guje wa ci gaba da yaduwar cutar.
Gwamnati ta yi amfani da bayanan wurin da mutum yake daga wayoyin salula don wannan dalili ya haifar da shakku kan batun sirri yayin da Amnesty International da sauran kungiyoyi sama da 100 suka fitar da takardu don nuna iyakancewar irin wannan sa ido.
An yi amfani da aikace-aikacen wayar hannu da dama ko kuma an shirya su don amfani da su a cikin yanayi na gaggawa, kuma tun daga ranar 7 ga Afrilu, 2020, sama da hukumomi 20 na ba da shawara kan batutuwan sirri kamar amfani da Bluetooth don haɗa mai amfani da wayar zuwa wasu wayoyi.
Masu amfani suna samun bayanai game da kusanci da aka yi wa wanda aka gwada yana da cutar COVID-19. Bayanai na yaudara suna yawo a ko'ina game da yadda za a hana kamuwa da cutar; misali, wanke hanci da ruwa da kuma yin taushi da ruwa a baki amma duk waɗannan ba su da tasiri.
Babu maganin rigakafin COVID-19, duk da cewa hukumomi da dama suna aiki tukuru don samar da shi.
Ana bada shawarar wanke hannu don hana yaduwar cututtuka.
CDC ta ba da shawarar cewa mutane su wanke hannu da sabulu da ruwa a kowane lokaci na akalla minti 20, musamman bayan sun je bayan gida ko kuma idan hannayensu suna da launin rawaya; kafin cin abinci; da kuma bayan sun yi taushi, yin tari ko kuma yin tari.
Wannan saboda a waje da jikin mutum, ana kashe kwayoyin cuta da sabulu na gida, sabulu mai kashe fata.
CDC ta kuma bada shawarar yin amfani da ruwan sha mai dauke da giya da sabulu da ruwa a cikin kashi 60 cikin dari idan babu su.
Hukumar ta WHO ta ba da shawarar kada a taɓa fuska, hanci, ko baki da hannaye ba tare da wanke su ba.
Za a iya kashe kwayoyin cuta ta hanyar amfani da ruwa mai guba (a cikin minti daya idan an yi ƙarfe kuma an taɓa mai cutar), wanda ya ƙunshi kashi 62% ethanol, 50% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.27.5% povidone-iodine.
Wasu magungunan ruwa, kamar su benzalkonium chloride da chrohexidine gluconate, ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan aka yi zargin ko kuma an tabbatar da cutar ta COVID a wani wuri kamar ofis ko wurin kula da yara, duk wuraren kamar ofis, wanka, wuraren shakatawa, kayan lantarki da ake rarraba su kamar su kwamfutar hannu, fuskokin taɓawa, kwakwalwa, motoci, da na'urar ATM da aka yi amfani da ita ta mutum mai cutar, ya kamata a tsabtace su.
Hukumomin kiwon lafiya sun ba da shawarar cewa mutane su rufe bakinsu da hanci da takardar rufewa da aka yi amfani da ita.
Ana ba da shawarar sanya abin rufe fuska ga waɗanda ke da cutar, saboda saka abin rufe fuska na iya rage tsawon lokaci da yawan lokacin da mutum zai iya magana, yin magana, da kuma yin magana.
Hukumar Lafiya ta Duniya ta bayar da umarni kan lokacin da kuma yadda ya kamata a yi amfani da abin rufe fuska.
A cewar Stephen Griffin, wani mai binciken kwayoyin cuta a Jami'ar Leeds, "Sanya takunkumi na iya rage yiwuwar kamuwa da cutar ta fuska kuma shine tushen yaduwar cutar fiye da yadda mutum zai iya idan bai wanke hannunsa ba.
WHO ta ba da shawarar cewa masu lafiya su sanya abin rufe fuska ne kawai a lokacin da suke cikin mawuyacin hali kamar su kula da wanda ke fama da cutar COVID-19, yayin da suka yi imanin cewa sanya abin rufe fuska zai taimaka wa mutane su guji tuntuɓar fuska.
Ƙasashe da yawa sun soma bukatar kowa ya saka abin rufe fuska.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska na kayan aiki, yayin da China ta ba da shawarar yin amfani da abin rufe fuska na likita sau ɗaya, musamman lokacin da mutum ya kusanci mutane (mita 1 (ƙasa 3) ko ƙasa da haka).
Hong Kong ta ba da shawarar sanya abin rufe fuska a lokacin da ake hawa motocin jama'a ko kuma a wuraren da jama'a suke.
Ma'aikatan kiwon lafiya a Thailand sun shawarci mutane su sanya abin rufe fuska a gida kuma su yi wanka a kowace rana.
Jamhuriyar Czech da Slovakia sun hana mutane fita daga gidajensu ba tare da sun saka abin rufe fuska ba.
A ranar 16 ga watan Maris, Vietnam ta bukaci kowa da kowa ya sanya abin rufe fuska a fili don kare kansa da kuma sauran mutane.
Gwamnatin Austria ta bukaci kowa ya saka abin rufe fuska sa'ad da ya shiga shago.
Isra'ila ta bukaci duk wani dan kasa da ya sanya abin rufe fuska a duk lokacin da yake cikin jama'a.
Taiwan, wacce ke yin abin rufe fuska miliyan goma a kowace rana tun tsakiyar ranar Laraba, a ranar 1 ga watan Afrilu ta bukaci fasinjojin jiragen kasa da bas da ke zirga-zirgar birane su sanya abin rufe fuska.
Panama ta sanya sanya abin rufe fuska doka ga kowa da kowa lokacin da ya fita daga gida, kuma tana ƙarfafa mutane su sanya abin rufe fuska a gida ga waɗanda ba za su iya saya ba.
An kuma yi amfani da tabarau a wurare da yawa a Japan, Koriya ta Kudu, Malaysia, da Singapore.
Nisa ya ƙunshi matakan da za a dauka don hana yaduwar cuta ta hanyar rage kusanci da mutane.
An kafa takunkumi, an hana mutane yin tafiye-tafiye, an rufe makarantu, wuraren aiki, filayen wasanni, wuraren shakatawa, da kuma kantuna.
Mutane za su iya rage nesa da suke yi daga gida, su rage yawan tafiya, su guji wuraren taro, su gai da mutane ba tare da sun taɓa su ba, kuma su yi kamar ba su san kowa ba.
Gwamnatoci da yawa yanzu suna tilasta wa mutane su ware kansu daga yankunan da cutar ta addabi.
Matsakaicin adadin mutanen da hukumomin gwamnati da na kiwon lafiya suka yi wa rigakafin ya ragu daga mutane 250 (lokacin da babu cutar COVID-19 a yankin) zuwa 50, sannan ya ragu zuwa mutane 10.
A ranar 22 ga watan Maris na shekarar 2020, Jamus ta soke taron jama'a fiye da biyu. Tsofaffi da waɗanda ke da wasu cututtuka kamar su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini da kuma rashin aiki na jijiyoyin jiki suna cikin haɗari kuma CDC ta ba da shawarar su zauna a gida kamar yadda zai yiwu musamman idan suna cikin yankunan da ke fama da cutar. A ƙarshen Maris na 2020, WHO da sauran hukumomin kiwon lafiya sun fara amfani da kalmar  warewa da  warewa don sanar da cewa manufar ita ce rage hulɗa tsakanin mutane amma don fadada mutane su dogara da wasu hanyoyin sadarwa ko kuma juna.
Yin amfani da kalmar nan "rabuwa" ya nuna cewa mutane su ware kansu daga juna, maimakon su ƙarfafa su su ci gaba da sadarwa da juna ta wasu hanyoyi. Wasu hukumomi sun ba da shawarar yin jima'i ba tare da haɗari ba a lokacin da aka fara.
Wannan aikin shine don ƙarfafa su su yi jima'i kawai tare da mutumin da suke zaune tare, wanda ba shi da cutar ko kuma ba shi da alamun cutar.
Ana ba da shawarar ware kai ga waɗanda aka gwada suna da cutar COVID-19 ko waɗanda ake zargin suna da cutar.
Hukumomin kiwon lafiya sun ba da umarnin keɓewa. Yawancin gwamnatoci suna tilasta ko ba da shawarar keɓewa ga duk mutanen da ke cikin yankunan da cutar ta shafa.
An ba da umarni mafi tsauri na keɓewa a yankunan da ke da haɗari.
Wadanda suka yi hulɗa da wani mai cutar COVID-19 da waɗanda suka yi tafiya zuwa ƙasashe ko yankuna inda cutar ke yaduwa an shawarce su da su keɓe kansu na tsawon kwanaki 14 daga lokacin da suka sami damar hulɗa da cutar.
Dabaru na farko da za a yi amfani da su shine magance su ko hana su.
An fara rigakafin ne a farkon barkewar cutar kuma yana nufin ganowa da kebe waɗanda cutar ta shafa tare da samar da ƙarin matakan rigakafi da rigakafi don dakatar da yaduwar cutar a cikin sauran al'ummomin.
Idan ba za a iya hana yaduwar cutar ba, to, ƙarfin ya koma kan yaki da cutar: ana iya ɗaukar matakai don rage yaduwar cutar da kuma hana tasirinsa ga tsarin kiwon lafiya da jama'a.
Za a iya amfani da rigakafi da makamai a lokaci guda.
Rage cutar na bukatar a yi aiki tukuru don a samu sauyin yanayi a lokacin da ake samun raguwar bambance-bambance 1. Ɗaya daga cikin hanyoyin da za a iya magance cutar ta hanyar rage yawan cutar da ake kira fashewa ita ce ƙoƙarin rage yawan yaduwar cutar da ake kira flattening the curve.
Wannan yana rage haɗarin sabis na kiwon lafiya mai aiki da yawa da kuma ba da isasshen lokaci don yin allurar rigakafi.
Hanyoyin da ba na magani ba na taimakawa wajen shawo kan cututtukan da suka barke sun hada da, ayyukan mutum-mutumin da za su hana kamuwa da cutar, kamar wanke hannu, sanya abin rufe fuska, da kuma ware kai; ayyukan jama'a na rage nesa kamar rufe makarantu da soke taron jama'a; karfafa yarda da shiga cikin irin wadannan ayyukan; da kuma ayyukan kare muhalli kamar tsabtace wurare da kayayyaki. An gudanar da ayyukan da suka dace na yaki da cutar a kasar Sin lokacin da cutar ta barke, kamar sanya keɓewar birane da kuma sanya takunkumin hana zirga-zirgar jama'a.
Sauran kasashe sun kuma kafa wasu matakan da za su rage yaduwar cutar.
Koriya ta Kudu ta kafa keɓewar jama'a da keɓewa, da kuma gargadi game da masu tafiya da suka kamu da cutar.
Singapore ta taimaka wa waɗanda suka yi keɓewa ta hanyar ba da kuɗi da kuma karɓar waɗanda suka ƙi.
Taiwan ta kara samar da abin rufe fuska da kuma hana mutane yin amfani da kwayoyi. Wani bincike da aka yi a Birtaniya da Amurka ya nuna cewa rigakafi (ragewa ba rage yaduwar cutar ba) da kuma rage cutar (hana yaduwar cutar) suna da kalubale.
Ingantaccen tsarin rigakafin cutar na iya rage yawan buƙatun magani da kashi biyu cikin uku da mutuwar mutane da rabi, amma hakan yana haifar da dubban mutuwar da rashin lafiyar marasa lafiya.
Za a iya rage kamuwa da cuta sosai amma dole ne a yi hakan muddin cutar ta riga ta yaɗu a cikin mutane (ko kuma har sai an sami rigakafin, idan hakan ya fara), amma cutar za ta iya dawowa idan an yi bincike.
Ƙoƙarin da ake yi na magance cututtuka na dogon lokaci yana jawo wa mutane lahani da kuma kashe kuɗi.
Babu wani magani da aka amince da shi don cutar COVID-19, amma ana ci gaba da yin amfani da maganin, wanda ya hada da gwajin kwayoyin da ake da su a halin yanzu.
Shan maganin mura, shan abin sha, da kuma hutawa na iya taimakawa wajen rage alamun cutar.
Dangane da girman haɗarin, ana iya buƙatar yin amfani da iska, ruwa da kuma kayan aiki.
Yin amfani da kwayoyin steroid zai iya sa yanayin ya yi wuya.
Ana nazarin magungunan da aka yi amfani da su a baya don magance wasu cututtukan kwayar cuta don amfani da su wajen magance COVID-19.
WHO ta kuma ce "wasu hanyoyin maganin gargajiya na iya rage wasu alamun cutar da SARS-CoV-19 ke haifarwa".
Ƙara iyawa da daidaitawa a cikin kulawar da ake buƙata don marasa lafiya na COVID-19 kamar yadda WHO ta bayyana babban mataki ne na magance barkewar cutar.
ECDC da ofishin WHO na Turai sun fitar da jagororin asibitoci da hanyoyin farko na kula da lafiya a matakai daban-daban ciki har da mayar da hankali kan ayyukan gwaji a cikin gwajin COVID-19, kawar da ayyukan da ba na gaggawa ba a duk lokacin da ya yiwu, keɓewa da keɓewar marasa lafiya na COVID-19, da haɓaka kulawa ta musamman ta hanyar horar da ma'aikata da haɓaka yawan kayan aikin taimako a asibitoci.
Akwai ra'ayoyi da dama game da asalin mai haƙuri na farko (wanda ake kira mai haƙuri zero).
An samu mutum na farko da ya kamu da cutar coronavirus a ranar 1 ga watan Disamba 2019 a Wuhan, Hubei, China.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya tashi a hankali.
Wadannan sun danganta ne da kasuwar kifin Huanan (Huanan Seafood Wholesale Market), wanda ke sayar da dabbobi masu rai, kuma wani ra'ayi ya ce kwayar cutar ta samo asali ne daga daya daga cikin wadannan dabbobi; ko, a wasu kalmomin, asalinsa yana cikin dabbobi. An gano wani nau'in cutar huhu da ba a sani ba a ranar 26 ga Disamba wanda likita Zhang Jixian ya kula da shi a Asibitin lardin Hubei, wanda Wuhan Jianghan CDC ta ruwaito a ranar 27 ga Disamba.
A ranar 30 ga watan Disamba, ƙungiyar likitoci a asibitin Wuhan ta yi gargadin abokan aikinta cewa za a iya samun wani nau'in kwayar cutar SARS.
An tuhumi takwas daga cikin likitocin, ciki har da Li Wenliang, da yin karya da 'yan sanda suka yi, yayin da wani mai suna Ai Fen, ya zargi shugabanninsa da yin fashin.
Hukumar kula da lafiya ta Wuhan ta bayar da sanarwar a ranar 31 ga watan Disamba kuma ta sanar da WHO.
An sanar da hukumomin Wuhan game da wasu marasa lafiya da ke da cutar da ba a san su ba a farkon watan Janairu.A farkon barkewar cutar, adadin masu cutar ya ninka kusan sau bakwai da rabi.
A farkon da tsakiyar watan Janairu na shekarar 2020, cutar ta bazu zuwa wasu sassan kasar Sin, saboda bikin sabuwar shekara da kuma yadda Wuhan ke da yawan zirga-zirga da kuma tashar jirgin kasa.
A ranar 20 ga watan Janairu, kasar Sin ta bayar da rahoton sabbin mutane 140 da suka kamu da cutar a rana daya, ciki har da mutum biyu a birnin Beijing da kuma mutum daya a birnin Shenzhen.
Daga baya, bayanan hukuma sun nuna cewa mutane 6,174 sun sami alamun cutar a ranar 20 ga Janairu, 2020. A ranar 26 ga Maris, Amurka ta zarce China a cikin adadin waɗanda aka tabbatar da cutar a duniya. A ranar 9 ga Afrilu, 2020, an gano sama da mutane 1.61 a duniya; sama da mutane 97,000 sun mutu kuma sama da mutane 364,000 sun warke.
Kimanin kasashe 200 sun samu mutum daya da ya kamu da cutar.
Saboda wannan matsalar a Turai, ƙasashe da yawa da ke yankin Schengen sun kafa takunkumi a kan yadda za su yi tafiya a ƙasashen waje kuma sun kafa wasu ƙuntatawa a kan iyakokinsu.
Wasu daga cikin kasashen da suka dauki matakan hana yaduwar cutar sun hada da keɓewa (wanda aka fi sani da dokar zama a gida, dokar hana fita, ko kulle-kulle) da kuma kafe. A ranar 2 ga watan Afrilu, mutane miliyan 300 ne ke da allurar rigakafi, ko kuma kusan kashi 90% na yawan jama'a a Amurka, sama da mutane miliyan 50 ne ke da allurar rigakafi a Philippines, miliyan 59 a Afirka ta Kudu, da kuma mutane biliyan 1.3 a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya sun kamu da cutar sankara, kuma adadin ya karu zuwa biliyan 2.6 bayan kwana biyu, wanda ya kai kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An gano mutum na farko da ke dauke da cutar COVID-19 a ranar 1 ga Disamba, 2019 a Wuhan; rahotanni da ba a tabbatar da su ba sun nuna cewa an gano mutum na farko a ranar 17 ga Nuwamba.
Dokta Zhang Jixian ya gano wani rukunin marasa lafiya da ba a san ko su waye ba da suka kawo shi a ranar 26 ga watan Disamba, bayan haka asibitin ya sanar da hukumomin Wuhan Jianghan CDC a ranar 27 ga watan Disamba.
Gwajin kwayoyin farko da aka yi a kan samfurori na marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna cewa suna da kwayar cutar coronavirus mai kama da SARS.
Hukumar kiwon lafiya ta Wuhan ta fitar da sanarwar ga jama'a a ranar 31 ga watan Disamba.
An sanar da WHO a ranar.
Bayan sanarwar, an gargadi likitoci a Wuhan da 'yan sanda saboda yaduwar jita-jita game da barkewar cutar.
Hukumar Lafiya ta kasar Sin a baya ta ce babu "bayanan da suka nuna" cewa mutane suna yaduwa daga mutum zuwa mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani yunkuri na yaki da cutar da sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping ya kira "yaƙin jama'a".
A cikin abin da aka kira "mafi girman keɓewa a rayuwar ɗan adam", an sanar da dokar kulle a ranar 23 ga Janairu don dakatar da zirga-zirga zuwa ko daga Wuhan, kuma an faɗaɗa shi zuwa birane 15 a Hubei, wanda ya shafi mutane miliyan 57.
An hana amfani da motoci masu zaman kansu a cikin birnin.
An soke bikin Sabuwar Shekara ta kasar Sin (25 ga Janairu) a wurare da dama.
Hukumomi sun kuma sanar da gina asibitin wucin gadi, asibitin Huoshenshan, wanda aka kammala cikin kwanaki 10.
An gina wani asibiti da ake kira Leishenshan Hospital don a kula da marasa lafiya.
Baya ga sabon asibiti da aka gina, kasar Sin ta sake gina wasu wurare 14 a Wuhan, kamar dakunan taro da filayen wasanni da asibitocin gaggawa.A ranar 26 ga Janairu, gwamnati ta gabatar da wasu sabbin ka'idoji don magance barkewar cutar COVID-19, gami da takardun shaida na masu tafiya da kuma tsawaita bikin hutun bazara.
Jami'o'i da makarantu a duk fadin kasar ma an rufe su.
An kafa takunkumi a Hong Kong da Macau, musamman a makarantu da jami'o'i.
An kafa tsarin samar da aikin yi a wurare da dama a kasar Sin.
An kafa takunkumin hana zirga-zirga a ciki da wajen Hubei.
An sauya hanyoyin sufuri na gari, kuma an rufe wuraren shakatawa na gargajiya na ɗan lokaci.
An fara aiwatar da takunkumin hana zirga-zirgar jama'a a birane da dama, kuma an kiyasta cewa mutane miliyan 760 (fiye da rabin yawan jama'a) sun shiga cikin wasu nau'ikan takunkumi. Yayin da cutar ta bazu a duniya a watan Maris, hukumomin kasar Sin sun kafa tsauraran matakai don hana cutar da kuma hana shi shiga kasar Sin.
Misali, Beijing ta sanya dokar keɓewa na kwanaki 14 ga duk 'yan kasashen waje da ke shiga kasar Sin. A ranar 23 ga watan Maris, a cikin kasar Sin akwai mutum daya da ya kamu da cutar a cikin kwanaki biyar da suka gabata kuma wannan matafiyi ne da ya dawo Guangzhou daga Istanbul.
A ranar 24 ga watan Maris na shekarar 2020, firaministan kasar Sin Li Keqiang ya bayyana cewa an rufe barkewar cutar a kasar Sin kuma an shawo kan barkewar cutar a kasar Sin.
A wannan ranar ne aka sake kafa takunkumin hana zirga-zirga a Hubei, ban da Wuhan, bayan watanni biyu da sanya dokar kulle. Ma'aikatar Harkokin Wajen Sin ta sanar a ranar 26 ga watan Maris 2020 cewa za a dakatar da biza ko izinin aiki zuwa China daga ranar 28 ga watan Maris zuwa gaba ba tare da bayyana lokacin da dokar za ta kare ba.
Wadanda suke son shiga kasar Sin za su bukaci neman biza daga ofishin jakadancin kasar Sin.
Gwamnatin kasar Sin ta bukaci 'yan kasuwa da kamfanoni su bude ranar 30 ga watan Maris, tare da samar da abubuwan jan hankali ga kamfanoni. Kwamitin Jiha ya fara da sanya ranar makoki ta kasa da yin shiru na mintina 3 daga karfe 4 na ranar 4 ga watan Afrilu, wanda ya yi daidai da bikin Qingming, amma gwamnatin tsakiya ta nemi iyalai su sanya sakon makoki ta yanar gizo da nufin hana sake yada sabon cutar COVID-19.
An tabbatar da cewa COVID-19 ya isa Koriya ta Kudu a ranar 20 ga Janairu 2020 daga China.
Hukumar Lafiya ta kasa ta bayar da rahoton karuwar masu kamuwa da cutar a ranar 20 ga watan Fabrairu, inda ta ce sakamakon taron da aka yi a Daegu na sabon cocin Shincheonji Church of Jesus ne.
Mabiya Shincheonji da suka yi tafiya zuwa Daegu daga Wuhan ne ake zargi da haddasa barkewar cutar.
A ranar 22 ga watan Fabrairu, mutane 9,336 na cocin, 1,261 ko kuma kusan kashi 13 cikin dari, sun ba da rahoton cewa suna da alamun cutar. Koriya ta Kudu ta ba da sanarwar mafi girma a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga watan Fabrairu, an samu fiye da mutane 2,000 da suka kamu da cutar a Koriya, kuma adadin ya kai 3,150 a ranar 29 ga watan Fabrairu.
An killace dukkan sansanonin sojoji a Koriya ta Kudu bayan da aka tabbatar da cewa sojoji uku suna da kwayar cutar.
An kuma yi wa tsarin zirga-zirgar jiragen sama wasu canje-canje.Koriya ta Kudu ta kafa wani tsari da ake ganin ya fi na duniya girma da inganci na tantance mutane da ke dauke da kwayar cutar, tare da ware duk wanda ke dauke da kwayar cutar ta hanyar bin diddigin mutum da kuma ware duk wanda ya taba hulɗa da wanda ke dauke da kwayar cutar.
Tsarin na iya hada da nuna alamun cutar ga baƙi ta amfani da manhajojin wayar salula, tuki zuwa wurin gwajin da kuma samun sakamakon a washegari, da kuma kara yawan gwajin da zai iya gwada mutane 20,000 a rana.
An yi la'akari da shirin Koriya ta Kudu a matsayin nasara wajen magance barkewar cutar duk da cewa ba dukkan biranen da aka sanya su keɓewa ba.
Yawancin 'yan Koriya sun sanya hannu kan takardar neman Moon ya sauka daga mulki suna mai cewa gwamnati ba ta kula da annobar ba yayin da wasu suka musanta matakin da ya dauka.
A ranar 23 ga watan Maris, an ba da rahoton cewa Koriya ta Kudu ta kasance mafi ƙarancin adadin masu kamuwa da cutar a duniya tsawon makonni huɗu.
A ranar 29 ga watan Maris aka sanar da cewa daga ranar 1 ga watan Afrilu duk matafiya daga kasashen waje za a killace su na tsawon makonni biyu.
A ranar 1 ga watan Afrilu, kafofin yada labarai sun ruwaito cewa Koriya ta Kudu ta nemi taimakon kayan aikin gwajin cutar daga kasashe 121.
Iran ta sanar da kamuwa da cutar SARS-CoV-2 a ranar 19 ga watan Fabrairu a Qom, kuma Ma'aikatar Lafiya da Ilimin Likita ta ba da rahoton mutuwar mutane biyu a ranar.
Matakan farko da gwamnati ta sanar sun hada da soke kide kide da wake-wake da bukukuwan al'adu, bukukuwan wasanni, sallar Juma'a, rufe jami'o'i, kwalejoji, da makarantu.
Iran ta kafa dala tiriliyan biyar don yaki da cutar.
A ranar 26 ga watan Fabrairun 2020, Shugaba Hassan Rouhani ya ce babu wani shiri na keɓewa a yankunan da cutar ta shafa kuma dole ne a keɓe mutane.
An sanar da shirin rage zirga-zirgar ababen hawa tsakanin birane da dama a ranar Laraba duk da cewa an ci gaba da gudanar da zirga-zirgar ababen hawa da yawa a lokacin bikin Sabuwar Shekara ta Farisa (Persian New Year Nowruz).
An bude wuraren ibada na Shia a Qom ga masu yawon bude ido har zuwa 16 ga watan Agusta 2020. Iran ta zama cibiyar yada kwayar cutar a kasar Sin a watan Fabrairu.
A yayin da ake zargin cewa an yi wani yunkuri na rufe cutar a Iran, sama da kasashe goma sun sanar da masu cutar da suka kasance a Iran a ranar 28 ga watan Fabrairu, wanda ke nuna cewa cutar ta fi yawan masu cutar 388 da gwamnatin Iran ta ce suna cikin kasar a ranar.
An dakatar da majalisar dokokin Iran, inda aka ce mambobi 23 daga cikin 290 sun kamu da cutar a ranar 3 ga watan Maris.
A ranar 12 ga watan Fabrairu, Human Rights Watch ta bukaci hukumomin gidan yari na Iran da su saki masu keta hakkin bil'adama ba tare da wani takunkumi ba tare da kuma sake duk wasu fursunoni da suka cancanci a sake su na wani lokaci.
An ce akwai hadarin da ke iya yaɗuwa a wurare masu yawan jama'a kamar kurkuku, inda babu isashen magani.
A ranar 15 ga watan Agusta, gwamnatin Iran ta sanar da mutuwar mutane 100 a rana daya, wanda shine mafi girma a kasar tun bayan barkewar cutar.
A ranar 17 ga watan Maris, a kalla shuwagabannin Iran 12 da na baya sun mutu sakamakon cutar.
Ya zuwa ranar 23 ga watan Maris, Iran tana samun sabbin mutane 50 a kowane awa daya kuma mutum daya na mutuwa a kowane minti goma daga cutar coronavirus.
A cewar jami'in WHO, adadin masu kamuwa da cutar a Iran na iya ninka na baya sau biyar.
An kuma ce takunkumin da Amurka ta kafa kan Iran na iya shafar ikon kasar wajen yaki da cutar.
Hukumar kare hakkin dan adam ta Majalisar Dinkin Duniya ta bukaci a sake biyan kudaden da aka sanya wa kasashen da suka fi fama da cutar, ciki har da Iran.
An tabbatar da barkewar cutar a Italiya a ranar 31 ga Janairu, lokacin da aka gwada masu yawon bude ido biyu na kasar Sin da cutar SARS-CoV-2 a Rome.
Yawan masu kamuwa da cutar ya fara hauhawa a cikin tseren da ya sa gwamnatin Italiya ta dakatar da duk jiragen da ke zuwa daga China kuma ta sanar da dokar hana fita.
An gano wani nau'in kwayar cutar da ba ta da alaƙa da COVID-19 daga baya, wanda ya fara ne da sabbin mutane 16 da aka tabbatar da su a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministocin ta ba da sanarwar sabon tsarin yaki da cutar, wanda ya haɗa da sanya mutane sama da 50,000 daga Municipalities a cikin keɓewa a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, "A wuraren da cutar ta bulla, ba za a yarda da shiga ko fita ba.
An dakatar da ayyukan wasanni a wuraren. "A ranar 4 ga watan Maris, gwamnatin Italiya ta sanar da rufe makarantu da jami'o'i a duk faɗin ƙasar, a lokacin da Italiya ta samu mutuwar mutane fiye da 100.
Duk manyan wasannin wasanni, ciki har da wasannin kwallon kafa na Serie A, an tsara za a buga su a cikin gida har zuwa ranar 1 ga Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasannin na akalla wata daya.
A ranar 11 ga watan Maris, Firayim Minista Conte ya sanar da dakatar da kusan dukkan ayyukan kasuwanci ban da kantunan sayar da kayayyaki da kantin sayar da magunguna. A ranar 6 ga watan Maris, Kwalejin Anaesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) ta ba da umarnin kan hanyoyin da za a bi a cikin gwaji wanda ya hada da hanyoyin da za a yi amfani da su wajen yin gwaji.
A ranar 19 ga watan Maris, Italiya ta zarce China a yawan wadanda suka mutu sakamakon cutar coronavirus a duniya, inda ta bayar da rahoton cewa mutane 3,405 ne suka mutu sakamakon cutar.
A ranar 22 ga watan Maris, an ba da rahoton cewa Rasha ta aika da jiragen sama tara na soja zuwa Italiya.
A ranar 5 ga watan Afrilu, an samu mutane 128,948 da suka kamu da cutar, 15,887 sun mutu, 21,815 sun warke a Italiya, yawancinsu a yankin Lombardy.
CNN ta ce yawan tsofaffi a Italiya da rashin gwajin cutar a duk inda suka kai, na iya haifar da yawan mutuwar.
A farkon lokacin da Birtaniya ta fara kula da cutar, an ga cewa ita ce mafi sauki a cikin kasashen da cutar ta shafa, kuma har zuwa ranar 18 ga watan Maris na shekarar 2020, gwamnatin Burtaniya ba ta sanya dokar hana fita ko kuma keɓewar jama'a ba.
A sakamakon haka, an zargi gwamnati da rashin kulawa da ta yi wa al'ummar da ke fuskantar matsalar. A ranar 16 ga watan Maris, Firayim Minista Boris Johnson ya sanar da cewa yana ba da shawarar mutane su guji yin tafiye-tafiye da kuma saduwa da mutane, yana mai cewa a duk lokacin da zai yiwu su yi aiki daga gida kuma su guji wuraren shan giya, wuraren cin abinci da wuraren shakatawa.
A ranar 20 ga watan Maris, gwamnati ta sanar da cewa za a rufe dukkan wuraren shakatawa kamar mashaya da kuma gidan giya da wuri-wuri, kuma ta yi alkawarin biyan kashi 80% na albashin ma'aikata har zuwa £2,500 a kowane wata don kaucewa rashin aikin yi a cikin wannan rikicin. A ranar 23 ga watan Maris, Firayim Minista ya sanar da tsare-tsaren rage nesa, hana tarurrukan mutane sama da biyu da hana tafiye-tafiye na waje da za a yi idan ya zama dole.
Baya ga matakan da aka dauka, 'yan sanda sun sa hannu wajen aiwatar da wannan dokar ta hanyar tara mutane da kuma soke dukan tarurruka.
An umarci mafi yawan kasuwancin da za a rufe sai dai wadanda ake kira 'yancin' wadanda suka hada da manyan kantuna, kantunan magunguna, bankuna, kantunan kayan masarufi, man fetur da kuma gidajen sayar da kaya.
A ranar 20 ga watan Janairu, mutum na farko da aka gano yana da cutar COVID-19 a jihar Washington da ke arewa maso yammacin tekun Pacific, wani ne da ya dawo daga birnin Wuhan a ranar 15 ga watan Janairu.
An kafa Hukumar Kula da Cutar Coronavirus ta fadar White House a ranar 29 ga watan Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta sanar da dokar hana fita ta kiwon lafiya a kasar kuma ta sanya takunkumi kan matafiya daga kasar Sin.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka ta Amurka ta sanar da cewa ta samar da na'urorin bincike na kanta.
Duk da haka, Amurka ta fara kamuwa da cutar, wanda ya hana fahimtar yadda cutar ta kasance.
Gwajin ya haifar da rikici na yin amfani da gwaje-gwaje marasa inganci a ranar Talata, gwamnati ta hana yin amfani da gwaje-gwaje marasa inganci (kayan aikin bincike, kamfanoni da asibitoci) har zuwa ƙarshen Talata, da kuma hana mutane cika ka'idodin gwaji har zuwa ranar Talata (bayan haka, ana buƙatar umarnin likita).
A ranar 27 ga watan Fabrairu, jaridar The Washington Post ta ruwaito cewa an gwada mutane kasa da 4,000 a Amurka.
A ranar 13 ga Maris, jaridar The Atlantic ta ba da rahoton cewa an gwada mutane 14,000.
A ranar 22 ga Maris, Associated Press ta rubuta: "Mutane da yawa da suka sami izinin likita suna jira na sa'o'i ko kwanaki don a gwada su. Bayan mutuwar mutum na farko a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ba da dokar ta baci, kuma sauran jihohi ma sun bi wannan umurnin.
Makarantu a yankin Seattle sun soke tarurruka a ranar 3 ga Maris kuma a tsakiyar watan Maris, makarantu a duk faɗin ƙasar sun fara rufewa. A ranar 6 ga Maris, 2020, ƙungiyar masu binciken cututtuka a Kwalejin Imperial ta London ta ba da shawara ga Amurka game da matsalar da ta fuskanta game da cutar.
A wannan rana ne Shugaba Trump ya sanya hannu kan dokar bayar da tallafin gaggawa (Coronavirus Preparedness and Response Supplemental Appropriations Act) wanda ya ba da dala biliyan 8.3 ga gwamnatocin jihohi don yaki da cutar.
Hukumomi sun hana ma'aikata yin ayyuka, sun hana su yin taro, kuma sun gaya wa ma'aikata su yi aiki daga gida.
An dakatar da bukukuwan wasanni da wasannin motsa jiki. A ranar 11 ga watan Maris, Trump ya sanar da dakatar da tafiye-tafiye a yawancin ƙasashen Turai, ban da Burtaniya, na tsawon kwanaki 30, daga ranar 13 ga watan Maris.
Washegari, ya faɗaɗa dokar zuwa ƙasar Ingila da kuma Ireland.
A ranar 13 ga watan Maris, ya ayyana dokar hana fita a duk fadin kasar wanda hakan ya sa aka kashe kudaden jihohi wajen magance cutar.
Tun daga ranar 15 ga watan Maris, kamfanoni da dama sun rufe ko rage lokutan aiki a ko'ina cikin Amurka don kokarin rage yaduwar cutar.
A ranar 17 ga watan Maris, an tabbatar da cutar a jihohi 50 da Gundumar Columbia. A ranar 23 ga watan Maris, an bayar da rahoton cewa Birnin New York yana da mutane 10,700 da suka kamu da cutar coronavirus, wanda ya fi adadin da aka samu a Koriya ta Kudu.
A ranar 25 ga watan Maris, gwamnan ya ce, an ga cewa keɓewar kai yana da tasiri sosai, saboda yawan masu kamuwa da cutar ya ragu daga kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga watan Maris, an samu mutane 32,308 da suka kamu da cutar a birnin New York, kuma mutane 672 sun mutu sakamakon cutar. A ranar 26 ga watan Maris, Amurka ta ce tana da adadin mutane da suka kamu da cutar a duniya, ciki har da China da Italiya. A ranar 8 ga watan Afrilu, an sami mutane 400,335 da suka kamu da cutar a Amurka, kuma mutane 12,841 sun mutu.
Jaridar Per Media a ranar 30 ga watan Maris ta ruwaito cewa Shugaba Trump na Amurka ya yanke shawarar tsawaita dokar nesa har zuwa ranar 30 ga watan Afrilu.
A wannan ranar, wani asibiti mai suna USNS Comfort, wanda ke aiki a kan jirgin ruwa mai ɗakuna 1,000 ya isa birnin New York.
A ranar 3 ga watan Afrilu, Amurka ta samu mutuwar mutane 884 sakamakon cutar coronavirus a cikin awanni 24.
A New York, wadanda suka kamu da cutar sun haura 100,000 a ranar 3 ga Afrilu. Fadar White House ta yi watsi da matsalar da kuma kula da bayanan jama'a ta hanyar umarci likitoci da masana kimiyya su aika da duk wani bayani da takardu da aka fitar daga ofishin Mataimakin Shugaban Kasa Mike Pence.
A cikin al'amarin, ana kallon yadda Trump ya yi da wannan ƙwallon ƙwallo a matsayin wani abu da ya dace da shi.
Wasu jami'an Amurka da manema labarai sun soki Amurka saboda dogaro da shigo da kayayyakin da ake bukata, ciki har da magunguna daga China.
An yi amfani da binciken tafiye-tafiye na iska don nuna yadda cutar ke yaduwa kuma an buga shi a cikin The Journal of Travel Medicine a tsakiyar watan Janairu 2020.
A cewar wani rahoto na 2018 daga Kungiyar Sufurin Jiragen Sama ta Duniya, Bangkok, Hong Kong, Tokyo, da Taipei sun fi yawan fasinjojin da suka fito daga Wuhan.
Dubai, Sydney, da Melbourne sun kuma kasance manyan wuraren da baƙi daga Wuhan ke zuwa.
An nuna cewa Bali ita ce birni mafi ƙarancin birni a cikin biranen birni 20 da aka fi samun dama a cikin yanayin shiri, yayin da biranen Ostiraliya aka nuna cewa suna da ƙarancin ƙarfi. Ostiraliya ta ba da sanarwar shirin ta na Novel Coronavirus (COVID-19) a ranar 7 ga Fabrairu.
An ce akwai abubuwa da yawa da za a gano game da COVID-19, kuma Australia ta fi mai da hankali kan iyakokinta da hanyoyin sadarwa wajen magance cutar.
A ranar 21 ga watan Maris, an kafa dokar hana fita a Ostareliya.
Bayan da aka samu nasarar aiwatar da dokar keɓewa a Wuhan da Hubei, kasashe da dama sun shirya fitar da 'yan kasashensu da jami'ansu daga yankin, ta hanyar jirgin da aka yi haya daga kasar da ke ba da izinin shiga kasar ta China.
Kasashen farko da suka shirya su kai 'yan gudun hijira su ne Kanada, Indiya, Sri Lanka, Faransa, Argentina, Jamus, Japan, Amirka, da kuma Thailand.
Pakistan ta ce ba za ta fitar da duk wani dan kasarta daga kasar Sin ba.
A ranar 7 ga watan Fabrairu, Brazil ta kori mutane 34 daga cikinta, ko kuma 'yan uwa guda, ciki har da 'yan Poland hudu da kuma wani dan Indiya.
'Yan ƙasar Poland, Sin, da Indiya sun bar ƙasar Poland, inda jirgin ya sauka kafin ya ci gaba zuwa Brazil.
An killace 'yan Brazil da suka je Wuhan a sansanin soja da ke kusa da Brasília.
A wannan ranar, an kai 'yan Kanada 215 (176 daga jirgin farko, da 39 daga jirgin na biyu da gwamnatin Amurka ta yi haya) daga Wuhan zuwa CFB Trenton don keɓewa na makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama mai dauke da 'yan Kanada 185 daga Wuhan ya isa CFB Trenton.
Hukumomin Australiya sun kwashe 'yan kasar 277 a ranar 3 da 4 ga watan Fabrairu zuwa Cibiyar Tsare-tsare ta Tsibirin Kirsimeti, inda aka kafa wani wuri na keɓewa na kwanaki 14.
Jirgin New Zealand da ya kwashe mutanen ya isa Auckland a ranar 5 ga Fabrairu; fasinjojinsa (ciki har da wasu daga Australia da Pacific) an killace su a Whangaparoa, arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kori Amurkawa ta jirgin ruwa, Diamond Princess.
A ranar 21 ga watan Fabrairu, jirgin da ke dauke da fasinjoji 129 na Kanada da suka tashi daga Diamond Princess ya isa Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasarta daga Iran. A ranar 14 ga watan Maris, gwamnatin Afirka ta Kudu ta yi hayar jirgin South African Airways don kwashe 'yan kasarta 112.
An gudanar da gwajin lafiya kafin tashin jirgin kuma an bar 'yan Afirka ta Kudu da ke da alamun cutar coronavirus a baya don rage haɗarin.
'Yan Afirka ta Kudu da ba su da cutar za a mayar da su gida.
Sakamakon binciken ya nuna cewa duk 'yan Afirka ta Kudu suna cikin koshin lafiya, gami da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal, jami'an 'yan sanda da sojoji da ke cikin ayyukan agaji, kuma duk sun kasance a karkashin kulawa da keɓewa na kwanaki 14 a The Ranch Resort.
A ranar 20 ga watan Agusta, Amurka ta fara janye dakarunta daga Iraki saboda annobar.
A ranar 5 ga Fabrairu, Ma'aikatar Harkokin Waje ta kasar Sin ta ce ƙasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar, da Iran) sun aika da taimako.
Dalibai 'yan kasar Sin da ke jami'o'in Amurka sun hada kai don kai agaji a yankunan kasar Sin da cutar ta fi yawa, inda wata kungiya a Chicago ta aika da abin rufe fuska N95 50,000 zuwa asibitocin Hubei a ranar 30 ga Janairu. Kungiyar agaji ta Direct Relief tare da FedEx, sun aika da abin rufe fuska 200,000 da sauran kayan agaji ciki har da fam guda biyu zuwa asibitin Wuhan Union a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da tallafin dala miliyan 100 ga WHO don gudanar da bincike kan allurar rigakafi da kuma samar da magani da kuma kare "mutane da ke fama da matsalar a Afirka da Kudancin Asiya".
Interaksyon ta ruwaito cewa gwamnatin China ta ba da allurar rigakafi 200,000 ga Philippines a ranar 6 ga watan Fabrairu bayan da Jakada Richard Gordon ya ba da allurar rigakafi miliyan 3.16 a Wuhan.
A ranar 19 ga watan Fabrairu, Red Cross ta Singapore ta sanar da cewa za ta tura dala miliyan 2.26 na agaji zuwa kasar Sin.
Japan ta ba da gudummawar abin rufe fuska miliyan daya ga Wuhan, Turkiyya ta ba da kayan aikin likita, Rasha ta aika da tan 13 na kayan aikin likita zuwa Wuhan, Malaysia ta sanar da cewa ta ba da tallafi ga China na tan miliyan 18, Jamus ta ba da kayan aikin likita daban-daban ciki har da kayan Hazmat 10,000, yayin da Amurka ta ba da tallafin kayan aikin likita na tan 17.8 ga China kuma ta yi alkawarin ba da ƙarin dala miliyan 100 don taimakawa ƙasashen da cutar ta shafa. Yayin da cutar ta ragu a China, China ta aika da tallafi ga ƙasashe da dama da cutar ta shafa.
A watan Maris, China, Chuba da Rasha sun aika da kayan aikin kiwon lafiya da masana don taimakawa Italiya kan cutar coronavirus.
Dan kasuwa Jack Ma ya aika da kayan gwaji miliyan 1.1, da tabarau miliyan 6, da kuma takardun shaida 60,000 zuwa Addis Ababa, Habasha, a karkashin yarjejeniyar Tarayyar Afirka.
Sai ya aika da na'urori na gwaji 5,000, abin rufe fuska 100,000, da kuma na'urori biyar na numfashi zuwa Panama.
Ƙasar Netherlands, Spain, Turkiyya, Georgia, da Jamhuriyar Czech sun yi gunaguni game da allunan gwaji da ake yi a ƙasar Sin.
Misali, Spain ta soke kayan gwajin cutar coronavirus 58,000 da aka yi a China wanda ingancinsa ya kai kashi 30 cikin dari, yayin da Netherlands ta soke kayan gwajin cutar China 600,000 da suka mutu.
Belgium ta zubar da abin rufe fuska 100,000 da aka ɗauka cewa daga China ne, amma a gaskiya daga Kolombiya ne.
A wani bangaren kuma, tallafin da kasar Sin ta bayar ya samu karbuwa sosai a yankunan Latin Amurka da Afirka. A ranar 2 ga watan Afrilu, Bankin Duniya ya kaddamar da tallafin gaggawa ga kasashe masu tasowa.
Hukumar Lafiya ta Duniya ta yaba wa kokarin da kasar Sin ke yi na shawo kan cutar.
WHO ta gano bambanci tsakanin barkewar cutar SARS a shekara ta 2002-2004, lokacin da aka bukaci shugabannin kasar Sin su yi shiru kan abin da ya hana hana a hana a hana a yi maganin cutar, da kuma halin da ake ciki yanzu da gwamnatin tsakiya "ke ci gaba da gargadi ga jama'a kan yadda za su guji yin zanga-zanga a shirye-shiryen bikin sabuwar shekara".
A ranar 23 ga watan Janairu, a mayar da martani ga matakin da jami'an gwamnati suka dauka na dakatar da zirga-zirga a Wuhan, wakilin WHO Gauden Galea ya ce, "duk da cewa ba WHO ce ta yanke shawarar ba, wannan mataki ne mai kyau da kuma nuna jajircewa wajen yaki da cutar a yankin da ta fi yaduwa" kuma ya bayyana shi a matsayin "wanda ba a taba ganin irinsa ba a tarihin kiwon lafiya". A ranar 30 ga watan Janairu, lokacin da aka tabbatar da kamuwa da cutar daga mutum zuwa mutum a wajen kasar Sin kuma yayin da adadin masu kamuwa da cutar ke karuwa a kasashen waje, WHO ta ayyana cutar a matsayin Matsalar Lafiya ta Duniya (PHEIC), wanda ya zama na shida da aka bayyana a matsayin gaggawa tun lokacin da cutar ta barke a watan Oktoba na shekarar 2009.
Daraktan WHO Tedros Adhanom ya ce PHEIC ta samo asali ne daga "matsalar yaduwar cutar a duniya, musamman a ƙasashe masu karancin kuɗi da matsakaitan kuɗi waɗanda ba su da ingantaccen tsarin kiwon lafiya.
Da yake mayar da martani game da dakatar da sufuri, Tedros ya ce "babu wani dalili da zai sa ba za a iya hana sufuri da cinikayya a duniya ba" kuma "WHO ba ta goyon bayan rage cinikayya da tafiye-tafiye ba".
A ranar 5 ga Fabrairu, WHO ta bukaci mutane a dukan duniya su ba da dala miliyan 675 don tallafa wa shirye-shirye a ƙasashe masu tasowa, ta nuna bukatar gaggawa na tallafa wa ƙasashe "waɗanda ba su da hanyoyin gano cutar idan ta ɓarke".
Tedros ya kuma bayyana cewa "ƙarfinmu ya yi daidai da inda muke da rauni" kuma ya yi kira ga mutane a duniya "su jira a yau ko kuma su biya mafi girma a nan gaba". A ranar 11 ga Fabrairu, WHO a wani taron manema labarai ya sanar da COVID-19 a matsayin sunan cutar.
A wannan ranar, Tedros ya ce Sakataren Majalisar Dinkin Duniya António Guterres ya amince da ba da "dukkanin ƙarfin Majalisar Dinkin Duniya don magance cututtuka".
An kafa tawagar kula da rikice-rikice ta Majalisar Dinkin Duniya (UN Crisis Management Team), don daidaita ayyukan Majalisar Dinkin Duniya, wanda WHO ta ce zai taimaka musu "su mai da hankali kan kiwon lafiya yayin da sauran hukumomi ke ba da ƙwarewarsu don taimakawa al'amuran zamantakewa, tattalin arziki da ci gaba a lokacin annobar".
A ranar 14 ga watan Fabrairu, an kafa wata tawagar hadin gwiwa da WHO ta kafa a kasar Sin don isar da kwararru daga kasashen duniya da WHO zuwa kasar Sin don taimakawa wajen gudanar da ayyukan gida da kuma nazarin "matsanancin yaduwar cutar" ta hanyar shirya tarurruka da tarurruka tare da manyan hukumomi a cikin kasar da kuma tafiya zuwa yankuna don tabbatar da "sakamakon ayyukan da aka yi a matakin lardi da lardin, ciki har da yankunan birane da na karkara". A ranar 25 ga watan Fabrairu, WHO ta sanar da cewa "duniya ta fi shiri don yin la'akari da cewa cutar coronavirus na iya zama wata cuta ta duniya", kuma duk da cewa an riga an bayyana cutar a matsayin annoba ta duniya, kasashen sun ce ya kamata su kasance a shirye don "tsare kanta".
A ranar 28 ga watan Fabrairu, jami'an WHO sun ce za a rage yawan cutar coronavirus a duniya daga "mai tsanani" zuwa "mai tsanani", wanda shine matakin da suka fi dacewa na kimantawa.
Mike Ryan, darektan shirin gaggawa na WHO, ya yi gargaɗi: "Wannan shi ne gwaji ga kowace gwamnati a duniya: Ku farka.
Cutar na iya kasancewa a kan hanya kuma kuna buƙatar kasancewa a shirye", ya yi gargadin cewa samun hanyoyin da suka dace na magance ta na iya taimaka wa duniya ta guji "mafi munin".
Ryan ya kuma ce bayanin da ake samu a yanzu bai sa jami'an kiwon lafiya su bayyana cutar a matsayin annoba ta duniya ba, ya ce irin wannan sanarwar zai nuna cewa "mun amince cewa kowa a duniya zai kamu da cutar".
A ranar 11 ga watan Maris, WHO ta ayyana cutar coronavirus a matsayin annoba ta duniya.
Darakta Janar ya ce WHO na "da matukar damuwa game da yadda cutar ke yaduwa da kuma yadda take da muni, da kuma yadda ba a dauki mataki ba". WHO ta fuskanci zargi sosai saboda rashin iyawar da ta nuna wajen magance cutar, ciki har da jinkirin bayyana matsalar lafiya da gaggawa da kuma bayyana ta a matsayin babbar matsalar duniya.
Wannan zanga-zangar ta hada da neman daraktan WHO Tedros Adhanom ya yi murabus, inda aka samu sa hannu 733,000 a ranar 6 ga watan Afrilu.
A ranar 26 ga watan Maris na shekarar 2020, kwararru kan hakkin dan Adam na Majalisar Dinkin Duniya sun jaddada bukatar girmama hakkin dan Adam a lokacin annobar COVID-19.
Kwamitin ya ce kowa na da hakkin samun lafiya kuma wannan hakki ne na gwamnati.
Kungiyar ta jaddada cewa rashin kayan aiki ko inshorar lafiya ba za a iya ɗauka a matsayin dalilin nuna wariya ga wasu mutane ba.
Masana sun nuna cewa kowa yana da hakkin samun lafiya, ciki har da nakasassu, 'yan tsiraru, tsofaffi, waɗanda ke cikin sansanonin 'yan gudun hijira, marasa gida, waɗanda ke cikin mawuyacin hali, fursunoni, da 'yan gudun hijira da duk wasu da ke bukatar taimakon gwamnati.
Hukumomin gwamnati a duk duniya suna magance tasirin COVID-19 ga tattalin arziki da zamantakewar al'umma.
Kungiyar hadin gwiwar tattalin arziki da ci gaba ta kafa wata hanya ta hanyar bayar da cikakken bayani game da tsarin da aka kafa a kasashen duniya, da kuma ra'ayoyi da shawarwari.
Daga dabarun inganta kiwon lafiya da tattalin arzikin duniya zuwa magance tasirin kulle-kulle da rufe zirga-zirga, tsarin ya hada da Country Policy Tracker, wanda ke da nufin taimakawa kasashe su koyi darasi daga juna da kuma daidaita kokarin duniya wajen magance kalubalen coronavirus.
Gwamnatin kasar Sin ta yi wa Amurka, Ministan hukuma na Burtaniya Michael Gove, da kuma dan shugaban kasar Brazil Jair Bolsonaro Eduardo Bolsonaro korafi kan yadda suka magance matsalar, wadda ta fara ne a lardin Hubei na kasar Sin.
An kori wasu manyan jami'an jam'iyyar kwaminis ta kasar Sin (CPC) daga mukamin saboda yadda suka gudanar da aikin killace mutane a tsakiyar kasar Sin, wanda ke nuna rashin gamsuwa da yadda hukumomi ke kula da cutar a yankin.
Wasu masu sa ido sun yi imanin cewa an yi wannan ne don kare Sakataren Jam'iyyar Kwaminis ta Sin Xi Jinping daga fushin jama'a game da cutar coronavirus.
Wasu jami'an kasar Sin, ciki har da Zhao Lijian sun musanta ra'ayin farko na cewa cutar coronavirus ta samo asali ne daga Wuhan, suna goyon bayan ra'ayoyin da ke nuna cewa COVID-19 ya samo asali ne daga Amurka ko Italiya.
Shugabancin Donald Trump a Amurka ya ambaci coronavirus a matsayin "Cutar Sin" ko "Cutar Wuhan" yana mai cewa "cin nasarar da kasar Sin ta yi ya sa suka kirkiro cutar da ta zama babbar matsalar duniya", wanda wasu mutane suka yi zargin cewa nuna wariyar launin fata ne "saboda gazawar shugabancin kasar wajen yaki da cutar".
Daily Beast ta samu wani sako daga gwamnatin Amurka da ke nuna wata sanarwa daga kwamitin tsaron kasa, wanda ke cewa "Dukkanin ya shafi kasar Sin.
An umurce mu da mu yi kokarin yada wannan labarin ta kowace hanya, ciki har da taron manema labarai da kuma nunawa a talabijin". Jaridu kamar Politico, Foreign Policy, da Bloomberg sun ce kokarin da kasar Sin ke yi na samar da agaji ga kasashen da cutar ta shafa na daga cikin abubuwan da suke so su yi domin samun karbuwa a duniya.
Shugaban harkokin wajen EU Josep Borrell ya yi gargadin cewa akwai "siyasa ta kasa da take da 'yancin kai da kuma 'siyasa ta kishin kasa'".
Borrell ya ce: "Sinanci yana ƙoƙari ya nuna cewa shi mai gaskiya ne, ba kamar Amirka ba".
China ta kuma bukaci Amurka ta cire sinadarin da ake amfani da shi a Syria, Venezuela da Iran, yayin da take ci gaba da aikawa da taimakon agaji ga kasashen.
An kama tallafin Jack Ma na dala 100,000 ga Cuba a kan takardar shaidar Amurka a ranar 3 ga watan Afrilu.
An kuma zargi hukumomin Amurka da kwace tallafin da ake kaiwa kasashen waje.
An kuma yi jayayya game da maganin rigakafi tsakanin ƙasashe kamar su Jamus, Austria, da Switzerland; da Jamhuriyar Czech da Italiya.
Ƙari ga haka, Turkiyya ta ba da ɗarurruwan na'urorin numfashi zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki Tarayyar Turai saboda rashin tsayawa tare da Italiya a yayin da ake fama da cutar coronavirus.
Maurizio Massari, wakilin Italiya a Ƙungiyar Tarayyar Turai ya ce: "Kamar dai ƙasar Sin ce ta damu da ku.
Wannan ba alama ba ce mai kyau ga Tarayyar Turai".
A ranar 22 ga watan Maris, bayan tattaunawa ta waya da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya cewa sojojin Rasha za su aika da likitocin soja, motocin motsa jiki, da sauran kayan aikin kiwon lafiya zuwa Italiya.
Jaridar La Stampa ta Italiya da ta yi ƙaulin "wani babban ɗan siyasa" da ba a yi ba da hujja ba ta ce kashi 80 cikin ɗari na taimakon Rasha "ba shi da amfani ko kuma ba shi da amfani ga Italiya".
Wannan ɗan siyasa ya yi kashedi cewa Rasha za ta yi "cin-da-kan siyasa".
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Waje na Italiya Luigi Di Maio sun yi watsi da labarin kuma sun nuna godiya.
Rasha ta kuma aika da jirgin sama mai dauke da kayayyakin kiwon lafiya zuwa Amurka.
Kakakin gwamnatin Rasha Dmitry Peskov ya ce "ta wajen ba da taimakon ga Amirka, [Putin] yana fatan cewa idan masu aikin magani a Amirka suka gyara yanayin kuma suka koma cikin tsari, za su iya biyansa idan ya cancanta".
Shirin NATO na "Defender 2020" a Jamus, Poland, da ƙasashen Baltic, wanda shine babban shirin sojin NATO tun bayan ƙarshen Yakin Cacar Baki, zai kasance a cikin tsari na musamman.
Sakatariyar Kamfen na Kare Makaman Nukiliya Kate Hudson ta soki shirin Defender 2020: "A cikin matsalar lafiya ta yanzu, yana barazana ga rayukan sojojin Amurka da na kasashen Turai da kuma 'yan kasar da suke aiki". Gwamnatin Iran ta kamu da cutar, tare da 'yan majalisa sama da 20 da suka kamu da cutar da kuma wasu' yan siyasa 15.
Shugaban Iran Hassan Rouhani ya rubuta wasika ga shugabannin duniya yana neman taimako a ranar 14 ga watan Agusta, 2020, yana mai cewa kasarsa za ta sha wahala wajen magance cutar saboda takunkumin Amurka da ta sanya kan Iran. Barnar cutar ta kara daukaka Amurka kan bin manufofin zamantakewar da aka fi sani da su a kasashe masu arziki, wadanda suka hada da kiwon lafiya ga kowa, kula da yara, fansho, da kuma saka hannun jari a cikin al'amuran jama'a.
Masu sa ido kan harkokin siyasa sun yi hasashen cewa hakan na iya shafar damar da Donald Trump zai samu na sake zabarsa a zaben shugaban kasa na 2020.
Koriya ta Kudu ta soki manufar Japan ta "karya da kuma rashin rigakafi" bayan da Japan ta sanar da cewa duk wani dan kasar Koriya ta Kudu za a killace shi a wuraren da gwamnati ta keɓe na tsawon makonni biyu.
A baya can, an raba Koriya ta Kudu saboda yadda Shugaba Moon Jae-in ya magance matsalar cutar.
Yawancin 'yan Koriya sun sanya hannu kan wata sanarwa da ke neman a kori Moon saboda abin da suka kira gwamnatin da ta yi watsi da cutar, yayin da wasu ke goyon bayan tsarinsa. Wannan rikici ya sa kasashen duniya suka dauki matakan gaggawa don magance shi.
Wasu masu lura da al'amura sun ce wannan zai iya sa gwamnati ta riƙe ikonta.
A Hungary, majalisar dokoki ta yi wa firaminista Viktor Orbán takardar amincewa da yin mulki nan ba da jimawa ba, ta dakatar da majalisar da kuma gudanar da zabe da kuma hukunta wadanda ake zargi da yada labaran karya game da cutar da kuma yadda gwamnati ke magance matsalar.
An bayar da hujjar barkewar cutar coronavirus a matsayin hujja don rage yawan kayayyaki, sakamakon karuwar kayayyakin da ake amfani da su a duniya don magance cutar, sayayya da yawa a lokaci guda, da kuma katsewar masana'antu da sauran ayyuka.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargadin rashin isasshen magunguna da kayan aikin likita saboda karuwar bukatarsu da kuma cikas a samar da su.
Ƙari ga haka, ana yawan sayayya a wurare da yawa, kuma hakan ya sa manyan kantuna suka kasa samun kayayyaki kamar abinci, kayan zaki, da ruwan sha, kuma ba a wanke kayan wanki sosai ba.
Musamman masu kera na'urorin sun yi gargadin cewa za a sami jinkiri wajen tura na'urorin.
A cewar shugaban WHO Tedros Adhanom, bukatar kayayyakin kariya ta ninka sau 100.
Wannan bukatar ta haifar da karuwar yawan masu cutar sau ashirin kuma ta haifar da jinkirin samar da kayayyakin kiwon lafiya na tsawon watanni hudu zuwa shida.
Hakan kuma ya haifar da karancin kayan aikin kare lafiyar duniya, wanda WHO ta yi gargadin cewa hakan zai sanya lafiyar likitoci cikin hadari.
A Ostiraliya, annobar ta ba 'yan kasuwa damar sayar da kayayyakin Australiya zuwa China.
Wannan ya haifar da karancin abinci ga jarirai a wasu kantuna kuma daga bisani gwamnatin Australia ta hana shi. Duk da cewa akwai manyan cututtukan COVID-19 a Arewacin Italiya da yankin Wuhan, saboda haka akwai bukatar abinci mai yawa, waɗannan yankuna biyu ba su fuskanci karancin abinci ba.
Hanyoyin da China da Italiya suka bi wajen magance cin hanci da rashawa da kuma cinikin haram sun taimaka wajen kauce wa karancin abinci da ake tsammani a Turai da Arewacin Amurka.
Ba a taɓa samun ƙarancin abinci a arewacin Italiya da ke cike da noma ba, amma farashin zai iya ƙaruwa bisa ga wakilan masana'antu.
An samu karancin abinci a cikin 'yan kwanaki, har ma a birnin Wuhan, inda jami'an gwamnatin China ke rufe kantunan naman alade don tabbatar da cewa mutane suna da isasshen abinci.
Akwai dokoki a Italiya da ke buƙatar masu sarrafa abinci su kiyaye abinci saboda irin wannan cutar.
Tasirin da tattalin arzikin duniya ya samu: a cewar wani rahoto da aka fitar a ranar 16 ga watan Maris, tattalin arzikin kasar Sin ya yi matukar rauni a watanni biyu na farko na shekarar 2020 sakamakon matakan da gwamnati ta dauka na dakile yaduwar cutar, kuma tallace-tallace ga jama'a sun ragu da kashi 20.5%.
Kasar Sin tana da tattalin arziki mai karfi da kuma samar da kayayyaki masu yawa, saboda haka cutar ta yi tasiri sosai ga tattalin arzikin duniya.
Agathe Demarais na Economist Intelligence Unit ya yi hasashen cewa kasuwannin za su kasance cikin rashin tabbas har sai an sami cikakken hoto game da yiwuwar koma baya.
A watan Janairun 2020, wasu masana sun yi hasashen cewa cutar za ta yi tasiri sosai ga ci gaban tattalin arzikin duniya fiye da yadda cutar SARS ta yi a shekarar 2002-2004.
Wani manazarci a Jami'ar Washington da ke St. Louis ya kimanta cewa za a yi asarar dala biliyan 300 a dukan duniya a cikin shekaru biyu.
Kungiyar Kasashen Da Ke Fitar Da Man Fetur (OPEC) ta ce ta yi kasa-kasa bayan da farashin man fetur ya fadi sakamakon raguwar bukatarsa a kasar Sin.
Kasuwancin hannayen jari na duniya sun fadi a ranar 24 ga Fabrairu saboda karuwar adadin masu kamuwa da cutar COVID-19 a wajen kasar Sin.
A ranar 27 ga watan Fabrairu, sakamakon ci gaba da fargabar annobar coronavirus, yawancin alamun hannun jari na Amurka ciki har da NASDAQ-100, S&amp;P 500 Index, da Dow Jones Industrial Average sun nuna raguwar mafi girma tun shekarar 2008, inda Dow ya fadi da maki 1,191, wanda ya kasance mafi girma tun bayan rikicin tattalin arziki na 2007-08.
A cikin mako guda, adadin ya ragu da kashi 10 cikin ɗari.
A ranar 28 ga watan Fabrairu, kamfanin Scope Ratings GmbH ya tabbatar da cewa kasar Sin tana da darajar bashi mai karfi, amma ya nuna cewa wannan zai iya canzawa (Negative Outlook).
Hannun jari sun sake faduwa saboda tsoron coronavirus, inda aka samu raguwa sosai a ranar 16 ga watan Maris.
Mutane da yawa suna jin tsoron cewa tattalin arziki zai yi sanyi.
Ministan kudi Mohamed El-Erian ya yaba da tsarin banki na yankuna.
Bankunan tsakiya sun tashi da sauri fiye da yadda suka yi a lokacin matsalar tattalin arziki ta 2008.
Yawon shakatawa na daga cikin manyan kamfanonin da ke fama da matsalar dakatar da zirga-zirga, rufe wuraren shakatawa da wuraren shakatawa, da kuma shawarwarin gwamnati na hana duk wani tafiya a duniya.
Sakamakon haka, kamfanonin jiragen sama da dama sun soke zirga-zirgar su saboda rashin tsari, ciki har da British Airways, China Eastern Airlines, da Qantas, yayin da kamfanin jirgin sama na Burtaniya Flybe ya fadi.
Ba a taɓa ganin irin wannan ƙalubale a kamfanin jirgin ruwa ba.
An kuma rufe tashoshin jiragen kasa da tashoshin jiragen ruwa da yawa.
Cutar ta auku ne a daidai lokacin da ake bikin Chunyun, lokacin da ake yin tafiye-tafiye masu yawa domin bikin sabuwar shekara ta kasar Sin.
Yawancin bukukuwan da suka fi yawa sun kasance a cikin gwamnatin tsakiya da na lardin, ciki har da bikin Sabuwar Shekara, tare da rufe kamfanoni masu zaman kansu da wuraren shakatawa kamar Hong Kong Disneyland da Shanghai Disneyland.
An rufe bukukuwan Sabuwar Shekara da wuraren shakatawa don kauce wa taron jama'a, ciki har da Forbidden City a Beijing da kuma wuraren shakatawa na tsoffin masallatai.
A larduna 24 daga cikin 31 na kasar Sin, da kuma kananan hukumomi, shugabannin sun tsawaita hutun Sabuwar Shekara zuwa 10 ga watan Fabrairu, suna ba da umarnin a yi ayyukan da ba za a bude ba har sai wannan ranar.
Wadannan yankuna sun kai kashi 80% na GDP da 90% na fitar da kayayyaki.
Hong Kong ta kara yawan cututtukan da ke yaduwa zuwa mafi girma kuma ta sanar da dokar hana fita, rufe makarantu har zuwa watan Maris da kuma soke bukukuwan Sabuwar Shekara. An yi wa sashen sayar da kayayyaki rauni a duniya, yayin da shagunan ke rage lokutan buɗewa ko rufewa.
Sayen kayayyaki daga waɗannan dillalai a Turai da Latin Amurka ya ragu da kashi 40 cikin ɗari.
Masu sayar da irin wannan kayan a Arewacin Amurka da Gabas ta Tsakiya sun sami raguwar ayyukan su da kashi 50 zuwa 60%.
Wannan kuma ya haifar da raguwar kashi 33 43% na masu tafiya zuwa kantin sayar da kayayyaki a ranar Laraba idan aka kwatanta da ranar Talata.
Masu kula da manyan kantuna a duniya sun kafa wasu matakai, kamar su tsaftace-tsaftace, a sanya matakan zafin jiki a gaban masu sayayya, da kuma soke bukukuwan.A cewar kimantawa na Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka, lalacewar tattalin arziki da cutar ta haifar na iya barin mutane tsakanin miliyan 14 zuwa 22 a cikin matsanancin talauci fiye da yadda ya kasance a Latin Amurka idan ba a magance matsalar ba.
A watan Janairu da Maris na shekarar 2020, lokacin da cutar ta fi yawa a Wuhan, mutane miliyan 5 a kasar Sin sun rasa ayyukansu.
Yawancin mutane miliyan 300 da suka yi gudun hijira zuwa karkara a kasar Sin sun makale a gidajensu a lardin Hubei. A watan Maris na shekarar 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Cutar coronavirus na iya haifar da asarar ayyuka miliyan 47 a Amurka da rashin aikin yi har zuwa kashi 32%, a cewar kimantawar Bankin Tarayya na St. Louis. Kullewa a Indiya ya sa miliyan miliyan Masu aiki na yau da kullun na Indiya ba su da aikin yi. Binciken da Angus Reid Institute ya gudanar ya gano cewa kashi 44% na iyalai a Kanada sun sha wahala daga matsalar rashin aikin yi. Kimanin ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da suka tafi hutu a tsakiyar watan Agusta 2020.
A cikin watan Maris na biyu, Ma'aikata miliyan 4 a Faransa sun nemi taimakon rashin aikin yi na wucin gadi, kuma ma'aikata miliyan 1 a Burtaniya sun nemi tsarin bashi na duniya. Kimanin kamfanoni dubu 50 a Jamus sun tura ma'aikatansu zuwa tsarin gwamnati na aiki na ɗan lokaci da biyan kuɗi wanda aka sani da Kurzarbeit.
An kuma fara amfani da tsarin aikin ɗan lokaci na Jamus a Faransa da Birtaniya.
Wasanni da kuma kula da al'adu sun sha wahala sosai, wanda ya sa kamfanoni da masu zaman kansu suka yi amfani da su a duk duniya.
Ƙungiyoyin al'adu sun yi ƙoƙari su ci gaba da yin aiki (wanda yawanci ana biyan kuɗi) na ba da izinin shiga wuraren al'adu, kiyaye lafiyar ma'aikatan su da sauran jama'a, da kuma tallafa wa masu zane-zane idan ya cancanta.
A watan Maris na shekarar 2020, a duk fadin duniya, gidajen tarihi, dakunan karatu, wuraren shakatawa, da sauran cibiyoyin al'adu suna rufe yayin da ake gudanar da nune-nunen, da sauran bukukuwa da aka soke ko kuma aka jinkirta.
Sakamakon annobar kuma ya hada da dakatar da ayyukan addini, wasanni, sauran ayyukan nishaɗi, kamar kide kide da wake-wake, darussan fasaha, da bukukuwan salon.
Vatican ta sanar da cewa an dakatar da bikin Makon Mai Tsarki a Roma, wanda ya faru a makon karshe na Azumi.
A wasu larduna, an umurci Kiristoci tsofaffi su zauna a gida maimakon su yi Mass a ranar Lahadi; wasu majami'u sun saka addu'o'i a kan rediyo, a kan intane, ko kuma a talabijin; wasu kuma sun yi addu'o'i a cikin mota.
Sa'ad da Cocin Katolika na Roma suka rufe cocinsu da kuma St. Peter's Square kuma suka rage masu zuwa, sauran addinai sun daina yin addu'o'insu kuma sun rage taro a majami'u, masallatai, majami'u, wuraren bauta, da kuma gidajen ibada.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa kuma daga baya aka rufe masallatai, yayin da Saudi Arabiya ta dakatar da masu yawon bude ido daga kasashen waje da 'yan kasarta daga shiga wuraren ibada na Makka da Madina.
Cutar ta haifar da rikice-rikice mafi girma a kalandar wasanni tun bayan Yaƙin Duniya na II.
An soke ko kuma an kara wasanni da dama da suka shahara, ciki har da 2019 UEFA Champions League 20, 2019 Premier League 20, UEFA Euro 2020, 2019 NBA 20, da 2019 NHL 20.
Cutar ta katse shirin gasar Olympics ta shekarar 2020, wanda aka shirya fara a karshen watan Yuli; kwamitin wasannin Olympics na kasa da kasa ya sanar a ranar 24 ga watan Maris cewa za a sake shirya wasannin bayan shekarar 2020 amma ba a baya ba lokacin bazara na 2021". An rufe gidajen caca da sauran wuraren wasanni a duk duniya kuma an tsawaita ko soke wasannin karta.
Wannan ya sa masu caca suka soma shiga dandalin, inda shafukan caca na kan layi suke nuna cewa yawan masu yin caca ya ƙaru. Har ila yau, masana'antar nishaɗi ta yi taɓarɓarewa, inda ƙungiyoyi da yawa suka dakatar da waƙoƙinsu ko kuma suka dakatar da tafiye-tafiyen su.
Manyan gidajen wasan kwaikwayon da yawa har da na Broadway sun soke dukan wasanninsu.
Wasu mawaƙa sun gwada wasu hanyoyin da za su iya buga da kuma raba ayyukansu ta hanyar intanet maimakon tsarin gargajiya na yin waƙa kai tsaye, kamar wasan kwaikwayon raye-raye na kan layi ko kuma shirya bukukuwa ta yanar gizo (yankin yanar gizo) inda mawaƙa za su iya yin waƙa, watsa shirye-shirye, da kuma tallata ayyukansu.
A kan intanet, bayanai masu yawa game da cutar coronavirus sun bazu sosai har mutane da yawa suka fara yin dariya da wasa a cikin rashin sani.
Tun bayan barkewar cutar COVID-19, an sami nuna bambanci, nuna bambanci, da nuna bambanci tsakanin kabilanci da aka nuna wa mutanen da suka fito daga China da Gabashin Asiya, da kuma mutanen da suka fito daga yankunan da abin ya shafa a Turai, Amurka da sauran ƙasashe.
An ga tsoro, zalunci, da kuma mugunta a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amirka, da yankin Asiya da Fasifik.
Rahotanni daga ranar Talata (yayin da mafi yawan masu kamuwa da cutar har yanzu suna cikin China) sun nuna nuna bambancin launin fata ga kungiyoyin Sinawa a duk duniya da ya kamata su kasance masu kamuwa da cutar ko kuma su sami abin da ake ganin ya dace.
Wasu ƙasashe a Afirka ma sun ga ƙiyayya da ake yi wa Sin.
Mazauna Wuhan da Hubei da dama sun ce ana nuna musu wariya saboda yankin da suka fito.
An samu tallafi ga Sinawa, a kan layi da kuma sauran wurare, da kuma waɗanda ke zaune a yankunan da cutar ta shafa.
Bayan yaduwar cutar zuwa wasu kasashe, mutanen Italiya, kasar Turai da ta fara kamuwa da cutar COVID-19, sun fara fuskantar nuna wariya da nuna wariya. 'Yan ƙasa a ƙasashe kamar Malaysia, New Zealand, Singapore, da Koriya ta Kudu sun fara sanya hannu kan takardun hana shigowar Sinawa a cikin ƙoƙarin hana cutar.
A Japan, taken #ChineseDontComeToJapan ya yi tasiri sosai a shafin Twitter.
Sinawa da wasu 'yan Asiya a Ingila da kuma Amirka sun yi fargabar cewa ana nuna musu wariya, ana wulakanta su, ana kuma yi musu barazana.
An yi ta sukar shugaban kasar Gurduwaras Donald Trump kan yadda ya kira coronavirus "kwayar cutar Sin", kalmar da masu zanga-zanga suka kira nuna wariyar launin fata da kuma nuna kyamar China.
Masu zanga-zanga a Ukraine sun kai hari kan bas da ke dauke da 'yan kasar Ukraine da na kasashen waje a Wuhan don kai su Sanzhary.
Dalibai daga Arewa maso Gabashin Indiya, wanda ke da alaƙa da China, suna karatu a manyan biranen Indiya da aka ruwaito sun shiga cikin rikici game da cutar coronavirus.
Shugaban jam'iyyar Bharatiya Janata na West Bengal Dilip Ghosh ya ce Sinawa sun lalata muhalli kuma "wannan shine dalilin da ya sa Allah ya hukunta su".
Wannan maganar daga baya ta fusata jakadan kasar Sin a Kolkata, wanda ya kira ta "kuskure". A kasar Sin, nuna kyamar 'yan kasashen waje da nuna wariya ga 'yan kasar da ba Sinawa ba ne suka yi sanadiyar cutar, inda ake kiran 'yan kasashen waje "ƙazamar ƙasashen waje" kuma ana sa ido a kan "saki".
Yawancin jaridu da ke da shafukan yanar gizo sun cire su kuma sun sanya wasu ko duk bayanan da suka shafi coronavirus a cikin su.
Masu wallafa littattafan kimiyya da yawa sun ba da littattafan da suka yi magana game da wannan cuta kyauta.
Wasu masana kimiyya sun tsai da shawarar su raba abin da suka gano a kan dandalin sada zumunta mai suna bioRxiv.
Cutar da ke yaduwa  Cutar da ke yaduwa daga ƙwayoyin cuta da ba a san inda suka fito da kuma yadda suke yaɗuwa
Cutar zazzabin cizon sauro da kuma cututtuka  Bayanai game da yaduwar cututtuka a duniya
 Jerin annoba da annoba  Jerin mutuwar cututtuka masu yaduwa
Rashin lafiyar da ke tattare da safarar namun daji da kuma cutar zoonoses
Gwajin gwaji na cutar coronavirus 2019 (COVID-19) da kwayar cutar SARS-CoV-2 sun hada da tsarin gano kwayar cutar da kuma na gano kwayar cutar da aka samar da kwayar cutar.
Ana tabbatar da kwayar cutar a cikin samfuran gwajin ta hanyar RT-PCR, wanda shine ke gano RNA na coronavirus.
An yi gwajin ne ta hanyar gwada kwayar cutar SARS-CoV-2 RNA kawai.
Ana amfani da shi wajen sanin ko akwai ƙwayoyin cuta da suka kamu da mutum ko kuma sun riga sun kamu da su.
Ana iya amfani da maganin rigakafi (serology) don gano cutar ko kuma gano yawan mutanen da suka kamu da cutar.
Ana iya yin gwajin rigakafin cutar a kan mutanen da suka kamu da cutar, har da waɗanda ba su da alamun cutar ko kuma waɗanda ba su da alamun cutar.
Za a iya sanin ainihin adadin mutanen da suka mutu da kuma yadda mutane suka kamu da cutar ta hanyar yin wannan gwajin.
Saboda rashin isassun gwaje-gwaje, a watan Maris na shekarar 2020 babu wata kasa da ke da cikakken bayani game da yadda cutar ta ke a cikin al'ummarta.
A ranar 23 ga watan Maris, babu wata kasa da ta gwada fiye da kashi 3 cikin 100 na yawan al'ummarta, kuma akwai bambancin da ke tsakanin adadin mutanen da aka gwada a duniya.
Wannan bambancin zai iya shafar yawan mutuwar marasa lafiya, wanda zai iya zama mafi girma a wasu ƙasashe.
Ta amfani da tsarin sake fasalin polymerase chain reaction (rRT-PCR) na lokaci na ainihi, ana iya yin gwajin ne a kan samfurori na jini da aka samo ta hanyoyi daban-daban, ciki har da hanci da hanci da kuma fitsari ko kuma samfurin da aka gano.
Ana samun sakamako a cikin 'yan sa'o'i zuwa kwanaki 2.
Ana iya yin gwajin RT-PCR da kuma gwajin kwayar cutar a cikin mako na farko na kamuwa da cutar.
Bayan haka, ƙwayoyin cuta za su iya ɓace a cikin hanci yayin da suke ƙara yawaita a cikin huhu.
Ga marasa lafiya da aka gwada a mako na biyu, ana iya cire samfurori daga cikin jijiyoyin numfashi ta hanyar amfani da catheter na tsotsa ko kuma ana iya amfani da mai bincike.
An fara yin gwajin PCR a Charité a Berlin a watan Fabrairun 2020 ta hanyar yin amfani da kwafin polymerase chain reaction (rRT-PCR), wanda ya haifar da kayan aikin gwaji 250,000 da aka ba wa Hukumar Lafiya ta Duniya (WHO).
Kasar Ingila ma ta fara samar da tsarin gwaji a ranar 23 ga Janairu 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya samar da gwajin SARS-CoV-2 mai amfani da PCR (PowerChek Coronavirus) a ranar 28 ga Janairu 2020.
Yana gano kwayar "E" a cikin dukkan kwayar cutar beta, kuma kwayar RdRp tana cikin SARS-CoV-2 ne kawai. A China, BGI Group na ɗaya daga cikin kamfanoni na farko da suka sami izinin gaggawa daga Hukumar Kula da Kayayyakin Kiwon Lafiya ta China don amfani da gwajin PCR na SARS-CoV-2. A Amurka, Cibiyoyin Kula da Cututtuka da Rigakafi (CDC) suna ba da gwajin 2019-Novel Coronavirus (2019-nCoV) na Real-Time RT-PCR Diagnostic Panel don gwajin gwamnati ta hanyar International Reagent Resource.
Daya daga cikin gwaje-gwaje uku na kwayoyin halittar da aka yi a cikin tsohuwar hanyar gwajin ya nuna sakamakon da ba shi da tabbas saboda kuskuren reagents, tare da matsalar gwajin a CDC a Atlanta; wannan ya sa ba a samar da samfura 100 a rana ba har zuwa ƙarshen Fabrairu 2020.
Ba a sami tabbacin gwajin gwaji biyu ba har zuwa 28 ga Fabrairu, 2020, kuma har zuwa wannan lokacin ba a ba da izinin gwajin jihohi da na yankuna ba.
An ba da izinin gwajin ta Hukumar Abinci da Magunguna a karkashin tsarin ba da izinin Amfani da Gaggawa.
A ranar 5 ga watan Maris na shekarar 2020 LabCorp ta sanar da cewa an gudanar da gwajin COVID-19 a duk fadin kasar bisa tsarin RT-PCR.
Hakanan Quest Diagnostics ya ba da damar yin gwajin COVID-19 a duk faɗin ƙasar har zuwa 9 ga Maris 2020.
Ba su bayyana iyaka ba; tattara da kuma sarrafa gwaje-gwaje dole ne a yi bisa ga bukatun CDC.
A Rasha, Cibiyar Bincike ta Jiha ta Virology da Biotechnology VECTOR ce ta haɓaka kuma ta buga gwajin COVID-19.
A ranar 11 ga watan Fabrairun 2020 an yi rajistar wannan na'urar gwajin ne a cikin Hukumar Kula da Kiwon Lafiya ta Tarayya. A ranar 12 ga watan Maris na 2020, Mayo Clinic ta kirkiro wani na'urar gwajin COVID-19. A ranar 13 ga watan Maris na 2020, Roche Diagnostics ta sami amincewa daga FDA don gwajin da za a iya yi a cikin awanni 3.5, wanda ke ba da damar na'urar guda ɗaya ta yi gwajin mutane 4,128 a cikin awanni 24.
A ranar 19 ga watan Maris na shekarar 2020, FDA ta ba da izinin gaggawa ga Abbott Laboratories don yin gwaji kan tsarin Abbott na m2000; FDA ta riga ta ba da izini iri ɗaya ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga watan Maris na shekarar 2020, Cepheid ta samu izinin FDA na gaggawa don gudanar da gwajin da zai dauki kimanin minti 45.
FDA ta yi gwajin amfani da fasahar isothermal nucleic acid amplification maimakon PCR.
Saboda ba a bukatar a canja yanayin zafin jiki, wannan tsarin zai iya ba da sakamakon kamuwa da cutar cikin minti biyar, kuma ya ba da sakamakon rashin kamuwa da cutar cikin minti 13.
A halin yanzu akwai kimanin na'urori 18,000 a Amurka kuma Abbott na fatan kara samar da su domin gudanar da gwaje-gwaje 50,000 a kowace rana. Ana sa ran gwajin amfani da kwayar cutar ta monoclonal wanda ke da alaka da kwayar nucleocapsid (N protein) na sabon kwayar cutar coronavirus da ake ci gaba a Taiwan, wanda zai iya samar da sakamako cikin mintuna 15 zuwa 20 kamar yadda ake yi a gwajin gaggawa.
Wani bincike da aka yi a watan Maris na shekarar 2020 ya kammala da cewa "binciken kirji ba shi da tasiri a farkon, kuma sakamakon CT [computed tomography] na iya zama da alamun cutar kafin a gane su".
Abubuwan da aka saba gani a CT sun hada da bambancin gilashin multilobar na biyu da kuma rarrabawar peripheral, asymmetric da posterior.
Subpleural dominance, crazy paving da kuma consolidation suna girma yayin da cutar ke ci gaba.
Binciken da aka yi a Wuhan inda cutar ta fara ya nuna cewa CT na iya yin aiki da sauri fiye da PCR, duk da cewa ba a kula da shi sosai, saboda yawancin hotunan da aka yi sun yi kama da cutar pneumonia da sauran cututtuka.
A watan Maris na shekarar 2020, Kwalejin Kula da Maganin Radiology ta Amurka ta ba da shawarar cewa "Ba za a yi amfani da CT ba don gano ko yin gwajin farko na COVID-19".
Wani abu da ake yi a lokacin kamuwa da cutar shine samar da kwayoyin cutar IgM da IgG.
Ana iya amfani da su wajen gano kwayar cutar a cikin mutane daga kwanaki 7 bayan bayyanar cututtuka, gano kwayar cutar, da kuma lura da yawan mutanen da suka kamu da cutar. Ana iya yin gwajin a cibiyar bincike ta tsakiya (CLT) ko a gwajin-wuri-na-jidda (PoCT).
Tsarin sarrafa kansa mai saurin aiki a cikin gwaje-gwaje da yawa zai iya yin wannan gwajin amma kasancewar sa zai dogara da yawan kowane tsarin da aka fitar.
A CLT, ana amfani da jini na farko, ko da yake ana iya amfani da jini na biyu don lura da yadda ake yin jini.
A PoCT ana samun jini sau ɗaya ta hanyar yin tafin ido.
Ba kamar tsarin PCR ba, ba a buƙatar matakin cirewa kafin a gudanar da gwajin. A ranar 26 ga Maris, 2020, FDA ta sami hukumomi 29 da suka ba da rahoton yadda ya kamata kuma don haka yanzu suna iya rarraba kayan aikin su na gwajin antibody.
A ranar 7 ga Afrilu 2020, FDA ta amince da gwajin sau ɗaya kawai a cikin tsarin amincewa da gaggawa. A ƙarshen Maris 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kayan aikin gwajin su, wanda zai iya gano IgG da IgA antibodies a cikin samfuran jini.
Za su iya gwada ɗaruruwan samfurori a cikin 'yan sa'o'i kaɗan kuma saboda haka ya fi sauri fiye da hanyoyin PCR na yau da kullun don cutar RNA.
Antibodies yawanci ana iya gano su cikin kwanaki 14 bayan kamuwa da cutar. A farkon watan Afrilu, Birtaniya ta gano cewa duk kayan gwajin antibody da ta saya, babu wanda ya yi aiki yadda ya kamata.
Hong Kong ta kafa tsarin da ke nuna cewa mutanen da ake zargi da kamuwa da cutar su zauna a gida, "sashen gaggawa zai ba wa mai haƙuri tabarau na tattara gwaje-gwaje", wanda mai haƙuri zai yi amfani da shi, ya aika da katin kuma ya sami sakamakon gwajin daga baya. NHS ta Burtaniya ta sanar da cewa tana gwajin tsarin gwajin cutar a gida, wanda ke kawar da matsalar kamuwa da cutar idan ta je asibiti ko kuma idan an yi amfani da asibiti. A cikin tsarin da ke nuna cewa COVID-19 ya mutu a cikin waɗanda ake zargi da cutar a gida, likitan da ke kula da su ba ya bin ƙa'idodin kiyayewa.
Cibiyoyin gwajin Drive-through sun taimaka wa Koriya ta Kudu ta yi gwajin gaggawa, a kan yawan jama'a fiye da kowace ƙasa. A Jamus, Ƙungiyar Likitocin Kula da Kiwon Lafiya ta Kasa ta ce a ranar 2 ga Maris, za ta iya gwada kusan mutane 12,000 a kowace rana a cikin tsarin dawowa da dawowa kuma an gwada 10,700 a cikin makon da ya gabata.
Inshorar inshora ce take biyan kuɗin idan likita ya umurce shi.
A cewar shugaban Cibiyar Robert Koch, Jamus na da damar gwada mutane 160,000 a kowane mako.
A ranar 19 ga watan Maris ne aka gudanar da gwajin rigakafin cutar a manyan birane da dama.
Har zuwa 26 ga watan Maris na shekarar 2020 ba a san yawan mutanen da aka gwada a Jamus ba, saboda ana sanar da sakamakon cutar ne kawai.
Binciken farko na gwaji ya nuna cewa a cikin makon 12/2020 an gwada jimillar samfura 483,295 har zuwa makon 12/2020 wanda ya hada da 33,491 (6.9%) wadanda ke dauke da kwayar cutar SARS-CoV-2. A Isra'ila, masu bincike daga asibitin Technion da Rambam sun haɓaka kuma sun gwada tsarin gwajin gwajin daga marasa lafiya 64 a lokaci guda, suna haɗa samfurin tare da gwajin amsawa don gano kwayar cutar. A Wuhan, gwajin gwajin mai nisan murabba'in 2000square-meter mai suna "Huo-Yanpolo" (a Sinanci: 火眼, ko "Fire Eye", a Turanci, a Yuganda) wanda ya fara aiki a watan Agusta na 2020 ya samar da samfurori sama da 10,000, wanda zai iya yin aiki a ranar 5 ga watan Agusta, wanda ya wuce ranar 5 ga watan Agusta, wanda ya kasance a cikin BGI.
Aikin gina shi ne wanda BGI mai kafa Wang Jian ya gudanar, kuma ya dauki kwanaki 5, kuma kimantawa ya nuna cewa yawan masu kamuwa da cutar a Hubei zai kai kashi 47% kuma za a ninka kudin da ake kashewa wajen kebe mutane idan ba a gina wannan cibiyar gwajin ba.
An yi gwajin Wuhan nan da nan a Huo-Yan a Shenzhen, Tianjin, Beijing, da Shanghai, a birane 12 a duk fadin kasar Sin.
A ranar 4 ga watan Maris na shekarar 2020, an samu kimanin mutane 50,000 da ake gwadawa a kowace rana. An gabatar da tsarin da aka tsara da yawa wanda ba na kasuwanci ba wanda Origami Assays ya samar wanda zai iya gano COVID-19 a cikin samfuran marasa lafiya 1122 ta amfani da gwaje-gwaje 93 kawai. Ana iya amfani da waɗannan hanyoyin a cikin ƙananan gwaje-gwaje ba tare da buƙatar yin amfani da mutummutumi ba.
A watan Maris, karancin alluran rigakafin da ake amfani da su wajen yin gwaji ya zama cikas ga gwaji masu tsada a EU da Burtaniya da Amurka.
Wannan ya sa wasu masu bincike suka gwada tsarin shirya samfurori ta hanyar fara a zafin 98 °C (208 °F) na tsawon minti 5 don samar da genomes na RNA don ƙarin bincike. A ranar 31 ga Maris an sanar da cewa Hadaddiyar Daular Larabawa tana gwada yawan jama'arta na Coronavirus fiye da kowace ƙasa, kuma tana da niyyar ƙara yawan gwajin zuwa mafi yawan jama'ar ƙasar.
An yi hakan ne ta hanyar hada tsarin kai mutum zuwa cibiyoyin gwaji, da kuma sayen gwajin mutum mai yawa daga Group 42 da BGI (bisa ga gwajin gaggawa na "Huo-Yan" a kasar Sin).
Wannan gwajin da aka gina cikin kwanaki 14 yana da ikon yin dubban gwajin RT-PCR a kowace rana kuma shine na farko a duniya da aka yi aiki a wajen kasar Sin.
An samar da wasu nau'ikan kwayoyin da ke niyya ga kwayoyin cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan, da Amurka.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa kamfanin Jamus ya fitar da gwajin ga ƙasashe masu tasowa waɗanda ba su da ikon samar da nasu.
An fitar da maganin Jamus a ranar 17 ga Janairu, 2020; ba a fitar da tsarin da Cibiyoyin Kula da Cututtuka na Amurka suka samar ba har zuwa ranar 28 ga Janairu, wanda ya hana gwajin a Amurka. China da Amurka suna da matsala game da ingancin kayan aikin gwaji a farkon lokacin cutar, kuma waɗannan ƙasashe da Ostiraliya ba su iya samar da isassun kayayyaki don biyan buƙatu da kuma amincewar masana kiwon lafiya don amfani da su a cikin gwajin ba.
Akasin haka, masana sun ce yawan gwajin cutar a Koriya ta Kudu ya taimaka wajen rage yaduwar cutar coronavirus.
An gina ikon yin gwaji, musamman a cikin gwaji mai zaman kansa, shekaru da yawa da suka gabata ta gwamnatin Koriya ta Kudu.
A ranar 16 ga watan Maris, Hukumar Lafiya ta Duniya ta ba da shawarar ci gaba da shirin gwajin a matsayin hanya mafi kyau don rage yaduwar cutar COVID-19. Bukatar gwajin da ke tattare da cutar ta haifar da ƙarancin gwajin gwaji a cikin gwaji na masu zaman kansu a Amurka, kuma ba a wadatar da kayan aikin gwaji.
A watan Maris na shekarar 2020 kasar Sin ta bayyana cewa akwai wasu matsaloli game da ingancin kayan aikin gwajin.
A Amurka, kayan aikin da CDC ta samar sun sami matsala; a nan gwamnati ta kawar da takunkumin da ke hana gwajin mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar mallakar.
Kamfanin ya bayyana cewa sakamakon da ba daidai ba zai iya kasancewa sakamakon rashin yin amfani da samfurin da ya dace ko kuma gwajin da ya dace.
Ma'aikatar Spain ta ce za ta janye gwajin da aka yi wa Shenzhen Bioeasy, wanda ya wuce na wasu. 80% na gwajin da Jamhuriyar Czech ta sayo daga China ya ba da sakamako mara kyau. Slovakia ta sayi samfurori miliyan 1.2 daga China wanda aka gano ba daidai ba.
Firayim Minista Matovič ya ce an sayar da su ne a Danube. Ateş Kara na Ma'aikatar Lafiya ta Turkiyya ya ce alluran da Turkiyya ta sayo daga China suna da "iyakar damar yin kuskure" kuma "ba a yi amfani da su ba". Burtaniya ta sayi alluran 3.5 miliyan daga China amma a farkon watan Afrilu 2020 ta sanar da cewa ba za a iya amfani da su ba.
Gwajin, wanda ya biyo bayan keɓewar waɗanda suka kamu da cutar da kuma gano waɗanda suka kasance kusa da SARS-CoV-2, ya ba da sakamako mai kyau.
Masu bincike a garin Vò na Italiya, inda aka samu mutuwar COVID-19 ta farko a Italiya, sun yi gwaje-gwaje biyu a kan mutane 3,400, a tsakanin kwanaki goma.
Kusan rabin mutanen da suka kamu da cutar ba su da alamun cutar, kuma duk waɗanda suka kamu da cutar an killace su.
Saboda an hana su shiga cikin jama'a, an dakatar da yiwuwar samun sabon kamuwa da cutar.
Binciken da aka yi na mutanen da suka yi hulɗa da su, hana shiga, gwaji, da keɓewar mutane, sun taimaka wajen rage cutar coronavirus ta 2020 a Singapore fiye da sauran ƙasashe masu tasowa, amma ba tare da rufe manyan kayayyaki kamar kayan abinci da ƙananan shagunan ba.
An dakatar da abubuwa da yawa, kuma Singapore ta fara gaya wa 'yan ƙasa su zauna a gida a ranar 28 ga Maris, amma makarantu sun sake buɗewa a kan lokaci bayan hutun ranar 23 ga Maris.
Wasu kasashe da dama sun kuma yi nasarar shawo kan cutar ta hanyar gano mutanen da suka yi hulɗa da su, hana shiga, yin gwaji, da kuma ware marasa lafiya, amma ba tare da yin amfani da takunkumi ba, kamar Iceland da Koriya ta Kudu.
Binciken da aka yi ya gano cewa kasashen da suka yi gwajin cutar da yawa, idan aka kwatanta da yawan mutanen da suka mutu, suna da ƙananan adadin mutanen da suka mutu, mai yiwuwa saboda waɗannan ƙasashe suna iya gano waɗanda ba su da alamun cutar ko kuma ba su da alamun cutar.
WHO ta ba da shawarar cewa ƙasashe da ba su da isasshen gwajin COVID-19 da ƙasashe da ba su da isasshen ƙwarewar COVID-19 su aika da samfuran su na farko na marasa lafiya na COVID-19 da na farko 10 masu rai zuwa ɗayan gwaje-gwajen WHO 16 da aka bincika don tabbatar da gwajin su.
Daga cikin gwaje-gwaje 16 da aka yi, bakwai suna Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amirka, ɗaya kuma a Ostareliya.
A cikin teburin da ke ƙasa, ƙimar Masu kamuwa da cutar a cikin % na gwajin sun dogara ne akan tsarin gwajin ƙasa.
Kasar da ke gwada kawai mutanen da aka ba su izinin shiga asibiti za ta sami kashi mafi girma na masu kamuwa da cutar a cikin kashi % da aka gwada fiye da ƙasar da ke gwada yawan jama'a, ko suna da alamun cutar ko a'a, idan duk sauran sun kasance daidai.
Wanke hannu, wanda kuma ake kira da tsabtace hannu, aikin wanke hannu ne na mutum da nufin cire datti, mai, ƙwayoyin cuta, ko wasu abubuwa marasa amfani.
Wanke hannu da sabulu a "mafi yawan lokutan" na rana yana hana yaduwar cututtuka da yawa, kamar su ciwon farji, wanda ke yadawa ta hanyar numfashi.
Mutane kuma suna iya kamuwa da cutar ta hanci da na hannu kamar mura, alal misali, idan ba su wanke hannuwansu ba kafin su taɓa fuska, hanci, ko baki (wato, wurare masu sanyi).
Lokaci biyar mafi muhimmanci na rana don wanke hannu da sabulu shine lokacin da ake buƙatar aiki: kafin ko bayan bayan gida, bayan wanke bayan jariri ko canza mata farantin, kafin ciyar da jariri, kafin cin abinci da bayan dafa abinci ko taɓa nama ko kifi.
Idan ba a samu sabulu da ruwa ba, za a iya wanke hannaye da toka. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu:
Kafin in ci abinci, ina dafa shi, bayan haka kuma ina dafa shi.
Kafin ka je wajen wani da yake rashin lafiya da kuma bayan ka je wajen.
Bayan na canja kati ko kuma na yi wa jariri wanka bayan na fito daga bayan gida.
Bayan ka yi masa fure, ka yi masa yanka ko kuma ka yi masa yanka.
Bayan ka taɓa dabba, abincin dabba, ko kuma ƙashin dabba.
Tsabtace hannu na likita shine tsabtace hannu da ke da alaƙa da magani.
Wanke hannu kafin a ba da magani ko kuma a yi jinya zai iya rage yaduwar cututtuka.
Babban manufar wanke hannu shine kashe ƙwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta masu cutarwa) da kuma cire magunguna masu cutarwa ko cututtuka.
Wannan yana da mahimmanci ga mutanen da ke kula da abinci ko kuma masu kula da lafiyar jiki, amma yana da kyau ga kowa.
Wanke hannu yana da fa'idodi da yawa, gami da rage yaduwar mura, coronavirus, da sauran cututtukan da ake yaduwa; guje wa abubuwa masu guba; rage cututtukan da ke yaduwa;
rage yawan mutuwar yara a lokacin da ake renon su a gida.
Wani bincike na 2013 ya nuna cewa kara wanke hannu zai iya inganta ci gaban yara 'yan kasa da shekaru biyar.
A ƙasashe masu tasowa, ana iya rage yawan mutuwar yara da ke da nasaba da cututtuka masu saurin kamuwa da cuta da kuma ciwon daji ta hanyar sauya halayen, kamar wanke hannu da sabulu.
Wannan mataki mai sauƙi zai iya rage yawan mutuwar mutane da kashi 50 cikin dari.
Inganta wanke hannu zai iya rage yawan hayaki da kashi daya bisa uku, kuma wannan ya yi daidai da samar da ruwa mai tsafta a yankunan da ke da karancin kudi.
Za a iya rage yawan kamuwa da cuta da kashi 48% ta hanyar wanke hannu da sabulu. Wanke hannu da sabulu shine hanya mafi inganci da mafi arha don guje wa kamuwa da cuta, wanda aka tsara a gidaje, makarantu da al'ummomi a duniya.
Ciwon sukari, wanda shine mafi yawan cututtukan cututtukan cututtuka, shine babban wanda ke kashe yara a ƙarƙashin shekaru biyar, yana kashe kusan yara miliyan 1.8 a kowace shekara.
Cutar zazzabin cizon sauro da kuma ciwon zazzabin cizon sauro suna kashe yara kusan miliyan 3.5 a kowace shekara.
A cewar UNICEF, wanke hannu da sabulu kafin cin abinci da kuma bayan amfani da bayan gida zai iya ceton rayuka fiye da maganin rigakafi ko magani, yana rage yawan mutuwar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuk
Wanke hannu sau da yawa yana tare da sauran ayyukan tsabta kamar wani ɓangare na aikin ruwa, tsabtace muhalli da tsabta (WASH).
Wanke hannu yana kuma hana kamuwa da cututtukan fata da ake kira maƙarƙashiya, wanda ke yaduwa ta hanyar taɓa mutum kai tsaye.
Wani hadari na wanke hannu akai-akai shi ne idan ya shafi fata ko kuma ya bushe.
Wani bincike da aka yi a shekara ta 2012 a Denmark ya nuna cewa yawan wanke hannu yana iya sa mutum ya yi ciwon fata mai saurin kumbura, wanda ake kira eczema ko kuma cututtukan fata, kuma hakan ya zama ruwan dare a tsakanin likitoci.
Wanke hannu sau da yawa kuma ana ganin alama ce ta matsalar maimaitawa ta damuwa, wanda aka sani da rikicewar damuwa-da-jajircewa (OCD).
Akwai manyan lokuta guda biyar a rana inda wanke hannu da sabulu ke da muhimmanci don rage kamuwa da cutar ta baki: bayan ka yi amfani da gidan wanka (haushi, wanke kanka), bayan ka yi wanka (canja wanki), kafin ka ciyar da yaro, kafin ka ci abinci da kuma kafin ka dafa abinci ko kuma bayan ka taɓa nama ko kifi.
Sauran lokutan da wanke hannu da kyau ya zama dole don guje wa yaduwar cuta sun hada da kafin ko bayan taɓawa da naman kaza ko kaza; bayan yin fitsari, yin taushi, ko yin gumi; bayan taɓawa da naman dabba ko dabba; da kuma bayan taɓawa da sharar gida.
A ƙasashe da yawa, wanke hannu da sabulu ba shi da muhimmanci.
Binciken wanke hannu a kasashe 54 a shekarar 2015 ya gano cewa a matsakaici, kashi 38.7% na iyalai sun wanke hannu da sabulu. Binciken da aka gudanar a shekarar 2014 ya nuna cewa Saudi Arabia ce ta fi wanke hannu da kashi 97 cikin dari; Amurka ta kasance a tsakiyar kashi 77 cikin dari; yayin da China ta kasance mafi ƙanƙanta da kashi 23 cikin dari. A halin yanzu akwai matakai da yawa na sauya halayyar mutane don ƙara al'adar wanke hannu da sabulu a wannan mawuyacin lokaci. Wanke hannu tare a cikin rukuni a makaranta a cikin lokutan da aka tsara a rana yana ɗaya daga cikin mafi yawan al'ummomin da ke tasowa don shigar da tsarin wanke hannu a cikin kwakwalwar yara.
Shirin kula da lafiya na musamman da Ma'aikatar Ilimi ta Philippines ke gudanarwa, misali ne na ayyukan inganta lafiyar yara da kuma ilimantar da su.
Shan maganin kashe ƙwari sau biyu a shekara, wanda ya haɗa da wanke hannu da sabulu kowace rana, da kuma yin buroshin haƙori da fluoride, sune manyan abubuwan da ake yi a wannan shirin na kasa.
An yi amfani da wannan tsarin sosai a ƙasar Indonesia.
Ana ƙara sabulu a cikin ruwa don cire ƙwayoyin cuta daga fata.
Aikin sabulu shi ne ya rage yawan ruwa da ke hana ruwa fita, kuma ya sa ya yi saurin narkewa.
Ruwa kaɗai ba zai iya tsabtace fata ba domin mai da furotin, waɗanda suke cikin ƙasa, ba sa narkewa cikin ruwa.
Maimakon haka, ana yin amfani da ruwa mai gudana don a yi tafiya.
Sabulu na dafa abinci, da yake ana sake amfani da shi, yana iya zama da ƙwayoyin cuta daga waɗanda suka yi amfani da shi.
Karamin bincike kan kwayar cutar da ke cikin sabulun dafa abinci ya nuna cewa yana da wuya a iya kwayar cutar saboda tana tafiya a cikin busassun.
CDC ta kuma ce "sabulu mai ruwa yana da kyau idan aka wanke shi ba tare da an taɓa shi ba".
An ƙarfafa mutane da suke kula da lafiyarsu su yi amfani da sabulu mai guba.
A yanzu, babu tabbaci cewa maganin kashe ƙwayoyin cuta yana kashe ƙwayoyin cuta.
Maimakon haka, sabulu yana ɗauke da maganin kashe ƙwayoyin cuta mai suna triclosan, wanda ke ɗauke da abubuwa da yawa da ke kashe ƙwayoyin cuta.
Saboda haka, ba a zaɓi maganin rigakafi da sabulu na ƙwayoyin cuta ba, kuma ba zai yi aiki yadda aka ce ya yi ba.
Baya ga kayan kare fata, magunguna daban-daban na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) a matsayin mai kula da pH, antimicrobially active benzoic acid da sauran kayan shafawa (aloe vera, bitamin, menthol, tsire-tsire). Bincike mai zurfi daga Jami'ar Oregon School of Public Health ya nuna cewa sabulu na yau da kullun yana aiki daidai da sabulu na kwayoyin cuta wanda ke haifar da triclosan a cikin rigakafin cututtuka da kuma kawar da ƙwayoyin cuta daga hannu.
Ruwan wanka mai zafi ba ya ƙone ƙwayoyin cuta.
Kwayar cuta tana girma da sauri a zafin jiki (37 °C).
Maimakon haka, ruwan zafi mai sabulu yana da tasiri fiye da ruwan sanyi mai sabulu wajen kawar da ƙwayoyin cuta da suke manne wa ƙasa.
Akasin abin da ake tsammani, bincike na kimiyya ya nuna cewa ruwan zafi ba ya canja adadin ƙwayoyin cuta da ke hannunka.
Maganin wanke hannu ko kuma maganin kashe kumburi shi ne wanda ke wanke hannaye ba tare da samun ruwa ba.
A ƙarshen shekarun 1990 da kuma farkon rabin ƙarni na 21, masu tsabtace hannu da aka yi da giya (wanda ake kira rubs na hannu da ke ɗauke da barasa, antiseptic hand rubs, ko kuma masu tsabtace hannu) sun zama sanadiyar samun ci gaba.
Yawancin ana yin su ne da isopropyl alcohol ko ethanol wanda aka haɗa da wani abu mai wuya kamar Carbomer (polymer na acrylic acid) don sanya shi mai laushi, ko humectant kamar glycerin zuwa ruwa, ko kumfa don sauƙaƙa masu amfani da shi da kuma rage ƙarancin giya.
Ƙara hydrogen-peroxide mai narkewa yana ƙara ƙarfin maganin rigakafi. Sanitizers na hannu da ke da kashi 60 zuwa 95% na barasa suna kashe ƙwayoyin cuta.
Maganin tsabtace jiki da ke ɗauke da barasa yana kashe ƙwayoyin cuta, ƙwayoyin cuta masu ƙin shan magani (MRSA da VRE), tarin fuka, da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, vaccinia, mura, da hepatitis) da fungi.
Maganin tsabtace hannu na giya mai kashi 70% yana kashe kwayoyin cuta 99.97% (3.5 log rage, idan aka kwatanta da rage decibel 35) a hannu bayan dakika 30 da kuma 99.99% zuwa 99.999% (4 zuwa 5 log rage) na kwayoyin cuta a hannu bayan minti 1 da amfani. Maganin tsabtace hannu yana da tasiri sosai akan kwayoyin cuta amma ba shi da tasiri ga wasu ƙwayoyin cuta.
Maganin tsabtace hannu da aka yi da barasa ba ya aiki sosai a kan kwayar cutar norovirus (ko Norwalk), wanda shine babban dalilin cutar ciwon ciki. Dole ne a yi amfani da maganin kashe kumburi ko kuma rubbing na giya don wanke hannu biyu.
A gaban da bayan dukkan yatsun hannu da kuma a wuraren da yatsun hannu suke, a yi amfani da shi na tsawon dakika 30 har sai ruwa, kumfa ko kuma tsotsa sun narke.
Dole ne a wanke yatsun hannu sosai, ana shafa su a duka bangarorin. Cibiyar Kula da Cututtuka da Rigakafin Amurka ta ba da shawarar wanke hannu fiye da amfani da maganin tsabtace jiki, musamman idan hannayen hannu suna da ƙazanta.
Amfani da waɗannan kayan ya dogara ne da sauƙin amfani da saurin kashe ƙwayoyin cuta; duk da haka, ba a buƙatar maye gurbin tsabtace hannu sai dai idan sabulu da ruwa ba su da.
Yin amfani da magungunan tsabtace jiki da ke dauke da barasa sosai zai iya sa fata ta bushe sai dai idan an haɗa da kayan shafawa da/ko masu sanyaya fata.
Za a iya rage ko kuma kawar da rashin tsabta ta hanyar haɗa kayan tsabtace jiki da kayan shafawa.
A cikin binciken likita, kayan tsabtace jiki da aka yi da giya da aka haɗa da kayan shafawa sun sa fata ta yi bushe sosai fiye da sabulu ko sabulu.
Allergic contact dermatitis, contact urticaria syndrome ko rashin shan giya ko kuma abubuwan da ake amfani da su wajen wankewa da giya ba sa faruwa a yawancin lokuta.
Rashin cutar fata mai saurin fuska ya jawo hankalin mutane idan aka kwatanta da wanke hannu da sabulu da ruwa.
Ko da yake suna da kyau, kayan wanke hannu da ba a yi su da ruwa ba sa tsabtace hannu da sauri, suna kawar da ƙwayoyin cuta ne kawai.
Wannan shine dalilin da ya sa masu tsabtace jiki ba su da tasiri kamar sabulu da ruwa wajen magance yaduwar ƙwayoyin cuta, saboda ƙwayoyin cuta suna iya zama a hannayenku.
Maganin tsabtace jiki da ba ya da barasa yana da amfani sosai, kuma a tarihi ba ya yin tasiri kamar giya da maginin tsabtace jiki da ke da barasa.
Kwanan nan, an gano cewa sinadarin da ke amfani da benzalkonium chloride suna da tasiri sosai kuma suna kashe kwayoyin cuta fiye da giya, wanda aka gano cewa yana rage tasiri tare da ƙarin amfani, mai yiwuwa saboda rashin lafiyar fata.
Mutane da yawa a ƙasashe masu tasowa ba sa samun sabulu, saboda haka, suna amfani da toka da ƙasa.
Tutsiyar ƙasa ko kuma toka za ta iya yin aiki fiye da ruwa, amma ba za ta yi aiki kamar sabulu ba.
Matsalar ita ce, idan ƙasa ko ƙura suka zama masu ƙwayoyin cuta, hakan zai iya ƙara yaduwar cututtuka maimakon rage su.
Kamar sabulu, toka tana kawar da ƙwayoyin cuta domin tana da ruwan da ke sa ya zama mai ƙamshi.
Hukumar ta WHO ta amince a yi amfani da toka ko yashi maimakon sabulu idan babu sabulu.
Tsarin wanke hannu da ya dace da Cibiyoyin Kula da Cututtuka na Amurka suka ba da shawarar don hana yaduwar cutar ya haɗa da waɗannan matakan:
Kada ka wanke hannunka da ruwan zafi ko sanyi.
Ana buƙatar ruwa mai gudana saboda ruwa mai gudana zai iya ɗaukar kwayoyin cuta, kuma zafin ruwan ba ya haifar da bambanci.
Ka kawo wanka a hannunka da yawa da sabulu, a bayan yatsanka, a cikin rami, da kuma a ƙarƙashin ƙwanƙwasa.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa wanke hannu da sabulu ya fi wanke hannu da ruwa mai tsabta.
Na yi wanka na minti ashirin.
Wanke hannu yana sa ya zama mai daɗi, yana sa ya zama mai tsabta, kuma wanke hannu da daɗewa yana kawar da ƙwayoyin cuta.
Ka yi amfani da ruwa mai guba.
Yin amfani da ruwa mai guba zai iya sa hannayenka su sake kamuwa da cuta.
Ka yi amfani da tawul da ya bushe ko kuma ka bar shi ya bushe.
Wuraren da aka fi manta da su su ne, ƙashin ƙugu, ƙashin ƙugu, da kuma ciki.
A kan abinci, ana iya saka kayan lambu a kan abinci don ɓoye ƙwayoyin cuta.
Ana amfani da kayan shafawa don kare hannayen hannu; fata mai bushewa na iya haifar da rauni a fata wanda zai iya ƙara haɗarin kamuwa da cuta.
Akwai wasu hanyoyin da za a iya amfani da su wajen wanke hannu kamar  ruwa mai taya/safi ko sabulu ba ya samuwa, kamar zubar da ruwa daga bututun da aka rataye ko kuma mai amfani da ash idan ya cancanta a ƙasashe masu tasowa. A cikin yanayin da babu isasshen ruwa (kamar makarantu ko ƙauyuka a ƙasashe masu tasowa), akwai hanyoyin da za a rage amfani da ruwa, kamar "tippy-taps" da sauran hanyoyin da ba su da tsada.
Tippy-tap wani tsari ne mai sauƙi wanda ke amfani da ƙugiya mai ɗaure da igiya, wanda mutum zai iya ɗauka don ya ɗora ruwa kaɗan a kan hannunsa da kuma sabulu.
Wanke hannu yana da muhimmanci wajen tsabtace hannu, amma akwai jayayya game da yadda za a wanke hannu a cikin gidajen wanka.
Bincike da yawa sun nuna cewa tawul ɗin takarda sun fi na lantarki da ake samu a gidajen wanka da yawa inganci.
A shekara ta 2008, jami'ar Westminster da ke Landan, da kuma wani taron da aka yi a Turai, sun yi bincike don su gwada tsabtace hannu da ke cikin tawul da aka yi da takarda da kuma na'urar da ake bushe hannu da iska.
Bayan wanka da wanke hannaye da kuma amfani da iska mai zafi, an sami ƙaruwa na 194% na ƙwayoyin cuta a hannaye da 254% a kan takalma.
Goge hannu a cikin iska mai iska mai iska ya haifar da karuwar kwayoyin cuta a hannayenka da kashi 42% da kuma a yatsun hannu da kashi 15%.
Bayan wanka da bushewa da tawul na takarda, adadin kwayoyin cuta ya ragu da kashi 76% a hannaye da kashi 77% a kan yatsunsu. Masana kimiyya sun kuma gudanar da gwaje-gwaje don gano ko akwai damar da masu amfani da gidan wanka ke da ita na kawar da ƙwayoyin cuta da kuma yanayin gidan wanka daga nau'ikan tsabtace hannu.
Wani injin iska mai ƙarfi, wanda yake hura iska da saurin 180 m/s (650 km/h; 400 mph), zai iya hura ƙwayoyin cuta daga hannunsa da kuma cikinsa kuma zai iya yaɗa su zuwa ga sauran masu amfani da banɗaki kuma ya watsa su a cikin banɗaki da ke nisan mita biyu.
Ta yin amfani da na'urar da ake amfani da ita wajen hura iska mai zafi, sai ta hura ƙwayoyin cuta da ke nisan kusan mita biyu da rabi.
Tashin hannu na takarda bai nuna cewa yana iya yada kwayar cutar ba. A cikin 2005, a cikin binciken da TÜV Produkt und Umwelt ya gudanar, an bincika hanyoyin wanke hannu daban-daban.
An gano canji na gaba a yawan kwayoyin bayan wanke hannu:
Akwai masu yin wanka da yawa, kuma an kwatanta wankan hannu da wanke hannu da tawul.
Ana amfani da wanke hannu da takarda mai laushi don tafiya ba tare da sabulu da ruwa ba.
Dole ne a yi amfani da maganin tsabtace jiki da ke dauke da barasa aƙalla kashi 60 cikin dari.
An soma wanke hannu don a guji kamuwa da cuta ne bayan da likitan Hungary Ignaz Semmelweis ya gano cewa wannan hanyar tana da amfani sosai (a shekara ta 1846) wajen guje wa kamuwa da cuta a asibitoci.
Ana amfani da na'urori da ke sa ma'aikatan asibiti su tuna cewa suna bukatar su wanke hannuwansu.
Wani bincike ya gano cewa kamuwa da cuta ya ragu yayin da ake amfani da na'urorin.
Wanke hannu don hana kamuwa da cuta yana ɗaukar aƙalla mintuna 15, tare da sabulu da ruwa don wankewa da kuma tsabtace kowane ɓangaren hannu.
Dole ne a yi wa hannayen hannu da kuma waɗanda suke da alaƙa da su.
Idan akwai ƙazanta a cikin gida, a yi amfani da goga mai zafi don cire ta.
Tun da yake ƙwayoyin cuta suna iya zama a cikin ruwan hannu, yana da muhimmanci a motsa shi sosai kuma a goge shi da tawul mai tsabta.
Bayan an bushe, ya kamata a yi amfani da tawul na takarda don rufe ruwa (kuma a buɗe ruwan idan ya cancanta).
Hakan yana hana hannayenka samun ƙwayoyin cuta daga waɗannan abubuwa.
Amfanin wanke hannu a asibiti shine kawar da kwayoyin cuta da kuma gujewa yada su.
Jaridar New England Journal of Medicine ta ce rashin wanke hannu har ila matsala ce a asibitoci da yawa, inda likitoci da ma'aikatan jinya da yawa suke mantawa da wanke hannu kafin su taɓa marasa lafiya, kuma hakan yana sa su yi amfani da maganin kashe cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da kuma wasu matakai masu sauƙi na iya rage kamuwa da cuta a jini da kashi 66 cikin dari. Hukumar Lafiya ta Duniya ta fitar da takarda da ke nuna yadda ake wanke hannu da kuma yin amfani da tawul a asibitoci.
Ana kuma iya samun takardun da ke nuna yadda ake wanke hannu a dandalinsa.
Whitby da abokansa sun yi bincike mai kyau.
Akwai na'urori da za su iya gwada tsabta, idan ya cancanta don tabbatar da cewa ya dace da ka'idojin doka.
Hukumar Lafiya ta Duniya ta ba da "Matakai Biyar" don wanke hannu:
bayan sun taɓa jini/ruwa
idan za ka taɓa wani abu da ba shi da ƙwayoyin cuta, da kuma
bayan an yi wa mai ciwo magani. Yin amfani da sabulu mai guba yana sa sabulu ya yi aiki sosai.
Ana iya buƙatar maganin rigakafi kafin a yi wa mai haƙuri tiyata ko kuma a yanayin da kwayoyin cuta suka saba da maganin rigakafi. Yin amfani da kayan shafawa kafin a yi wa mai haƙuri tiyata, yana buƙatar yin amfani da kayan shafawa da za a iya cirewa, wanka da chlorhexidine ko iodine, tawul da aka dafa don wanke hannaye bayan wanka, da goga mai tsabta da sauran kayan wankewa.
Dole ne a kawar da dukan abubuwan da za su sa a yi banza.
Wannan aikin yana buƙatar wanke hannu da hannu biyu zuwa ƙugu na mintuna 2.6.
Ba a bukatar a yi wanka na tsawon lokaci (minti goma).
Idan kana motsawa, kada ka bar ruwa ya yi ta zubowa a hannunka.
Bayan an gama wanke hannu, ana wanke hannu da wanki da aka dafa, sai a wanke tufafin da kyau.
Don rage yaduwar kwayar cutar, yana da kyau a wanke hannu ko a yi amfani da maganin kashe ƙwayoyin cuta kafin a yi hulɗa da mai cutar da kuma bayan haka.
Don hana kamuwa da cutar staphylococcal a asibitoci, an gano cewa mafi kyawun amfanin wanke hannu ya fito ne daga kashi 20 cikin ɗari na farkon wanka, kuma an sami ƙarin fa'idodi kaɗan yayin da yawan wanke hannu ya ƙaru da kashi 35 cikin ɗari.
Wanke hannu da sabulu na yau da kullun yana sau uku ya kara kamuwa da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
A maimakon haka, sabulu da ruwa sun fi amfani da maganin tsabtace jiki na giya wajen rage kwayar cutar H1N1 influenza A da kuma Clostridium difficile spores daga hannaye. Matakan inganta tsabtace hannu a asibitoci na iya haɗawa da koyar da ma'aikata game da wanke hannu, ƙara kayan tsabtace hannu na giya, da kuma rubuta ko tunatar da ma'aikata.
Akwai bukatar ƙarin bincike kan abin da ya fi dacewa a cikin yanayin asibiti.
A ƙasashe masu tasowa, ana ganin wanke hannu da sabulu hanya ce mai tsada, da kuma lafiya, da kuma abinci mai gina jiki.
Duk da haka, rashin ruwa, sabulu ko kayan wanke hannu a gidaje, makarantu da wuraren aiki na kawo ƙalubale wajen yada da kuma inganta al'adar wanke hannu a ko'ina.
Misali, a yankunan karkara na Afirka, ana samun karancin kayan wanki na hannu kusa da kowane gidan wanka na masu zaman kansu ko na jama'a, duk da cewa akwai hanyoyin da ba su da tsada na gina wuraren wanki na hannu.
Maimakon haka, wanke hannu kaɗan na iya zama al'ada da mutum ya riga ya saba da ita ba wai kawai rashin ruwa da sabulu ba.
Tallafawa da kuma karfafawa ga wanke hannu da sabulu na iya canza manufofin al'umma, ilimantar da mutane game da fa'idodin wanke hannu da kuma canza dabi'un rayuwar mutane gaba daya.
Amma wannan aikin yana bukatar kulawa da kuma kulawa.
Wani bincike na musamman na sau 70 ya gano cewa tsarin da ke bisa al'umma a ƙasashe masu tasowa (LMICs) yana da tasiri wajen ƙarfafa mutane su wanke hannu; akasin haka, shi ne wanda ke da iko a kan kayan masarufi kuma ba ya yin hakan. Misali na wannan shi ne "Hanyar Taurari Uku" ta UNICEF; wannan tsarin ya haɗa da ƙarfafa makarantu su yi amfani da hanyoyi masu sauƙi da masu araha wajen ƙarfafa ɗalibai su wanke hannu da sabulu, a matsayin wani ɓangare na bukatun tsabta.
Idan aka samu maki na farko, makarantu za su iya samun taurari uku daga ɗaya zuwa uku.
Samar da wuraren wanke hannu na iya zama wani ɓangare na ƙoƙarin rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya misali ne mai kyau na yadda za a yi amfani da shi wajen karfafawa mutane su canza dabi'u.Dangane da annobar cutar coronavirus ta 2019-2020, UNICEF ta kirkiro wani shafin yanar gizo don karfafawa mutane gwiwa kan wanke hannu.
Akwai ƙananan bincike da suka bincika yiwuwar samun kuɗin kuɗi na al'umma na wanke hannu a ƙasashe masu tasowa idan aka kwatanta da ƙimar DALYs da aka ƙi.
Amma, wasu bincike sun nuna cewa wanke hannu da sabulu sun fi sauran hanyoyin samar da ruwa da kuma tsabtace muhalli.
An fara nuna muhimmancin wanke hannu ga lafiyar mutum musamman ga waɗanda suke cikin yanayi na kāriya kamar mata masu rauni ko sojoji da suka ji rauni a asibitoci a tsakiyar ƙarni na 19, a asibitin Vienna, Austria, da kuma Florence Nightingale, "mai binciken ilimin kiwon lafiya na zamani", wanda shi ɗan ƙasar Hungary ne.
A lokacin, an yi imani cewa ciwon yana zuwa ne daga wani ƙwayar cuta da ake kira miasmas.
A shekarun 1980s, cututtukan abinci da cututtukan da ke haifar da cututtukan cututtukan cututtuka sun sa Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka su rufe kuma su koyar da jama'a game da mahimmancin wanke hannu don hana yaduwar cututtuka.
Barkewar cutar sankarar naman alade a shekarar 2009 da kuma COVID-19 a shekarar 2020 sun sa kasashe da dama suka fahimci muhimmancin wanke hannu da sabulu don kare kansu daga cututtukan da ake yadawa.
Alal misali, an saka alluna da ke nuna "tsarin wanke hannu" a wuraren wanke hannu a ofisoshin gwamnati da kuma filayen jiragen sama a Jamus.
Furcin nan "wanke hannuwansa" yana nufin sanar da cewa mutum ya daina wani hakki ko kuma ya saka hannu a wani abu.
Wannan furucin ya bayyana a littafin Matta inda aka nuna cewa Bilatus Babunti ya wanke hannunsa sa'ad da ya yanke shawarar kashe Yesu Kristi; amma yanzu ana amfani da wannan furucin sosai a ƙasashen da ke ƙarƙashin mulkin Ingila.
A cikin Shakespeare's Macbeth, an gaya wa Mrs. Macbeth ta wanke hannunta yayin da take ƙoƙarin yin tunani a kan abin da take tunani, wanda ke nuna baƙin cikin da take ji saboda laifin da ta yi da kuma jinkirin da mijinta ya yi.
An kuma lura cewa mutane suna wanke hannuwansu fiye da yadda suke yi a dā, kuma suna daraja kayan wanka fiye da yadda suke yi a dā.
Bugu da ƙari, waɗanda aka yarda su wanke hannayensu bayan sun yi hakan ba su da wata dama ta sake shiga cikin ayyukan tsabta kamar su aikin jin kai.
Addinai na addini suna ƙarfafa wanke hannu don tsabta da kuma alama. Wanke hannu na alama, wanda shine amfani da ruwa mara sabulu don wanke hannu, ɗayan ƙananan wanke hannu ne da ake yi a cikin addinai da yawa, gami da Bahai, Hindu, Tebula da netilat yadayim a cikin addinin Yahudanci, Lavabo a cikin Krista, da Budhu a cikin Musulmai. Addinai kuma suna ƙarfafa wanke hannu musamman bayan wasu ayyuka.
Addinin Hindu, Yahudanci da Musulunci sun bukaci a wanke hannu bayan an fita daga bayan gida.
Addinan Hindu, Buddha, Sikh, Yahudawa, da Musulmai suna ƙarfafa mutane su wanke hannayensu kafin su ci abinci da kuma bayan sun ci.
Matsalar COVID-19 a wurin aiki
Abubuwan da ke hana matsalolin aiki na COVID-19 shine kafa matakan kariya da hanyoyin kariya daga cutar coronavirus 2019 (COVID-19).
Ingantattun hanyoyin hana haɗari a wurin aiki ya dogara da wurin aiki da ƙalubalen da ke tattare da gano tushen haɗarin, girman matsalar cutar a cikin al'umma, da haɗarin haɗari ga ma'aikata da kuma ma'aikata da ke da saurin kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aikin Aikin Amurka (OSHA), ayyukan da ke da ƙananan haɗari ba su da haɗari sosai ga ma'aikata da sauran ma'aikata, kuma ana iya magance irin waɗannan haɗarin tare da ƙarancin kulawa ta farko, ƙarfafa ma'aikata su zauna a gida lokacin da suke rashin lafiya, ƙa'idodin numfashi, da kuma ƙoƙarin tsabtace wuraren aiki da kuma kashe ƙwayoyin cuta.
Ayyukan da ba su da haɗari sun haɗa da waɗanda ke da alaƙa da mutane da ba a san ko kuma waɗanda ake zargi da cutar COVID-19, amma waɗanda za su iya kamuwa da cutar ta hanyar yaduwar cutar a cikin gida ko ta hanyar tafiya zuwa wasu ƙasashe.
Wannan ya haɗa da ma'aikata da suke hulɗa da jama'a, kamar su makarantu, wuraren aiki da kuma manyan kasuwanni.
Wannan rigakafin na jama'a ya hada da matakan rigakafin farko, ciki har da amfani da kayan aikin iska, da kuma sanya tufafin kariya idan akwai mai cutar COVID-19 a kusa.
Manufar OSHA ta ba da shawarar cewa likitoci/ma'aikatan jinya su yi aiki a wuraren da ake zargin cewa suna da cutar COVID-19 saboda suna da babban haɗari, kuma wannan haɗarin ya fi tsanani idan ma'aikatan suka ɗauki samfuran jikin mutum daga jikin wanda ya mutu ko kuma wanda ake zargin cewa yana da cutar COVID-19.
Hanyoyin da za a iya hana masu aikin yin aiki su shiga cikin hadari sun hada da hanyoyin da ake amfani da su wajen gina gine-gine, kamar su hana iska daga cikin ɗaki zuwa cikin ɗaki, da kuma yin amfani da kayan aiki na jiki da ya dace da aikin da ake yi.
Cutar COVID-19 na iya haifar da tasiri mai yawa a kan ayyukan yi.
Ma'aikata na iya rasa aikin saboda rashin lafiya, bukatar kula da wasu, ko kuma tsoron kamuwa da cutar.
Kasuwanci na iya canzawa, a kan abubuwan da mutane ke so da kuma yadda suke sayen waɗannan kayayyaki (misali sayen a lokacin da aka fi sayarwa ko kuma son kawo kayayyaki da suke bukata ko kuma ba sa barin motoci a lokacin da suka isa wurin da ake sayarwa).
A ƙarshe, ana iya kawo cikas ga jigilar kayayyaki daga wuraren da cutar ta COVID-19 ta shafa. Shirye-shiryen kamuwa da cuta da hanyoyin magance su suna da mahimmanci don taimakawa jagorantar ayyukan rigakafi.
Shirye-shiryen suna la'akari da matakan haɗari da ke tattare da wurare daban-daban na aiki da kuma aikin da kansa, ciki har da sakamakon rigakafin, haɗarin gida da na al'umma, da sauran abubuwan haɗari kamar shekaru ko cututtuka na yau da kullun.
Sun kafa matakan da suka dace don magance wannan haɗarin, da kuma matakan kariya ga yanayin da zai iya tasowa saboda cutar.
Shirya don kamuwa da cuta zai iya zama abin da ya shafi dukan ƙasar ko kuma yankin.
Manufofin da ake da su na magance cututtukan da suka taso sun hada da rage yaduwar cutar a tsakanin ma'aikata, kare mutanen da ke cikin hadarin kamuwa da cutar daga kamuwa da cutar, ci gaba da ayyukan, da kuma rage cutar ga wadanda kamfanonin ke hulɗa da su a cikin ayyukan su.
Cutar ta addabi al'ummar da ke da alhakin kasuwanci, inda ta yi tasiri wajen magance ta.
Tsarin rigakafin matsala shi ne tsarin da aka fi amfani da shi a duniya wajen daidaita matsalar aiki da rayuwa ta hanyar rarraba hanyoyin da ake amfani da su bisa ga ingancin su.
Matsalar COVID-19 ba za a iya kawar da ita ba, ta farko ta hanyar ingantattun sarrafa injiniya, ta biyu ta hanyar sarrafawa, kuma ta ƙarshe ta hanyar sarrafa mutum.
Gudanar da aikin injiniya yana nufin kawar da ma'aikata daga matsalolin aiki ba tare da la'akari da halin aiki ba kuma wannan shine mafi kyawun farashi don aiwatarwa.
Gudanar da sarrafawa shine canje-canje a cikin tsarin aiki ko tsarin aiki wanda ke buƙatar ma'aikaci ko mai aiki ya dauki mataki.
Kayan kariya na mutum (PPE) ana ganin ba su da inganci sosai wajen hana kamuwa da cuta ko kuma hana kamuwa da cuta amma suna iya taimakawa wajen hana kamuwa da cuta.
Ya kamata a zaɓi duk PPE bisa ga haɗarin da ma'aikaci zai iya fuskanta, ya kamata a sanya shi a inda ya dace kuma a kiyaye shi (misali a lokacin da aka cire shi), a saka shi a kai a kai kuma a kiyaye shi, a bincika shi a kai a kai, a kula da shi, a mayar da shi zuwa inda ya dace, a cire shi a inda ya dace, a gyara shi, a adana shi ko a zubar da shi don guje wa kamuwa da cuta.
A cewar Hukumar Kula da Lafiya da Lafiya a Aikin Aikin Amurka (OSHA), ayyuka marasa haɗari suna da ƙananan hulɗa da abokan aiki.
Abubuwan da aka tsara a kowane wuri na aiki sun haɗa da wanke hannu da kyau, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, al'ada a cikin yin taushi ko yin taushi wanda ya haɗa da rufe bakinsu lokacin da suke yin taushi ko motsawa, samar da takardun tsabta da takardun tsabta, shirya don sadarwa ta waya ko musayar aiki idan ya cancanta, ƙarfafa ma'aikata kada su yi amfani da kayan aiki, da kuma tsabtace wurin aiki da kuma yin ƙoƙarin kashe ƙwayoyin cuta.
Gano waɗanda ake zargi da kamuwa da cutar da wuri da kuma ware su daga sauran mutane yana taimakawa wajen ceton ma'aikata, abokan ciniki, baƙi da sauran mutane a wuraren aiki.
Cibiyar Kula da Cututtuka da Rigakafin Cutar (CDC) ta Amurka ta ba da shawarar cewa ma'aikata da ke da alamun cutar numfashi mai tsanani su zauna a gida har sai zafin zazzabin, da bayyanar zazzabin, da sauran alamun sun kare aƙalla awanni 24 ba tare da shan maganin zazzabin ba kuma cewa tsarin hutun ma'aikata ya kamata ya kasance mai sassauci, ya ba ma'aikata damar zama a gida don kula da marasa lafiya, kuma ma'aikata su san waɗannan ƙa'idodin.
A cewar OSHA, ayyukan da ke da ƙananan haɗari su ne waɗanda ke buƙatar mutane su kasance a nesa da mutane masu nisan kafa shida (1.8 m) daga mutanen da ba a san suna da ko ake zargin suna da COVID-19, amma waɗanda za su iya samun SARS-CoV-2 saboda yaduwar cutar a yankin kasuwancin ko kuma saboda mutumin ya yi balaguro a ƙasashen waje a cikin yankin da aka san cewa yana da tasirin COVID-19.
Wannan ya hada da ma'aikata da ke hulda da sauran al'umma kamar makarantu, wuraren aiki, da wuraren cin kasuwa da ke cike da cunkoso. Ingantaccen sarrafawa a cikin waɗannan wuraren da kuma kungiyoyin da ke cikin haɗari sun haɗa da sanya kayan aikin iska mai iska mai iska a cikin gidaje, ƙara girman ɗakunan, kafa ɗakunan kiwon lafiya mafi kyau bisa ga al'amuran mutum kamar bus, da kuma samar da windows na masu saurin shiga cikin motocin da ke ba da izinin ma'aikata su isa ga abokan ciniki ba tare da ɓata lokaci ba. Don gudanar da gudanarwa na yau da kullun (adminitative controls) a kan wannan rukunin yana ba da horo ga ma'aikata don ƙarfafa ci gaba da kasancewa mai tsabta, hanyoyin da za a iya magance cutar COVID-19 da kuma yadda za a iya magance cutar, tare da yin amfani da kayan aiki na gida, da kuma samar da bayanan da suka dace, da kuma samar da hanyoyin da za a iya kiyaye COVID-19 a cikin gida, da kuma yin amfani da kayan aiki na gida, da kuma samar da hanyoyin da za a iya kiyayewa, da kuma samar da bayanan da suka dace, da kuma samar da hanyoyin da za a iya kiyaye COVID-19 a cikin gida, da kuma samar da hanyoyin da za a iya kiyayewa a cikin gida, da kuma samar da hanyoyin da za a iya amfani da su a cikin gida.
Ma'aikata a cikin wannan rukunin ba sa bukatar yin amfani da na'urar numfashi.
Idan mutum ya kamu da cutar a jirgin sama, hanyoyin da suka dace na hana ma'aikatan jirgin da sauran fasinjoji sun hada da ware mai cutar daga sauran mutane na tsawon kafa 6, samun wani ma'aikaci ya kula da mai cutar, da kuma ba da takunkumi ga mai cutar ko kuma neman mai cutar ya rufe bakinsa da hanci da takardar tsabta lokacin da yake yin taushi ko yin taushi.
Ma'aikatan jirgin sama dole ne su sanya safofin hannu na lokaci guda lokacin da suke kula da fasinjoji marasa lafiya ko kuma lokacin da suka taɓa wani abu da ya fito daga jiki ko kuma wani abu da ya nuna cewa yana da cutar, kuma su yi wanka idan mutumin da suke kula da shi yana da zazzaɓi, yana da ciwon hanci, ko kuma yana da wahalar numfashi.
Ya kamata a ajiye safofin hannu da sauran kayan da za a iya amfani da su sau ɗaya a cikin jakar da ake zubar da abubuwa masu guba, da kuma kayan da aka kwashe da kuma tsabtace su da kuma maganin su. A cikin jiragen ruwa masu jigilar kaya, abubuwan da ke haifar da haɗari sune, tsawaita tafiya idan kun yi rashin lafiya, keɓewa da kuma sanar da ma'aikatan jirgin idan kun ji zazzabin cizon sauro ko wasu alamun cutar yayin da kuke cikin jirgin.
A cikin yanayi, ana yin sa ido a cikin ɗakin da aka ajiye mai cutar. A makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan lokaci don tsabtace da kuma kashe kwayoyin cuta idan mai cutar ya kasance a cikin ginin makaranta kuma ba a yada cutar a yankin ba.
Idan akwai yaduwar cutar a cikin al'umma, ana iya amfani da matakan keɓewa, kamar soke ziyarar, yin layi a makaranta, da sauran manyan tarurruka kamar yin motsa jiki ko ƙungiyoyin motsa jiki ko cin abinci a cikin ɗakin karatun, ƙara wuraren zama a kan kujerun ɗalibai, daidaita lokutan dawowa da dawowa gida, rage baƙi marasa mahimmanci, da kuma amfani da ofishin kiwon lafiya na musamman don yara da ke da alamun cutar.
Idan akwai wata cuta mai tsanani a yankin, ya kamata a tsawaita matakin nesa, kuma a rufe makarantu na tsawon lokaci. Ga masu aikin 'yanci da ke aiki a kai a kai, CDC ta kiyasta cewa hadarin kamuwa da cutar ba shi da yawa.
An shawarci jami'an tsaro da ke hulɗa da mutanen da suka tabbatar da cewa suna da cutar COVID-19 su bi ka'idodin da ke kan gaggawa, gami da amfani da kayan aiki na jiki.
Idan an yi tuntuɓe a lokacin da aka kama mutum, ma'aikata su tsabtace da kuma kashe rigarsu kafin su sake amfani da su ta hanyar amfani da maganin numfashi ko kuma yin amfani da kayan shafawa, kuma su bi ka'idodin da aka sani a duk duniya na tsabtace kayan wanka da wanke tufafi.
OSHA ta sanya wasu ma'aikatan kiwon lafiya da ma'aikatan kantin sayar da kayayyaki a cikin wani yanayi mai matukar hadari na kamuwa da cutar.
Ayyukan da ke sa mutane cikin haɗari sun haɗa da masu kula da marasa lafiya a gida, masu tallafawa, masu gwajin gwaji, da masu aikin kiwon lafiya waɗanda ke kusanci da waɗanda aka sani ko ake zargin suna da COVID-19.
Waɗannan suna cikin haɗari sosai lokacin da ma'aikata ke yin aikin samar da iska a kan marasa lafiya ko kuma lokacin da suke riƙe samfuran daga mutanen da aka sani ko ake zargin suna da COVID-19.
Aerosol-generating procedures sun hada da yin kwaskwarima, bronchoscopies, hanyoyin da suka hada da yin gwajin hakori, ko kuma tattara samfurin invasive.
Ayyukan da ke da hadari a kan gawawwakin sun hada da shirya gawawwakin mutanen da aka san suna da cutar ko kuma ana zargin suna da cutar COVID-19 a lokacin da suka mutu; waɗannan suna da haɗari sosai lokacin da aka gano gawawwakin. Ingantaccen sarrafawa ga waɗannan rukunin masu haɗari sun haɗa da amfani da ɗakunan don ware waɗanda aka sani suna da cutar ko kuma ana zargin suna da cutar COVID-19, wanda ya haɗa da aiwatar da hanyoyin samar da iska (aerosol).
Tsarin iska mai matsin lamba mai ƙarfi na iya zama mai kyau a wasu yanayin kiwon lafiya da kuma na gawawwaki.
Ya kamata a yi amfani da matakan kiyaye lafiyar mutum (Biosafety Level 3 precautions) wajen daukar samfurori.
WHO ta ba da shawarar a ware sabbin marasa lafiya a wuraren jiran su na musamman idan ana zargin cewa suna da COVID-19. Baya ga sauran matakan PPE, OSHA ta ba da shawarar yin amfani da abin rufe fuska ga waɗanda ke aiki a cikin nisan ƙafa 6 na waɗanda ke kewaye da marasa lafiya da ke da cutar SARS-CoV-2 ko waɗanda ake zargin suna tare da waɗanda ke aiki a hanyoyin samar da iska.
A Amurka, dole ne a yi amfani da abin rufe fuska N95 da NIOSH ta amince da shi ko kuma mafi girma a cikin yanayi mai kyau wanda ya haɗa da gwaji na farko, horar da masu amfani, horo, da kuma gwajin asibiti.
Wasu nau'ikan rigakafi na iya taimakawa sosai wajen kiyaye ma'aikata suyi aikinsu. WHO ba ta ba da shawarar yin amfani da rigakafi ba saboda COVID-19 cuta ce ta kwayar cuta kuma ba a iya watsa ta ta hanyar ruwa.
Hukumar Lafiya ta Duniya ta amince da amfani da maganin rigakafi ga ma'aikatan da ke kula da masu cutar.
Ga waɗanda ke ɗaukar samfurori na jini daga mutane, masu kulawa, ko masu ɗaukar marasa lafiya na COVID-19 ba tare da yin amfani da hanyoyin samar da iska ba, WHO ta ba da shawarar yin amfani da kayan shafawa, tabarau ko abin rufe fuska, da safofin hannu.
A lokacin da ake yin aikin aerosol, ana amfani da na'urar numfashi ta N95 ko FFP2.
Saboda rashin isasshen kayan shafawa (PPE), WHO ta ba da shawarar rage amfani da kayan shafawa a lokacin da ake yin magani ba tare da tuntuɓar likita ba (telemedicine), amfani da abubuwan motsa jiki kamar su windows masu haske, ba da izinin shiga cikin dakin tare da mai cutar COVID-19, amfani da kayan shafawa na musamman don yanayin, amfani da kayan shafawa na musamman don hana marasa lafiya da ke da cutar, saka idanu da sadarwa, da hana amfani da su ga marasa lafiya marasa alamun cutar.
TASKANIN: Katherine Maher, Shugabar Gidauniyar Wikimedia
ERI: Ma'aikatan Gidauniyar Wikimedia
GASKIYA: [COVID-19] Rage aiki da kuma shirya don nan gaba
WATA/SA'A: 14 ga watan Maris, 2020, 00:24 UTC
LITTAFI MAI TSARKI: CC0: Babu haƙƙin mallaka
Muna cikin yanayi mai wuya a wannan watan.
Cutar COVID-19 ta nuna mana cewa duk mutane a duniya suna da alaƙa da juna kuma suna da alhaki ga juna.
Ba mu da misali a kan wannan kalubalen, amma mun san cewa amsarmu ta dogara ne da tausayi na duniya, zumunci, da kuma haɗin kai tsakanin al'umma wanda aka gina wannan ƙungiya.
Yadda abokanmu suke nuna mana ƙauna ta wajen aika mana saƙon imel, yin mana waya, da kuma tattaunawa a waya ya nuna cewa muna da dangantaka mai kyau da kuma farin ciki.
Ba ni da isashen kalmomin da zan yi amfani da su wajen nuna godiya ga abokaina.
A makon da ya gabata, wani ya gode mini don aikin da muke yi.
Ya tunatar da ni muhimmancin da duniya take da shi na samun Wikipedia a wannan lokaci, kuma wannan alama ce mai karfi da cewa Wikipedia tana da muhimmanci kuma ya kamata kowa ya kasance a kan layi don ya iya amfani da ita.
Ayyukanku sun taimaka mana wajen cimma wannan nasara, ta hanyar taimaka mana wajen kafa shafin yanar gizonmu, ta hanyar taimaka mana wajen biyan ma'aikatanmu ko kuma mutane don su kasance cikin yanayi mai lafiya.
A yanzu, duniya tana bukatar bayanan Wikipedia fiye da kowane lokaci.
Wannan lokaci ne da muke ganin cewa ayyukanmu da kuma yadda muke aikatawa suna shafan duniya.
Saboda muhimmancin wannan sadaukarwa da kuma aikinku a kan wannan batu, za mu yi wasu canje-canje a yadda muke gudanar da aikinmu daga mako mai zuwa.
Yin gyare-gyare a ayyukanmu da kuma tsarinmu
Kamar yadda Robyn ta ambata, an yi taron kwamitin da daddare don tattauna tsarinmu da kuma tsarin da za a bi a cikin watanni masu zuwa.
A cikin tattaunawarmu, mun tattauna abin da muke tunani game da yadda za mu shirya don fuskantar kalubale da kuma yadda za mu ci gaba da gudanar da harkokinmu a wannan lokaci.
Dukanmu muna son mu daina matsa wa mutane kuma mu goyi bayan abin da muke so na ɗan lokaci.
Idan kana son ka sake yin hakan, babu matsala.
Ga dukan ma'aikata, kwangila, da kuma ma'aikata na lokaci:
muna sa ran yin aiki na sa'o'i huɗu a rana ko kuma sa'o'i 20 a mako har sai mun sake yin canjin.
Ba mu sanar da ranar hutu ba  Idan za ka iya yin aiki fiye da haka, hukumar za ta iya ɗaukan ka aiki.
Amma, a wannan zamani na duniya da babu tabbas, ko kana son ka kula da waɗanda kake ƙauna, ko kana son ka sayi kayan gida, ko kuma kana son ka je asibiti, rayuwarka tana da muhimmanci a gare mu.
Ba za mu iya lura da lokacinku ba.
Idan kana rashin lafiya, kada ka yi aiki.
Ba za mu tattauna wannan batun ba, amma mun ga cewa ya dace mu yi hakan.
Ba a buƙatar ranakun rashin lafiya ko biyan bashin rashin aiki. Ka sanar da manajanka kuma ka taimaki abokan aikinka su daidaita tsarin aikin su don tabbatar da cewa an bi duk abin da aka tsara.
(Idan ka gwada kuma ka sami cutar COVID-19, sanar da Bryan a T&amp;C Ops know don T&amp;C ta ba ka tallafi da ake bukata kuma za ta yi ƙoƙarin tabbatar da lafiyarka da kuma samun tallafi da ake bukata daga shugabancinmu).
Za a biya ma'aikatan da suka yi aiki na sa'o'i ɗaya cikakken albashi.
Mun riga mun ambata, kuma a nan mun sake nanata cewa za mu yi biyayya ga alkawarin da muka yi wa 'yan kwangilarmu da kuma abokan aikinmu.
Za a biya kowa gwargwadon aikin da ya yi a yanayi na yau da kullum.
Wannan aiki ne na lura da lokacin da kake rashin lafiya ko kuma ba za ka iya aiki ba.
Idan kana son yin aiki, za mu goyi bayanka.
Mutane da yawa suna amfani da ayyuka a matsayin hanyar samun 'yanci daga matsi na mutane/abubuwa da ke kewaye da su.
A irin wannan lokaci ne muke samun gamsuwa da kuma albarka.
Ina sake gaya muku cewa, ku kula da kanku.
Abin da muke roƙonka shi ne ka tattauna da mai aikinka game da abin da za ka yi tsammani kuma ka yi gyara idan ya dace.
Wasu ayyuka suna da muhimmanci sosai.
Akwai abubuwa da ba za su tsaya ba.
SRE, HR Ops, Trust &amp; Wellness, da kuma kungiyoyin daukar ma'aikata (da sauransu) suna gudanar da ayyuka daban-daban da ke bukatar ƙarin taimako.
Za mu fara da ƙoƙarinmu na bincika abin da ya sa muke yin wannan aikin a yanzu kuma mu kafa abin da muke mai da wa hankali a yanzu don mu tallafa wa abubuwan da suka fi muhimmanci a ayyukanmu.
Muna da ayyuka da yawa, abin da muke bukata shi ne mu mai da hankali ga ayyukan da suka fi muhimmanci.
Saurin gudu ba zai shafi inda za mu je ba.
Ba ma shirin ƙara yawan lokacin da muke aiki don biyan bashin da muka yi bayan mun rasa wani abu.
Kada ka yi aiki fiye da yadda kake yi domin kana ganin ba za ka iya yin aikin ba.
Mun fahimci cewa yanayi ya canja, kuma za mu kafa sababbin makasudai da kuma daidaita yanayinmu.
Mene ne za a yi da Tsarin Shekara?
Don sauya yanayin rayuwarmu, da kuma tsammanin lokacin aiki na yau da kullun, muna fatan canzawa a cikin kwanakin ƙarshe don cimma burinmu na Shirin Shekarar 2020-2021.
Manufarmu ita ce mu ba da shawarar tsawaita shirinmu na 2019-2020 don ba da ƙarin lokaci don yin kasafin kuɗi don ma'aikata su ba da fifiko ga manyan fannoni, su kula da kansu, su kula da jama'arsu kuma su kula da waɗanda suke son yin aiki na ɗan lokaci a cikin 'yan makonni masu zuwa.
Wannan karin ya rage yawan ayyukan da ake yi a yanzu da kuma yawan aikin da ake yi a yanzu a dukkan sassan.
Za mu gabatar da shawarwarinmu ga Hukumar Mulki a mako mai zuwa kuma za mu sanar da wakilai da sauran masu goyon bayanmu game da abin da ya kamata mu yi bayan mun amince da su.
Na gode wa dukkan abokaina da suka tsara da kuma jagoranci a duk al'amura.
Yanayin ofishi, shuka, da kuma tsabtace
A makon da ya gabata, an sanar da mu cewa wani abokinmu a San Francisco ya kamu da cutar COVID-19.
Maimakon haka, da taka tsantsan, mun yi amfani da maganin kashe ƙwayoyin cuta kuma muka yi amfani da iska mai guba wajen tsabtace ofishinmu da ke San Francisco.
Sun yi amfani da maganin kashe ƙwayoyin cuta a kan kowane abu, daga kan ɗaki zuwa saman ofishinmu.
Masu ginin ma sun yi amfani da nasu hanyoyin kula da ma'aikatan.
Muna da kwanciyar hankali cewa za a shirya ofishin sosai kafin mu soma aiki.
Ofishinmu na DC yana cikin WeWork, kuma wannan cibiyar ta nuna mana shirin ta na yaki da COVID-19 kuma duk ma'aikatanta sun shiga cikin shirin.
A ƙarshen makon da ya gabata, an sake gina ofishinmu da ke birnin Washington DC zuwa wani wuri mai nisa, bisa ga shawarar da aka ba da a San Francisco.
Kuma kamar yadda wasu abokanmu a birnin New York suka sani, mun yi aure kuma mun yi hayar wani wuri a Brooklyn.
Wannan dangantaka tana ci gaba amma ana iya kai mata hari.
Wasu abokanmu sun soma yin aiki a gida.
Wasu abokanmu da suka daɗe suna yin wannan aikin sun san cewa yin hakan yana da wuya, kuma suna son su ba da shawara:
Ka bar akwatin a cikin awa ɗaya ko biyu.
Idan ana bukatar a yi taro na tsawon lokaci, ka yi la'akari da yadda za a canja lokacin taron zuwa kwanaki dabam dabam.
A kowane taro, ka yi tunani sosai, ka shirya abin da za a tattauna, kuma ka aika abin da za a tattauna tun da wuri.
Bidiyo da kuka fi so ta amfani da kayan aiki kamar Google Docs da Zoom don taimakawa cikin wannan tattaunawar.
Ka sa wani ya jagoranci kowane taro, wani ya kula da tattaunawar tambayoyi da kuma lokacin da aka ba da kuma wanda ya kula da masu magana da kuma wanda ya kawo shawarwari (ko kuma ya haɗa da duk abin da ya dace).
Idan kana bukatar kayan kunne, ka aika imel zuwa ga masu fasaha don samun kayan kunne masu kyau.
Ka yi amfani da kuɗin da aka mayar don ka kasance da kwanciyar hankali.
Shiga shafin #remoties a Slack kuma ku tattauna game da ayyukan da aka ba ku
Ma'aikatar ma'aikata na duba batun samar da hanyoyin sadarwa ta yanar gizo (webinar-based ergonomics guidance) domin taimakawa wajen gudanar da ayyukan da aka ba su a duk sassan ma'aikatar.
A makon da ya gabata, mun nemi masu karɓar tallafi su dakatar da duk wani taron Wikimedia da aka tallafawa, kamar su edithons, har sai WHO ta sanar da cewa an dakatar da shi.
Mun bayyana musu cewa mun fahimci cewa neman su soke ko kuma hana wasu ayyuka zai sa ya zama da wuya a aiwatar da wasu ayyukan da aka shirya kuma ba za a hukunta kowa ba saboda jinkirin kammala ko canza abubuwan da aka shirya.
A wannan makon, za mu ci gaba da yin nazari a kan Wikimania da kuma wasu darussan da za a yi a wasu wurare.
Abinda muke gani a tsakanin 'yan uwanmu a duk duniya shine cewa' yan uwanmu suna baƙin ciki da irin wannan sharewa amma suna jin kunya lokacin da suka fahimci cewa dole ne su kula da al'ummomin su, Wikimedia da sauransu.
A nan gaba, CRT za ta ci gaba da aiki don kafa shafin yanar gizon Meta-Wiki don ba da lokaci ga mutane su lura da yadda aka shafe su da kuma ci gaba da sadarwa tare da su.
Sadarwa game da COVID-19
Za mu kira ku ta hanyar kalandarku don taron na musamman na ranar Alhamis mai zuwa, 14:00 UTC/07:00 PT.
Za mu yi amfani da wannan lokacin mu tattauna wasu batutuwa, mu amsa tambayoyinku, kuma mu ɗan ɗanɗana.
Wannan batun ya shafi dukanmu, kuma ya kamata mu taimaka wa juna a duk inda za mu iya.
A halin yanzu, za ka iya samun wannan bayanin a cikin imel da kuma wasu shafukan yanar gizo da ke da bayanai game da COVID-19, da kuma a kan Office Wiki.
CRT za ta yi ƙoƙarin tattara bayanai na ƙarshe da ake buƙata a wuri ɗaya.
Muna kuma kokarin samun sadarwa na yau da kullum tare da ma'aikata a kasashen da suka fi fama da cutar a yanzu.
Idan kana da wata tambaya game da tafiye-tafiye, abubuwan da suka faru, kowane irin aiki ko ƙalubale na yin abin da ya kamata ka yi, ko wani abu da kake bukatar taimako, kada ka yi jinkirin sanar da mu kuma ka tuntuɓi CRT.
Muna shirye mu taimaka muku kuma mu tuntube ku game da duk wani abu da ya dace.
Idan kana da wata matsala ko kuma wata matsala da za ka iya yi, ka aika imel zuwa Bryan Judan, Daraktan HR International Global Operations.
Ba za mu ɗauki dukan waɗannan canje-canje kamar sun kawar da mu daga ayyuka da hakki ba.
Maimakon haka, suna taimaka mana mu fahimci cewa a yanzu, ayyukanmu da kuma hakkinmu wataƙila sun bambanta da na dā.
Mun gaskata cewa waɗannan ƙa'idodin suna da muhimmanci don tallafa wa juna don ci gaba da aiki, don tallafa wa ƙungiyarmu a kowane hanya da ta dace, da kuma don bauta wa mutane da kuma hidimar da suka dogara da ita.
Za mu iya cim ma dukan ayyukan da muka shirya.
A yanzu, ya dace mu ba da haɗin kai kuma mu tsara lokacin da za mu yi ayyuka masu muhimmanci a makonni da wata masu zuwa.
Muna bukatar dukanku don ku sa wannan ya faru, saboda haka muna bukatar dukanku ku kula da kanku da kuma iyalanku domin ku kasance da kwanciyar hankali a lokacin da muke bukata.
Yanzu, wasu  suna riƙe da hannuwansu kuma ba sa taɓa fuska!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da kuma wasu shugabannin (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da kuma Toby N).
Kwayar halitta mai canza Angiotensin 2 (ACE2) wani sinadarin ne da ke da alaka da kwayar halitta a cikin jijiyoyi, jijiyoyin jini, zuciya, koda, da kuma hanji.
ACE2 yana hana aikin enzyme mai canza angiotensin (ACE) ta hanyar rage yawan angiotensin-II ta hanyar kara Ang ((1-7) don sanya shi magani mai amfani don cutar zuciya. ACE2 kuma yana aiki azaman mai gabatar da rigakafi ga wasu coronavirus.
A cikin mutane, ana kiran wannan sinadarin hACE2.
Angiotensin-converting enzyme 2 shine zinc wanda ke dauke da enzyme na metallo wanda yake a saman kwayoyin jini da sauran kwayoyin halitta.
Kwayar ACE2 tana da N-terminal peptidase M2 domain da kuma C-terminal collectrin renal amino acid transporter domain.
ACE2 yana wucewa ta hanyar fata sau ɗaya, tare da manyan abubuwan da ke cikinsa a kan farfajiyar farfajiyar da ke cikin hanta da sauran jijiyoyi.
Ana amfani da wani abu da ake kira sheddase wajen fitar da ACE2 daga cikin fata, kuma ana amfani da shi wajen fitar da ruwan da ke cikin jini kuma a sake shi zuwa ruwa.
ACE2 yana samuwa a yawancin sassan jiki: ACE2 yana ɗaure ga ƙwayoyin halitta musamman ma na ƙwayoyin cuta na II a kan ganuwar ƙwayoyin cuta, ƙananan ƙwayoyin cuta, jijiyoyin jini da ƙwayoyin cuta, da kuma ƙwayoyin cuta na jijiyoyin jiki a yawancin sassan jiki.
Ana kuma samun ACE2 mRNA a cikin kwakwalwar kwakwalwa, da kuma a cikin kwakwalwar kwakwalwa, da kuma a cikin hypothalamus.
Babban amfani na ACE2 shine daidaita ACE
ACE yana ɗaure ga angiotensin I hormone a cikin vasoconstricting angiotensin II.
ACE2 kuma yana ɗaure zuwa carboxyl-terminal amino acid phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma ya bayyana a cikin mai haɓaka angiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 kuma na iya ɗaure kan sarƙoƙi da yawa da suka haɗa da [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, da ghrelin.
ACE2 kuma yana sarrafa tafiyar da kwayar halitta ta amino acid mai tsaka tsaki SLC6A19 wanda ake zargi da cutar Hartnup.
A matsayin furotin mai dauke da kwayar halitta, ACE2 yana aiki a matsayin babbar hanyar shiga rigakafin wasu ƙwayoyin cuta na corona, ciki har da HCoV-NL63; SARS-CoV (kwayar cutar SARS); da SARS-CoV-2 (kwayar cutar COVID-19).
Musamman, haɗuwa da furotin na S1 na SARS-CoV da SARS-CoV2 zuwa babban sinadarin ACE2 a saman kwayar halitta yana haifar da kwayar cutar da abubuwan da ke cikin kwayar halitta daga wurin da suke kuma komawa cikin ɗakunan kwayar halitta.
Wannan tsarin shiga yana buƙatar gano S protein da kuma serine protease TMPRSS2, wanda ake nazarin fassararsa don ganin ko za a iya amfani da shi a cikin magani. Wannan ya haifar da wasu tunanin cewa ta hanyar rage yawan ACE2, a cikin kwayoyin, zai iya taimakawa wajen yaki da kamuwa da cuta.
Maimakon haka, hukumomi da hukumomi da dama na bayar da shawarar ci gaba da maganin ACE tare da maganin ARB.
Wani bincike mai zurfi na binciken da aka yi a ranar 11 ga Yuli, 2012, ya gano cewa "yin amfani da maganin hana ACE ya rage haɗarin cutar ciwon huhu da kashi 34 cikin dari fiye da sauran magungunan da aka tsara.
Bugu da ƙari, "an rage haɗarin ciwon huhu a cikin marasa lafiya da aka yi wa maganin ACE waɗanda ke da saurin kamuwa da ciwon huhu, musamman ma waɗanda ke da ciwon zuciya da kuma cututtukan zuciya.
Yin amfani da maganin hana ACE an kuma yi tunanin rage mutuwar cutar sankara, ko da yake sakamakon bai yi yawa ba kamar yadda cutar sankara ke yi"
Ana ganin ACE2 na mutum mai haɗuwa (rhACE2) shine sabon magani don cutar da ta fi ƙarfin ciwon huhu, kuma an nuna shi don inganta haɓakar jijiya da motsi na numfashi a cikin ƙananan ƙwayoyin cuta waɗanda ke da cutar ciwon huhu na lipopolysaccharide-induced acute respiratory distress syndrome.
Rage rhACE2 a cikin mutane yana ɗaukar sa'o'i 10 kuma fara aiki a cikin minti 30 tare da ƙarancin lokacin aiki (a cikin awa 24).
Sakamakon binciken da aka yi ya nuna cewa rhACE2 na iya zama magani mai kyau ga waɗanda ba su da juriya ga magungunan hana hana hana hana siginar renin-angiotensin (RAS inhibitors) ko kuma a cikin cututtuka inda ake inganta motsi na angiotensin II. Ana nazarin rhACE2 a cikin gwaji na asibiti don magance cututtukan da suka shafi jijiyoyin jiki.
Aikace-aikacen COVID-19 aikace-aikacen software ne na wayar hannu da aka tsara don taimakawa wajen bin diddigin mutanen da suka sadu da cutar coronavirus 2019-20, wanda shine tsarin gano mutanen (mutanen da suka sadu da mai cutar) waɗanda zasu iya kasancewa tare da mai cutar.
An kirkiro ko kuma an amince da aikace-aikace daban-daban, tare da tallafin hukuma a yankuna da yankuna daban-daban.
An tsara tsarin da yawa don gina aikace-aikacen da ke bin diddigin abokan hulɗa.
An tattauna batutuwan da suka shafi ƙuntatawa, musamman game da hanyoyin da suka danganci bin diddigin wurin da masu amfani da manhajar suke.
Sauran hanyoyin da ba su da yawa sun hada da amfani da raƙuman Bluetooth don haɗa wayar mai amfani da wasu lambobin da ke kusa
A ranar 10 ga Afrilu 2020, Google da Apple sun sanar da cewa za su haɗa kai don tallafawa aikace-aikacen Bluetooth a cikin Android da iOS kai tsaye a cikin aikace-aikacen su.
A China, gwamnatin kasar Sin, tare da hadin gwiwar Alipau, ta samar da wani manhajar da za ta baiwa 'yan kasar damar gano ko sun taba saduwa da mutanen da ke dauke da cutar COVID-19.
Ana amfani da shi a birane fiye da 200 na kasar Sin.
An kirkiro wannan manhajar ne daga ƙungiyar IT ta yankin, kuma an samar da ita a matsayin mai amfani da jama'a kuma za a ba da ita ga gwamnati. Arewacin Macedonia ta ƙaddamar da "StopKorona!", wani app na Bluetooth don bin diddigin masu shiga ciki da waɗanda ake tsammanin suna da cutar da kuma aika saƙonni da sauri ga ma'aikatan kiwon lafiya da hukumomi.
An kirkiro manhajar ne daga Ma'aikatar Sadarwa da Fasaha tare da Ma'aikatar Lafiya.
Ya zuwa ranar 14 ga Afrilu 2020, yayin da ake jiran amincewar aikace-aikacen daga Google Play Store da Apple App Store.
A ranar 12 ga watan Afrilu, gwamnati ta sanar da cewa ana kammala aikin samar da manhajar bin diddigin masu cutar, kuma za a fara aiki da ita nan da makonni. Ana shirin samar da irin wannan manhajar a Ireland, da Faransa ("StopCovid").
Ostiraliya da New Zealand suna la'akari da aikace-aikacen da ke kan aikace-aikacen TraceTogether na Singapore da yarjejeniyar BlueTrace. Rasha na shirin ƙaddamar da aikace-aikacen geofencing don waɗanda ke da cutar COVID-19 da ke zaune a Moscow, wanda aka tsara don tabbatar da cewa ba sa barin gida.
Ross Anderson, farfesa a fannin aikin tsaro a jami'ar Cambridge, ya bayyana wasu matsaloli da za a iya fuskanta da aikace-aikacen da aka kafa, ciki har da tunanin cewa sun yi aiki da kyau da kuma yiwuwar rashin aiki idan aikace-aikacen ya kasance mai amfani da masu amfani.
Don magance matsalar aikace-aikacen coronavirus masu ɓarna ko haɗari, Apple ya sanya takunkumi kan irin kamfanonin da za su iya haɗa aikace-aikacen da suka shafi coronavirus a cikin App Store, suna ba da izinin waɗannan kamfanoni ko hukumomin da aka sani kawai.
Google da Amazon ma sun kafa irin wannan takunkumi.
Masu fafutuka sun nuna damuwa game da tasirin da za a iya samu daga yawan masu amfani da manhajojin coronavirus, musamman ma idan za a iya kawar da sa ido da aka kafa don magance matsalolin farko bayan annobar ta ƙare.
Amnesty International da kungiyoyi sama da 100 sun gabatar da takarda da ke neman a hana irin wannan bin diddigin.
Hukumomi sun sanar da takunkumi takwas kan ayyukan gwamnati:
dole ne a yi sa'a, a yi amfani da shi yadda ya kamata, kuma a yi amfani da shi yadda ya dace.
Dole ne a yi bayani game da lokacin da za a kammala ƙarin sa ido.
Za a yi amfani da bayanan ne kawai don abubuwan da suka shafi COVID-19;
don kare mahaifina daga fashewa dole ne a kiyaye shi kuma a tabbatar da wannan ta hanyar shaida;
sa ido na kwamfuta ya kamata ya guji ƙara yawan batutuwan nuna bambanci da nuna bambanci;
rabawa da wasu bayanai dole ne a fassara a cikin doka;
dole ne a sami tsarin da zai kare hakkin 'yan Adam daga cin zarafi da kuma hakkin 'yan ƙasa su kare kansu daga nuna bambanci;
"Samun ra'ayi mai kyau" na duk "masu sha'awar" zai zama dole, gami da ƙwararrun masanan zamantakewar al'umma da ƙungiyoyin masu sha'awar. Ƙungiyar Kwamfuta ta Jamus (CCC) da Masu rahoto ba tare da iyaka (Reporter ohne Grenzen) (RSF) sun kuma ba da shawarar bin diddigin.
Shirin Google/Apple da aka kafa yana nufin magance matsalar rashin kulawa ta hanyar cire tsarin kulawa daga na'urorin su idan ba a buƙatar su ba.
Wasu kasashe sun yi amfani da wayar salula don bin diddigin wanda ya kasance a wurin aikace-aikacen, don hana saukar da aikace-aikacen da kuma damar da za a iya guje wa bin diddigin.
A Isra'ila, ana bin mutane ta waya.
Tsarin sa ido na wayar salula wanda ke ba da cikakken bayanin wurin da mutum yake yana da haɗari ga ɓoye sirri.
Duk da haka, ba duk masu amfani da sabobin da suka raba suna buƙatar samun izinin gano wurin da mutum yake ba; an kafa wasu hanyoyin ɓoyewa yayin da ake amfani da sabobin raba don sadarwa ta ciki.
A Koriya ta Kudu, an yi amfani da wata manhaja ta yanar gizo don bin diddigin mutanen da suka kamu da cutar
Maimakon amfani da manhaja mai zaman kanta, na'urar ta tattara bayanai daga wasu wurare daban-daban da suka hada da bin diddigin sakonnin waya da bayanan katin da aka yi amfani da su, kuma an haɗa su don rubuta saƙonni da kuma aika su ta wayar salula ga mutanen da ake tsammanin za su iya kamuwa da cutar.
Baya ga amfani da wannan bayanin don faɗakar da waɗanda suka taɓa haɗuwa da waɗanda suka kamu da cutar, gwamnati da bayanan wurin da mutane suke da su na iya samun damar kowa, wanda aka yarda da shi saboda canje-canje a cikin dokar hana fita bayan barkewar cutar MERS a ƙasar.
Ana samun wannan bayanin ga jama'a ta hanyar aikace-aikace da shafukan yanar gizo daban-daban. Kasashen Jamus sun yi la'akari da amfani da hanyar haɗin gwiwa tare da masu kare bayanan sirri.
A ranar 6 ga Afrilu, 2020, ba a riga an fitar da takardun shaida ba.
Binciken abokan hulɗa na zamani shine tsarin da aka tsara, wanda aka gudanar da bincike da yawa tun daga 2013. A ranar 7 ga Afrilu 2020, ƙungiyoyin ƙwararru da yawa suna aiki kan inganta tsarin sadarwa, kamar amfani da Bluetooth Low Energy (BLE) don gano wurin mai amfani dangane da sauran wayoyin.
Tabbas, PEPP-PT tsari ne na haɗin kai wanda ya ƙunshi tsari na yau da kullun da na yau da kullun, kuma ba sa bin ƙa'idodi iri ɗaya. Ka'idojin da aka rarraba sun haɗa da Bayanin Tsaro na Tsaro na Tsaro (DP-PPT/DP-3T), Lambobin Saduwa na Wucin gadi (TCN, kawai Lambobin taron Saduwa, CEN), Ka'idojin Tsaro na Tsaro da Tsarin Saduwa na Wayar Hannu (PACT) da sauransu.
A cikin wannan tsarin, ba a cire bayanan da ke nuna cewa mutum ya tashi daga matattu daga na'urar, kuma ana haɗa dukan bayanan da ke cikin na'urar.
Kungiyar Twekisize a MIT Media Lab ta kirkiro SafePaths, wani tsari da aka yi amfani da shi wajen yin amfani da hanyoyin da ba a san inda ake ba da bayanai ba wajen bincike da kuma amfani da dandalin watsa bayanai don lura da yaduwar cutar COVID-19.
Ya dogara ne akan binciken daga rahoton "Aikace-aikacen da suka tafi Rogue: Kula da Sirrinka a cikin annoba" wanda aka buga a watan Maris na 2020.
SafeTrace na gina fasaha mai aminci wanda zai ba masu amfani damar raba bayanan sirri na lafiyar su tare da sauran masu amfani da masu gudanarwa, ba tare da sanya wani abu a cikin hadari ba.
A ranar 5 ga Afrilu 2020, an kafa TCN Coalition ta hanyar kungiyoyi masu haɗin gwiwa ta hanyar amfani da tsari iri ɗaya da ƙa'idodi masu dacewa, tare da manufar rage ƙungiyoyi, da kuma iya haɗa kai don ƙirƙirar aikace-aikacen sa ido da aika saƙo, babban mahimmin abu don ba da damar mutane da yawa su shiga.
A ranar 9 ga Afrilu 2020, gwamnatin Singapore ta sanar da cewa tana amfani da yarjejeniyar BlueTrace da aka yi amfani da ita ta aikace-aikacen gwamnati.
A ranar 10 ga watan Afrilu na shekarar 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na Android da iOS, sun sanar da tsarin bin diddigin lambobin sadarwa, wanda suka ce zai kare sirrinmu, bisa la'akari da hadewar fasahar Bluetooth Low Energy da kuma rikodin sirri ta hanyar sigina.
Sun kuma wallafa wasu abubuwa game da fasahar yin magani.
A cewar Apple da Google, ana sa ran samar da maganin a matakai uku:
Bayyana abubuwan da suka dace don ba da damar gwamnati ta samar da aikace-aikacen hukuma don lura da cutar coronavirus amma tare da tsare sirri.
Shigar da wannan tsarin kai tsaye a cikin iOS da Android Google da Apple don magance matsalolin yarda da kuma saka idanu na yau da kullun yayin da aka fara raba wannan kayan ta hanyar inganta kayan aikin wayar hannu, sannan kuma daga baya cire shi lokacin da aka kawar da haɗarin.
b Sake sanya magani (wanda kuma ake kira sake amfani da magani, sake tsarawa, sake aiki ko sauyawar magani) shine sake amfani da magani da aka amince dashi don magance wasu cututtuka ko yanayin jiki wanda ya bambanta da wanda aka fara niyya.
Wannan shine ɗayan manyan binciken kimiyya da ake bi don haɓaka ingantaccen magani na COVID-19.
Sauran binciken da ake ci gaba da yi sun hada da samar da allurar rigakafin COVID-19 da kuma maganin jini. SARS-CoV-2 yana da sunadarai 66 da ke da magungunan rigakafi, kowannensu yana da wurare masu ɗaure ligand da yawa.
Binciken wuraren da ake ɗaurewa yana taimakawa wajen samar da maganin rigakafin COVID-19.
Daga cikin manyan sunadarai da SARS-CoV-2 ke niyya sune papain-like protease, RNA mai dogara da RNA polymerase, helicase, S protein, da ADP ribophosphatase.
Hussein A, et al sun yi bincike kan wasu abubuwa da suka shafi maganin da suka hada da kimantawa da kuma gano magungunan da suka fi dacewa da za a iya amfani da su don hanzarta samar da maganin cutar SARS-CoV-2 a cikin binciken da aka yi kafin a gabatar da shi a cikin shirin gwaji.
Chloroquine magani ne da ake amfani da shi wajen maganin zazzabin cizon sauro kuma ana amfani da shi wajen magance cututtuka da ke hana jiki kamuwa da cutar.
A ranar 18 ga watan Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine mai kama da shi za su kasance cikin wasu kwayoyi guda hudu da ake gudanar da bincike a kansu a matsayin wani ɓangare na gwajin haɗin gwiwa.
Gwamnan New York Andrew Cuomo ya sanar da cewa za a fara gwajin jihar New York na chloroquine da hydroxychloroquine a ranar 24 ga watan Maris. A ranar 28 ga watan Maris, FDA ta amince da amfani da hydroxychloroquine sulfate da chloroquine phosphate a ƙarƙashin izinin Amfani da Gaggawa (Emergency Use Authorization, EUA).
Ba a amince da maganin ba a gwajin asibiti na FDA kuma an amince da shi a cikin EUA ne kawai a matsayin magani na gwaji don amfani da gaggawa a cikin marasa lafiya da aka ba su asibiti amma ba su iya samun magani a cikin gwajin asibiti ba.
CDC ta ce "ba a san yadda za a yi amfani da maganin ba, ko kuma yadda za a yi amfani da shi, ko kuma lokacin da za a yi amfani da maganin maganin cutar SARS-CoV-2".
Likitoci sun ce sun yi amfani da maganin ne "ba tare da wani zaɓi ba".
Wata ƙungiyar masu bincike a Turkiyya a Istanbul suna yin ƙananan bincike kan amfani da chloroquine tare da zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da bincike mai zurfi a Jami'ar Duke da Jami'ar Oxford.
Makarantar Kiwon Lafiya ta NYU Langone tana gudanar da bincike kan tasirin maganin hydroxychloroquine.
Gwajin da aka yi a Wuhan da Shenzhen na kasar Sin ya nuna cewa favipiravir yana da "ingantaccen tasiri a kan cutar".
An gano marasa lafiya 35 a Shenzhen ba su da cutar a cikin kwanaki 4, yayin da cutar ta ci gaba har tsawon kwanaki 11 a cikin marasa lafiya 45 da ba su sami maganin ba.
A wani bincike da aka yi a Wuhan a kan marasa lafiya 240 da suka kamu da cutar, rabin su sun sha favipiravir, rabin kuma sun sha umifenovir.
Hukumar Kula da Magunguna ta Italiya ta tunatar da jama'a cewa bayanan da ke goyon bayan maganin ba su da yawa kuma ba su da yawa.
A ranar 2 ga watan Afrilu, Jamus ta sanar da cewa za ta sayi magungunan daga kasar kuma ta tura sojoji don kai su asibitocin jami'o'i inda za a yi amfani da su wajen kula da marasa lafiya da ke fama da cutar COVID-19.
A cewar South China Morning Post, Shinzo Abe ya yi tir da gwamnatin Trump kan sayen magungunan. Magungunan na iya zama marasa tasiri ga marasa lafiya da suka kamu da cutar.
Ana iya yin amfani da shi a cikin haɗari ga mata masu juna biyu ko waɗanda suke son su yi ciki.
Wani bincike na lopinavir/ritonavir (Kaletra), haɗin maganin rigakafi na lopinavir da ritonavir, ya ce "ba a ga amfanin ba".
An tsara maganin don hana yaduwar cutar HIV ta hanyar ɗaure shi da protease.
Masu bincike a Jami'ar Colorado suna kokarin canza kwayoyi don gano wani fili wanda zai iya hada kai da protease na SARS-CoV-2. Akwai ci gaba a fannin kimiyyar zamani wajen samar da kayan aiki don sake amfani da kwayoyi na zamani musamman wadanda aka tsara don maganin cutar HIV/AIDS.
Hukumar Lafiya ta Duniya (WHO) ta kuma hada da maganin lopinavir/ritonavir a cikin gwajin hadin kai na kasa da kasa.
An kirkiro Remdesivir kuma an haɓaka shi ta Gilead Sciences a matsayin maganin cutar Ebola da cutar Marburg. Daga baya Gilead Sciences ta gano cewa Remdesivir yana da aikin rigakafin cutar a cikin vitro a kan ƙwayoyin cuta na philo-, pneumo-, paramyxo-, da corona-viruses.
Wani dalili na maganin cutar shine haɓaka ƙwayoyin cuta ta hanyar haɓaka wanda zai iya haifar da ƙarin cututtuka da yaduwa.
Wasu binciken farko na asibiti sun nuna cewa remdesivir na iya samun maganin hana yaduwar cutar. Akwai gwajin asibiti da ake shirin gudanarwa, wanda ya hada da gwaje-gwaje biyu da asibitin Jami'ar Cleveland ya gudanar; daya a cikin marasa lafiya da kuma daya a cikin marasa lafiya.
Akwai gwaje-gwaje uku na gwaji na maganin bitamin C a cikin jijiyoyin jini a cikin marasa lafiya na COVID-19 da aka yi wa allurar rigakafi; biyu sun haɗa da maganin rigakafi (China, Kanada) kuma ɗaya ba tare da kwatancen ba (Italiya).
Jihar New York ta fara gwajin maganin rigakafin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya da Magunguna ta Japan (NCGM) tana shirin gwada maganin Teijin's Alvesco (ciclesonide), magani don rage ciwon tarin fuka, don magance marasa lafiya da ke da cutar coronavirus amma ba su nuna alamun cutar ba.
Tsarin enzyme mai canza angiotensin 2, Ana shirin gudanar da gwajin na biyu wanda ya hada da marasa lafiya 200 da za a cire daga asibitocin da aka yi a Denmark, Jamus, da Austria don ganin yadda za a bi da su.
Masu bincike daga Cibiyar Kula da Zuciya ta Montreal a Kanada sun gwada aikin colchicine wajen rage tsagewa da rikitarwa na huhu a cikin marasa lafiya da ke fama da cututtukan COVID-19.
Binciken COLCORONA, ya yi rajistar manya 6000 masu shekaru 40 zuwa sama waɗanda aka gano suna da cutar COVID-19 kuma suna da alamun rashin lafiya waɗanda ba sa buƙatar asibiti.
Mata masu juna biyu ko masu shayarwa ko kuma waɗanda ba su da tsarin yin allurar haihuwa ba a yarda da su ba.
Ana gwada maganin rigakafi da yawa a Italiya.
Ana amfani da heparin mai nauyin kwayoyin halittar ƙasa don kula da marasa lafiya, wanda ya sa Hukumar Magunguna ta Italiya ta fitar da umarnin amfani da shi.
An sanar da binciken da aka gudanar a wurare daban-daban kan marasa lafiya 300 da ke nazarin amfani da enoxaparin sodium don rigakafi da maganin warkarwa a ranar 14 ga Afrilu.
Kwayar SARS-CoV-2, da dama daga cikin binciken kimiyya na neman sake amfani da magungunan da aka amince da su don maganin cututtukan da suka faru a baya kamar su MERS, SARS, da kuma cutar West Nile.
Ribavirin: an amince da ribavirin don maganin COVID-19 bisa ga ka'idojin kasar Sin na 7
Umifenovir: an amince da ribavirin don maganin COVID-19 bisa ga umarnin China na matakin 7
Magungunan rigakafi da aka gano cewa za a iya sake amfani da su a matsayin maganin COVID-19:
Tocilizumab (mai karɓar mai hana IL-6): An amince da shi a kasar Sin.
Hakazalika, an gudanar da gwaji a Italiya da China. kuma duba Tocilizumab#COVID-19.
Maganin COVID-19 magani ne da ake tunanin samarwa don yaki da cutar 2019 (COVID-19).
Ko da yake babu maganin da ya wuce lokacin gwaji, an yi ƙoƙari da yawa don samar da irin wannan maganin.
A karshen watan Fabrairun 2020, WHO ta ce ba ta sa ran cewa za a samar da maganin rigakafin cutar SARS-CoV-2 a cikin watanni 18 ba.
Magungunan rigakafin da ake sa ran za a yi amfani da su biyar sun kasance cikin gwajin Phase I na gwajin cutar a watan Afrilu.
An gano COVID-19 a watan Disamba na 2019.
Cutar cutar ta covid-19 ta yadu a duniya a shekarar 2020, wanda hakan ya haifar da zuba jari sosai wajen bincike da kuma samar da allurar rigakafi.
Ƙungiyoyi da dama suna amfani da bayanan kwayoyin halitta da aka samar don samar da maganin rigakafin cutar SARS-CoV-2.
An fara binciken ne a ranar Alhamis, kuma abubuwan da ake bukata a cikin shirin CEPI na samar da allurar rigakafin sune tsere, iya samarwa, samar da allurar a cikin adadin da ake bukata da kuma rarraba ta a duniya.
A watan Afrilu, masana kimiyyar CEPI sun bayyana cewa cibiyoyin fasaha 10 na bincike da ci gaba a farkon 2020 don samar da allurar rigakafin COVID-19.
Manyan hanyoyin da aka samu a cikin binciken Phase I na gano hadarin sun hada da:
nucleic acid (DNA da RNA) (Mai tsara Phase I da kuma mai gabatar da rigakafin: Moderna, mRNA-1273)
mai ɗaukar hoto (Mai haɓaka na matakin I da kuma maganin da aka nufa: CanSino Biologics, adenovirus type 5 vector)
Kamar yadda masana kimiyya na CEPI suka ruwaito a watan Mayu, an riga an shirya alluran rigakafi guda 115, 78 daga cikinsu an amince da su a matsayin ayyukan ci gaba (79, a cewar Cibiyar Milken), kuma an sanar da wasu 37, amma ba a sami isasshen bayani game da su ba (wanda ake tsammanin ana shirin ko kuma ana rarraba su).
Gwajin gwaji na matakin I-II ya ƙunshi gwajin farko don gano haɗarin da gwajin rigakafi, ya ƙunshi bin diddigin, ya haɗa da maganin rigakafi, ana gudanar da shi a wurare da yawa, don gano mafi kyawun allurai.
Nazarin na Phase III yana da mahalarta da yawa da kuma gwajin gwaji don ganin yadda maganin ke aiki a cikin rigakafi, yayin da ake lura da tasirin da ya fito daga mafi girman allurai.
Daga cikin alluran rigakafi 79 da ake ci gaba da su (wanda aka amince da shi a farkon watan Afrilu 2020), 74 ba su kai ga amincewa da su ba (har yanzu suna cikin "binciken rigakafin cutar".
A ranar 24 ga Janairu, 2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana nazarin yiwuwar yin allurar rigakafin kwayar halitta da za ta iya canza tsarin kwayar cutar ta hanyar farfado da kwayar cutar.
A ranar 24 ga Janairu, 2020, Cibiyar Alurar rigakafin kasa da kasa (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da fara aikin samar da rigakafin, tare da tsammanin fara gwajin ɗan adam a 2021.
An sanar da aikin samar da rigakafin ne a Cibiyar Kula da Cututtuka da Rigakafin Cutar Sin a ranar 26 ga Janairu, 2020, da kuma Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, Kamfanonin Magunguna na Janssen, karkashin jagorancin Hanneke Schuitemaker, sun sanar da cewa sun fara aikin samar da rigakafi.
Janssen tana aiki tare da Vaxart wajen samar da rigakafin da za a iya samarwa ta hanyar amfani da fasahar kere-kere.
A ranar 18 ga watan Maris na shekarar 2020, Emergent BioSolutions ta sanar da samar da maganin tare da Vaxart don samar da rigakafin cutar.
A ranar 8 ga Fabrairu, 2020, gwajin OncoGen a Romania ya fitar da takarda kan tsarin rigakafin cutar kansa ta hanyar amfani da fasahar maganin cutar kansa.
A ranar 25 ga watan Maris ne shugaban hukumar bincike ya sanar da cewa sun kammala gwajin rigakafin kuma za su fara gwajin.
A ranar 27 ga Fabrairu, 2020, wani kamfani na Generex, NuGenerex Immuno-Oncology, ya sanar da cewa ya fara aikin samar da maganin maganin peptide na Ii-Key don yaƙi da COVID-19.
Sun yi ƙoƙari su yi allurar rigakafi da za su iya gwadawa a kan mutane "a cikin kwanaki 90".
A ranar 5 ga watan Maris na shekarar 2020, Jami'ar Washington da ke St. Louis ta sanar da shirin samar da rigakafin cutar.
A ranar 5 ga watan Maris na shekarar 2020, Rundunar Binciken Likitocin Amurka da Kayan Kayayyakin da ke Fort Detrick da Cibiyar Nazarin Sojoji ta Walter Reed a Silver Spring, dukansu a yammacin Maryland, sun sanar da cewa suna kan aikin samar da rigakafi.
A ranar 10 ga watan Maris na shekarar 2020, Emergent Biosolutions ta sanar da cewa ta kulla yarjejeniya da Novavax Inc.
a cikin samar da allurar rigakafi.
Abokan haɗin gwiwar sun kuma sanar da shirye-shiryen gwajin gwaji kafin gwajin gwaji na Phase I da za a fara a watan Yuli na 2020.
A ranar 12 ga watan Maris na shekarar 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa ana aiki da magungunan rigakafi guda 11, kuma ko da sun yi yawa, zai ɗauki akalla shekara daya da rabi zuwa shekaru biyu don samar da rigakafi.
A ranar 12 ga watan Maris na shekarar 2020, Medicago, wani kamfanin kere kere na Quebec City, Quebec, ya ce yana bunkasa kwayar cutar coronavirus ne tare da karamin tallafi daga Cibiyar Nazarin Lafiya ta Kanada.
Magungunan da ake niyya a kai yanzu yana cikin gwajin gwaji na gwaji, tare da amfani da ɗan adam wanda aka shirya a watan Yuli ko Agusta 2020.
A farkon makon, jaridar The Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya bai wa CureVac "'yan kudade' don gudanar da bincike kan allurar rigakafin Covid-19", wani abu da gwamnatin Jamus ta musanta.
A ranar 17 ga watan Maris na shekarar 2020, kamfanin samar da magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA.
allurar rigakafin da aka tsara ta mRNA shine BNT162, wanda a halin yanzu yana cikin gwajin gwaji na farko kuma ana sa ran fara gwajin a watan Afrilu 2020.
A Italiya ranar 17 ga watan Maris na shekarar 2020, Takis Biotech, wani kamfanin kere kere na kasar Italiya ya sanar da cewa zai gudanar da gwajin rigakafin kafin watan Afrilu na shekarar 2020 kuma za a fara gwajin rigakafin a cikin mutane a watan Satumba.
A Faransa a ranar 19 ga Maris, 2020, Coalition for Epidemic Preparedness Innovations (CEPI) ta sanar da cewa ta ba da haɗin gwiwa na bincike na allurar rigakafin COVID-19 na dala miliyan 4.9 tare da Institut Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, wanda ya sa jimillar CEPI ta binciken allurar rigakafin COVID-19 ya kai dala miliyan 29.
Sauran cibiyoyin CEPI da suka ba da tallafin tallafin COVID-19 sun hada da Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga watan Maris na shekarar 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi tare da allurar rigakafi guda biyar.
Masu bincike a kwalejin Imperial College London sun sanar a ranar 20 ga watan Maris 2020 cewa suna kan aikin samar da allurar rigakafin RNA mai kara karfin kanta don rigakafin COVID-19.
An samar da maganin rigakafin a cikin kwanaki 14 bayan an samu bayanai daga kasar Sin.
A karshen watan Maris, gwamnatin Kanada ta sanar da cewa ta ba da dala miliyan 275 don gudanar da bincike kan ayyukan COVID-96, ciki har da allurar rigakafi da aka yi niyya a kamfanoni da jami'o'i, kamar Medicago da Jami'ar Saskatchewan.
A daidai wannan lokacin, gwamnatin Kanada ta sanar da kashe dala miliyan 192 don samar da allurar rigakafin COVID-19, tare da manufar samar da wani babban kantin sayar da rigakafin da za a iya amfani da shi idan aka sami wani sabon kamuwa da kwayar cutar coronavirus.
A ranar 2 ga watan Afrilu na shekarar 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun fitar da rahoto kan gwajin PittCoVacc, wani maganin rigakafin COVID-19 a cikin fitsari, suna mai cewa "MNA ta fitar da wani nau'in maganin rigakafin SARS-CoV-2 S1 daga kwayar cutar da ke da matukar cutarwa [a cikin fitsari] wanda aka gano tun makonni 2 bayan allurar rigakafin.
A Kanada a ranar 16 ga watan Afrilu na shekarar 2020, Jami'ar Waterloo School of Pharmacy ta sanar da yin allurar rigakafin DNA; sun ce za a iya amfani da ita ta hanyar numfashi.
Ta hanyar amfani da kwayoyin cuta, za a gina DNA ta hanyar yin kama da kwayar cutar da ke jikin mutum don samar da kwayar cutar da ba ta da haɗari, wanda zai iya kawar da rigakafin jiki don samar da rigakafin cutar SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun ba da gudummawa don samun kayan aikin komputa na IBM, tare da kayan aikin komputa na girgije daga Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu alluran rigakafi suna da sakamako masu illa, wanda ake kira sakamako na rashin sani.
Wannan yana nufin cewa zai iya zama mafi tasiri fiye da yadda ake iya cutar da cutar.
Wani gwaji na gaggawa a Ostareliya yana bukatar a yi wa likitoci 4,170 rajista.
Za a iya samun rigakafin da ba shi da haɗari ko kuma ba zai yi tasiri ba.
Binciken farko da aka gudanar don tantance ingancin allurar rigakafin da aka yi amfani da ita a cikin wasu dabbobin da ke dauke da cutar COVID-19, kamar su ACE2-preventable worms, sauran dabbobin gwaji, da sauran dabbobi, ya nuna bukatar matakan kare lafiyar 3 na biosafety, da kuma hadin gwiwa a duniya don tabbatar da samar da lafiya.
An gwada alluran rigakafin SARS da MERS a kan dabbobi da ba mutane ba.
A shekarar 2020, babu wani magani ko rigakafin cutar SARS da aka gano cewa ba shi da hadari kuma yana da tasiri a cikin mutane.
A cewar takardun bincike da aka wallafa a shekarar 2005 da 2006, samar da sabbin magungunan rigakafi da maganin cutar SARS ya kasance babban abin farin ciki ga gwamnatoci da hukumomin kiwon lafiya a duniya.
Lokacin da cutar MERS ta fara yaduwa, an yi imanin cewa binciken SARS na iya ba da mahimman bayanai game da samar da allurar rigakafi da maganin cutar MERS-CoV.
Ya zuwa watan Maris na 2020, rigakafi guda ɗaya (wanda ya dogara da DNA) ya riga ya wuce gwajin gwaji na farko a cikin ɗan adam, kuma har yanzu akwai wasu uku da ke cikin aikin, waɗanda aka sani da allurar rigakafin ƙwayar cuta, waɗanda sune adenoviral-vectored biyu (ChAdOx1-MERS, BVRS-GamVac), da kuma MVA-vectored (MERS-VA-M-S).
Akwai jita-jita a shafukan sada zumunta cewa an riga an san kwayar cutar COVID-19 kuma an riga an samar da maganin rigakafinta.
Abubuwan da aka gano a kafofin watsa labarai sun yi nuni da ci gaban maganin da ke magance cututtukan da ke haifar da kwayar cutar coronavirus kamar SARS coronavirus.
Cutar Coronavirus ta 2019 (COVID-19) cuta ce mai saurin kamuwa da cuta ta hanyar cutar coronavirus 2 (SARS-CoV-2).
Alamun da suka fi nuna shi ne zazzabin cizon sauro, yin amai, da kuma shan iska.
Wasu alamun sun hada da karyewa, ciwon hanci, ciwon hanci, ciwon hanci, rashin wari, da kuma ciwon ciki.
Lokaci daga kamuwa da cutar zuwa lokacin da alamun cutar suka bayyana yawanci kwanaki biyar ne, amma zai iya wucewa daga kwanaki biyu zuwa goma sha huɗu.
Yawancin marasa lafiya suna da ƙananan cututtuka, wasu suna samun ciwon huhu da kuma rashin gaɓoɓin jiki.
Ya zuwa ranar 17 ga watan Afrilu, 2020, an samu fiye da mutane miliyan 2.24 da suka kamu da cutar a kasashe 210 da yankuna, inda mutane 153,000 suka mutu.
An warkar da mutane fiye da 568,000, yawanci ana yaɗuwa ne ta wurin kusanci, musamman ta wurin tsotsa, ta wurin tsotsewa, ko kuma ta wurin magana.
Hakika, ruwan da ke fitowa daga cikin iska, sau da yawa yakan faɗo a ƙasa ko kuma a kan abubuwa, ba ya kama mutane daga nesa.
Mutane za su iya kamuwa da cutar ta wajen taɓa fuska, hanci, ko kuma leɓunsu.
Kwayar cuta tana iya zama a kan wani abu na tsawon sa'o'i 72.
Ana yin allurar ne a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake ana iya yin allurar kafin bayyanar cututtuka a cikin matakan cututtuka. Hanyar da aka fi amfani da ita ita ce ta hanyar yin amfani da kwayar cutar polymerase chain reaction (rRT-PCR) ta hanyar cire ruwa daga cikin fitsari.
An bada shawarar yin amfani da abin rufe fuska ga waɗanda ake zargi da cutar da kuma masu kula da su.
Ana ba da izinin amfani da abin rufe fuska a cikin jama'a, yayin da wasu hukumomi suka hana, wasu sun ba da shawarar yin amfani da shi yayin da wasu suka ba da umarnin yin amfani da shi.
A halin yanzu, babu maganin rigakafi ko kuma maganin rigakafin COVID-19.
An samu yaduwar cutar a kasashe daban-daban a cikin kasashe shida na WHO.
Waɗanda suka kamu da cutar ba sa nuna ko kuma su sha wahala daga wasu alamun cutar kamar zazzabin zazzabin cizon sauro, tari, tari, da kuma wahalar numfashi.
Alamun da ba sa saurin fita sun haɗa da wahalar numfashi, ciwon kirji ko kuma matsi, rashin motsi, da kuma rashin iya tafiya ko kuma yin magana a fuska ko a baki; yana da kyau a nemi magani nan da nan idan alamun ba su tafi ba.
Alamun da ba safai ake gani ba sun hada da, upper, alamun da ke nuna cewa mutum yana da hanci mai tsami, da kuma tsokoki masu gudana ko kuma ƙura a hanci.
An lura da alamun cututtukan gastrointestinal kamar su tashin zuciya, amai da kuma rashin jin daɗi a cikin matakai daban-daban.
Da farko, wasu marasa lafiya a ƙasar Sin suna jin matsi a kirji da kuma ƙuƙwalwa a cikin hanci.
A wasu mutane, cutar za ta iya ci gaba har ta kai ga ciwon huhu, gaɓoɓin jiki da yawa su kasa aiki, har ma mutuwa.
Ana kiran wannan lokacin haihuwar haihuwa.
Lokacin haifuwa na COVID-19 yana tsakanin kwanaki biyar zuwa shida amma yana iya wucewa tsakanin kwana biyu zuwa 14.
Kashi 97.5 cikin 100 na mutanen da suka kamu da cutar suna nuna alamun cutar a cikin kwanaki 11.5 bayan kamuwa da cutar. Rahotanni sun nuna cewa ba kowa ba ne yake nuna alamun cutar.
Ba a san matsayin marasa cutar ba a yaduwar cutar ba tukuna; amma, bayanan farko sun nuna cewa suna iya yaduwar cutar.
Ba a san adadin mutanen da ke da alamun cutar ba a halin yanzu kuma ana ci gaba da bincike, kuma Cibiyoyin Kula da Cututtuka da Rigakafin Cutar (KCDC) na Koriya sun ba da rahoton cewa kashi 20% na waɗanda aka tabbatar da su ba su da alamun cutar a lokacin da suka kasance a asibiti.
Hukumar Lafiya ta kasar Sin ta fara kidaya marasa lafiya a cikin marasa lafiya na yau da kullun a ranar 1 ga Afrilu; daga cikin marasa lafiya 166 da suka kamu a wannan ranar, 130 (78%) marasa lafiya ba su da alamun cutar a lokacin da aka gwada su.
Ƙwayoyin cuta suna iya zama cikin ƙwayoyin cuta.
Yin ihu yana sa mutum ya yi magana fiye da yadda ake yi da magana.
Wani bincike da aka yi a Singapore ya nuna cewa idan mutum ya yi taushi ba tare da rufe bakinsa ba, zai iya fitowa daga rijiya mai tsawon kafa 15 da rabi.
Ko da yake ba a yadu da kwayar cutar ta hanyar iska ba, National Academy of Science ta ce ana iya yaduwa ta hanyar iska (bioaerosol transmission) kuma an gano kwayoyin da aka sanya a cikin iska a waje da jikin mutum da ke dauke da RNA.
Wasu hanyoyin magani kamar su intubation da cardiopulmonary resuscitation (CPR) na iya samun gurɓataccen abu daga makaman da ake watsawa ta iska, wanda hakan ke haifar da kamuwa da cuta ta hanyar iska.
Ko da yake akwai tsoron cewa za a iya yada cutar ta hanyar yin amfani da wuka, ana ganin cewa wannan hadarin ba shi da yawa. Kwayar cutar ta fi kamawa idan marasa lafiya sun nuna alamun; ko da yake yin amfani da wuka ba shi da alamun bayyanar cututtuka, wannan hadarin yana da ƙananan.
Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta Turai (ECDC) ta ce ko da yake ba a iya samun sauƙin yaduwar cutar ba, a matsakaici mutum ɗaya yana iya kamuwa da mutane biyu ko uku.
An gano cewa kwayar cutar tana iya yin kumburi bayan kwana ɗaya a kan takarda, bayan kwana uku a kan filastik (polypropylene) da kayan da ba su da tsada (AISI 304), da kuma bayan sa'o'i huɗu a kan kayan da ke dauke da kashi 99 cikin ɗari na jan ƙarfe.
Maimakon haka, tsawon lokacin ya bambanta bisa ga yanayin da kuma yanayin zafi.
Sabulu da kayan wankewa suna da amfani idan aka yi amfani da su yadda ya kamata; kayan wanki suna kawar da fata mai laushi, suna rage kumburi, kuma suna kawar da ƙura da kuma sauran abubuwa.
Wasu abubuwa masu saurin narkewa kamar su benzalkonium chloride da chlorhexidine gluconate (mai kashe ƙwayoyin cuta da ake amfani da shi wajen tsabtace jiki) ba su da amfani sosai. A wani bincike da aka yi a Hong Kong, an cire samfurori na fata daga mutane a cikin kwanaki biyu bayan an kwantar da su a asibiti.
A cikin mutane shida da suka kamu da cutar, samfurin farko ya nuna cewa yana da kwayar cutar kuma a rana ta biyu da aka gwada, an gano cewa mai haƙuri na shida yana da kwayar cutar.
Kwayar cutar coronavirus mai saurin numfashi mai saurin gaske 2 (SARS-CoV-2) kwayar cutar coronavirus ce mai saurin numfashi mai saurin gaske, wacce aka fara ganowa a cikin mutane uku da ke fama da cutar huhu yayin da ta yi karo da cutar da ke saurin numfashi mai saurin gaske da aka gano a cikin marasa lafiya a Wuhan.
Duk alamun cutar SARS-CoV-2 na faruwa ne a cikin kwayoyin cutar coronavirus da ke da alaƙa da jinsi.
Idan kwayar cutar ta shiga jikin mutum ta hanyar hada sabulu, sabulu na iya cutar da shi ta hanyar iska. SARS-CoV-2 ya dace da kwayar cutar SARS-CoV ta farko.
Cutar COVID-19 tana iya shafar huhu sosai saboda kwayar cutar tana shiga cikin hanji ta hanyar enzyme mai canza angiotensin 2 (ACE2), wanda aka fi ganowa a cikin nau'in II na ƙwayoyin alveolar a cikin huhu.
Kwayar cutar tana amfani da wani takamaiman glycoprotein da ake kira "karya" (peplomer) don haɗa ACE2 zuwa cikin kwayar cutar.
An gano ciwon zuciya mai tsanani a kashi 12% na waɗanda aka kwantar a Wuhan, China, kuma ya zama ruwan dare a cikin cututtuka masu tsanani.
Yawan cututtukan zuciya da jijiyoyin jini suna da yawa, wanda ya haifar da amsawar kumburi na tsarin da kuma rikicewar jijiyoyin jini a lokacin ci gaba da cutar, amma raunin myocardial mai tsanani na iya zama mai rikitarwa ga masu karɓar ACE2 a cikin zuciya.
Ana nuna masu karɓar ACE2 a cikin zuciya kuma suna da hannu a cikin aikin zuciya.
An gano cututtukan jini (31%) da kuma zubar da jini a cikin jijiyoyi (25%) a cikin marasa lafiya na COVID-19 waɗanda ke buƙatar ƙarin kulawa da ƙwayoyin cuta waɗanda ke da ƙwarewa kuma suna iya zama masu ƙin yarda da ra'ayoyin da ba daidai ba. Binciken jikin mutane da suka mutu daga COVID-19 ya gano lalacewar alveolar (DAD), da kuma ƙwayoyin cuta masu ƙwayoyin cuta da ke cikin jini.
Kodayake SARS-COV-2 yana da tasirin ACE2-an'uwa a cikin ƙwayoyin epithelial na jini, marasa lafiya da ke da COVID-19 suna da alamun cutar mai saurin kumburi.
Musamman, kwayoyin T-cell masu ɓoye GM-CSF masu cutar sun nuna cewa suna da alaƙa da ƙwayoyin cuta masu ɓoye IL-6 da kuma cututtukan huhu masu tsanani a cikin marasa lafiya na COVID-19.
An gano ƙwayoyin lymphocytic infiltrates a jikin gawawwaki.
Hukumar Lafiya ta Duniya ta fitar da wani rahoto na bincike kan wannan cuta.
Mafi yawan gwajin shine ainihin lokacin juyawa polymerase chain reaction (rRT-PCR).
Ana yin gwajin ne a kan samfurin da aka cire daga hanci da kuma samfurin hanci; amma ana iya amfani da hanci ko kuma hanci.
Ana samun sakamako a cikin 'yan sa'o'i zuwa kwana biyu.
Ana iya yin gwajin jini amma ana bukatar a samu samfurori guda biyu a cikin makonni biyu, kuma ba a yawan samun sakamako nan take.
Masana kimiyya na kasar Sin sun gano kwayar cutar coronavirus kuma sun fitar da bayanan kwayoyinta wanda hakan ya sa gwajin ya zama mai yiwuwa a duk duniya, gami da aiwatar da tsarin polymerase chain reaction (PCR) na gano cutar.
A ranar 4 ga Afrilu, 2020, ana ci gaba da gwajin rigakafi (wanda zai iya gano cutar ta jiki ko kuma cutar da ta riga ta faru) amma ba a yi amfani da shi ba.
Kwarewar gwaji a China ta nuna cewa daidaito na gwajin yana tsakanin kashi 60 zuwa 70 cikin dari.
Hukumar FDA a Amurka ta gabatar da gwajin farko na kulawa da sauri don amfani a ranar 21 ga watan Maris na wannan watan. Sakamakon gwajin da asibitin Zhongnan na Jami'ar Wuhan ya fitar ya hada da tsara hanyoyin rigakafi bisa alamun cutar da kuma hadarin cutar.
Rashin haske na multilobar na biyu tare da rarrabawar gefe, asymmetric da na baya na kowa ne a farkon kamuwa da cuta.
Wannan zai iya faruwa a lokacin da ciwon ya ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba.
Akwai bayanai kaɗan game da kumburin microscopic da kuma ilimin halittar COVID-19.
Wasu muhimman bayanai da aka samu a binciken da aka yi na gawawwakin mutane su ne:
Binciken da aka yi: ciwon zuciya, ciwon zuciya, ciwon huhu da kuma kumburi
Za a iya gano nau'o'in cutar pneumonia guda huɗu masu tsanani:
ciwon huhu mai saurin ragewa: kumburin huhu, hawan jini mai yawa, manyan ƙwayoyin cuta na jini, kumburin ciki da ke saurin shiga cikin ƙwayoyin cuta da kuma ƙwayoyin jini masu yawa
cutar sankarar bargo: lalacewar alveolar (DAD) da kuma ɓarkewar alveolar.
DAD ta haifar da mummunar matsalar numfashi mai tsanani (ARDS) da kuma matsanancin rashin karfin jini.
warkar da ciwon huhu: ko kuma tsarin da ke haifar da ciwon huhu da kuma ciwon huhu na interstitial fibrosis
Jini: ƙwayar jini mai yawa (DIC); maganin leukoerythroblastic
Matakan rage haɗarin kamuwa da cutar sun haɗa da zama a gida, guje wa wuraren da mutane suke, wanke hannuwanka da sabulu da ruwa sau da yawa na akalla sakan 20, yin tsabtace numfashi da kuma guje wa taɓa fuska, hanci ko baki kafin wanke hannu.
CDC ta ba da shawarar rufe baki da hanci a duk lokacin da kake yin hancinka ko fitsari kuma tana ba da shawarar samun hannu a lokacin da kake yin hanci ko yin hanci idan ba ka da igiya.
Ana bada shawarar a wanke hannaye bayan an gama yin tausa ko kuma yin taushi.
CDC ta ba da shawarar yin amfani da abin rufe fuska a cikin jama'a, wani dalili na wannan shi ne don kauce wa kamuwa da cuta musamman ga marasa lafiya masu alamun cutar. Tsarin nesa yana nufin rage hulɗa tsakanin mutane masu kamuwa da cuta da manyan ƙungiyoyi kamar makarantu da wuraren aiki, hana motsi da kuma soke taron jama'a.
Ana bin ƙa'idodin nesa kuma sun haɗa da yin tsalle na tsawon kafa shida (1.8 m).
Babu wani magani da aka sani na COVID-19. Lokacin da aka yi niyyar samar da rigakafin rigakafi a cikin 2021, dabarun magance COVID-19 shine ƙoƙarin rage yaduwar cutar, wanda ake kira "tsarin aiki".
CDC ta kuma ba da shawarar cewa mutane su wanke hannuwansu da sabulu da ruwa na akalla dakika 20, musamman bayan sun fita bayan gida ko kuma idan hannuwansu sun yi launin rawaya, kafin cin abinci da kuma bayan sun yi taushi, hancin ko kuma hancin.
Hukumar ta kuma bada shawarar yin amfani da maganin tsabtace jiki wanda ya ƙunshi aƙalla kashi 60 cikin ɗari na barasa, amma ana yin hakan ne idan sabulu da ruwa ba su da isasshen. A yankunan da ba a sayar da kayan tsabtace jiki, WHO ta ba da shawarwari biyu kan yadda za a yi.
A wannan yanayin, ana amfani da maganin kashe ƙwayoyin cuta daga barasa (ethanol) ko isopropanol.
Ana amfani da hydrogen peroxide don ya kashe ƙwayoyin cuta a cikin giya; ba "mai kashe ƙwayoyin cuta ba ne".
Glycerol yana cikin abin da ke fitar da ruwa (humectant.
Ana yin maganin da zai iya haɗa da ruwa, iskar oxygen, da kuma gyara gaɓoɓin da suka kamu.
Hukumar CDC ta ba da shawarar cewa duk wanda ke da cutar ya sanya abin rufe fuska.
An yi amfani da maganin oxygenation (ECMO) don magance matsalar rashin numfashi amma ana ci gaba da nazarin amfanin wannan hanya.
Ana ba da shawarar tsabtace mutum da kula da lafiyar mutum da cin abinci mai gina jiki don inganta lafiyar mutum.
Maganin tallafi na iya taimakawa waɗanda ke da alamun rashin lafiya a farkon kamuwa da cutar. WHO da Hukumar Lafiya ta China sun ba da shawarar yin maganin mutanen da aka yi wa allurar rigakafin COVID-19.
Likitocin Intensivists da likitocin huhu a Amurka sun rubuta takardun da suka dace da su daga hukumomi daban-daban kuma sun sanya su a cikin takardar kyauta, IBCC.
A watan Afrilu na shekarar 2020, babu wani magani na COVID-19 da aka samu.
A maganin alamun, wasu masana sun bada shawarar yin amfani da paracetamol (acetaminophen) a kan ibuprofen a matsayin magani na farko.
Ya kamata a yi taka tsantsan don rage haɗarin kamuwa da cutar, musamman a asibitoci inda ake yin wasu ayyuka na rashin lafiya kamar su yin amfani da intubation ko kuma na'urar numfashi.
Ga likitocin da ke kula da marasa lafiya da ke dauke da COVID-19, CDC ta ba da shawarar sanya mutum a cikin dakin da ke da iska mai iska (AIIR) wanda ke nuna cewa ana amfani da matakan kiyayewa na yau da kullun, kiyayewa na hulɗa da mutane da kiyayewa na iska. CDC tana kiyaye ƙa'idodin amfani da kayan aikin mutum (PPE) yayin ɓarkewar cutar.
Abubuwan da ake amfani da su a cikin kayan shafawa sune: maganin shafawa, maganin shafawa, maganin shafawa, kayan rufe ido, da kuma kayan shafawa. Idan akwai biyu, kayan shafawa (maimakon kayan shafawa) sun fi girma.
An amince da amfani da abin rufe fuska na N95 a masana'antu amma FDA ta ba da izinin amfani da abin rufe fuska na gaggawa (EUA).
An yi su ne domin su kare mutum daga abubuwa masu iska kamar ƙura, amma ba a tabbatar da cikakken kariya daga ƙwayoyin cuta ba ta hanyar amfani da su ba.
Idan ba a samun abin rufe fuska, CDC ta ba da shawarar cewa idan ba a sami kayan aiki ba, za a iya amfani da abin rufe fuska da aka yi a gida.
Yawancin masu cutar COVID-19 ba su da isasshen maganin shafawa amma akwai adadin mutanen da suke buƙatar sa.
Ana kula da nau'in tallafi na numfashi da ake buƙata ga mutanen da ke da matsalar numfashi na COVID-19 musamman a cikin marasa lafiya, kuma akwai bayanan da ke nuna cewa ana iya guje wa yin amfani da na'urar numfashi ta hanyar amfani da babban hanci mai gudana ko kuma matsin lamba mai kyau.
Ba a san ko ko ɗaya daga cikin waɗannan yana da sakamako mai kyau ga marasa lafiya masu tsanani ba.
Wasu likitoci sun fi son yin amfani da hanyar kwantar da iska ta hanyar inji idan akwai saboda wannan hanyar tana rage yaduwar kwayoyin idan aka kwatanta da na hanci mai gudana. Ana samun mafi munin rashin lafiya a cikin tsofaffi (waɗanda suka wuce shekaru 60 kuma musamman waɗanda suka wuce shekaru 80).
Yawancin ƙasashe masu tasowa ba su da isassun gadajen asibiti da ke da alaƙa da yawan jama'a, wanda ke rage ikon asibitoci don kula da marasa lafiya idan akwai wani yanayi na ɓarkewar COVID-19 wanda duk ke buƙatar yin allurar rigakafi.
Wani bincike a kasar Sin ya gano cewa kashi 5 cikin 100 na marasa lafiya da aka kwantar da su a asibiti, kashi 2.3 cikin 100 suna bukatar a yi musu allurar rigakafi, kuma kashi 1.4 cikin 100 sun mutu.
A China, kusan kashi 30% na masu cutar COVID-19 da ke asibiti suna zuwa sashen kulawa mai mahimmanci (ICU).
Aikin iska yana da matukar wahala saboda cutar ta COVID-19 da ke haifar da cutar ta Acute Respiratory Distress Syndrome (ARDS) kuma numfashi yana da matukar wahala.
Ana buƙatar masu sanyaya iska waɗanda ke aiki tare da PEEP mai yawa don samar da isasshen iskar oxygen yayin rage haɗarin rauni na huhu da pneumothorax.
Wataƙila ba a taɓa samun irin wannan na'urar a dā ba.
Binciken maganin da zai yiwu ya fara ne a watan Janairun 2020, kuma ana gwada magungunan rigakafin cutar da yawa a halin yanzu.
Remdesivir ne da ya nuna cewa za a iya samun mafita.
Duk da cewa ana iya jinkirta samar da sabon magani har zuwa 2021, an riga an amince da wasu magungunan gwaji don amfani da su a wasu cututtuka kuma yanzu gwajin su yana kan gaba.
Ana iya gwada maganin rigakafi a kan mutanen da ke fama da cututtuka masu tsanani.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar masu ba da kai su shiga gwajin gwaji don ganin ko maganin ya dace da kuma ko ba shi da haɗari. Hukumar FDA ta ba da izinin ba da izini na ɗan lokaci ga plasma mai warkewa a matsayin magani na ɗan lokaci a yanayin da rayuwar mutum ke cikin haɗari.
Kafin a yi gwajin, ana iya ganin ko yana da lafiya ko kuma yana warkar da cutar.
A watan Fabrairun shekarar 2020, kasar Sin ta kaddamar da manhajar wayar salula don taimakawa wajen lura da barkewar cutar.
Ana bukatar masu amfani su shigar da sunansu da lambar ID.
Aikace-aikacen na iya yin 'kwana' ta hanyar amfani da bayanan sa ido, don haka yana taimakawa wajen yin la'akari da yiwuwar cutar.
Kowane mai amfani zai iya duba matsayin sauran masu amfani uku.
Idan an gano wani hadarin da zai iya faruwa, app din ba wai kawai yana bada shawarar a killace kai ba, amma kuma yana gargadin hukumomin kiwon lafiya na yankin. Ana amfani da nazarin bayanai mai yawa akan sakonnin wayar salula, fasahar rufe ido, sa ido kan wayar salula da kuma ilimin kere kere don bin diddigin wadanda suka kamu da cutar da kuma wadanda suka yi hulda da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba hukumomi damar bin diddigin bayanan wayar salula na mutanen da ake zargi da kamuwa da cutar coronavirus.
An yi wannan ne domin a karfafa dokar killace mutane da kuma kare wadanda suka yi mu'amala da wadanda suka kamu da cutar.
A watan Maris na shekarar 2020, Deutsche Telekom ta raba bayanan wuraren da mutane ke zaune tare da cibiyar bincike ta Robert Koch, don gudanar da bincike da kuma hana yaduwar cutar.
Rasha ta kirkiro wata na'urar da za ta iya rufe idanun 'yan gudun hijirar.
Jami'in Ma'aikatar Lafiya ta Italiya Giulio Gallera ya ce an gaya masa ta hanyar wayar salula cewa "kashi 40 na yawan jama'a suna ci gaba da tafiya".
Gwamnatin Jamus ta yi bincike na sa'o'i 48 a ƙarshen mako, kuma mutane fiye da 42,000 ne suka halarci wannan binciken.
A wani bangare kuma, shugaban kasar Estonia, Kersti Kaljulaid, ya yi kira ga duniya da ta kirkiro wasu hanyoyin yaki da cutar coronavirus.
Mutane suna iya ƙin kansu domin an ware su daga wasu, an hana su fita daga wurare dabam dabam, an hana su samun magani, ko kuma suna tsoron kamuwa da cuta.
Rory O'Connor ta ce, "Rashin zaman kanta, kaɗaici, rashin zaman lafiya, matsi, da kuma rashin kuɗi suna shafan tunanin mutane da kuma rayuwarsu".
Cutar za ta iya zuwa da sauƙi ba tare da nuna alamun cutar ba, kamar yadda wasu cututtuka da ke da tsanani kamar su mura suke.
Sau da yawa, rashin lafiya mai tsanani yakan tafi cikin makonni biyu, amma na tsanani zai ɗauki makonni uku zuwa shida kafin ya warke.
Mata masu juna biyu na iya zama cikin haɗarin kamuwa da COVID-19 ta hanyar wasu ƙwayoyin cuta kamar SARS da MERS, amma ba a sami cikakken bayani game da COVID-19 a wannan batun ba. A cikin mutane, COVID-19 na iya shafar huhu kuma ya haifar da cutar huhu.
A cikin waɗanda cutar ta fi tsanani, COVID-19 na iya zama mai saurin kamuwa da cutar numfashi mai tsanani (ARDS) wanda ke haifar da rashin numfashi, tashin hankali ko kuma rashin aiki na gabobin jiki.
Abubuwan da ke haifar da cutar COVID-19 sun hada da rashin aiki na gabobin jiki (sepsis), rashin daidaiton jini (abnormal clotting) da kuma ciwon zuciya, koda da hanta.
An lura da hawan jini, musamman ma karuwar prothrombin time, a cikin kashi 6% na marasa lafiya da aka kwantar da su a asibiti saboda cutar COVID-19, yayin da aka lura da matsalar koda a cikin kashi 4% na wannan rukunin.
Kimanin kashi 20-30% na mutanen da ke da COVID-19 suna da ƙwayoyin hanta (ƙara enzymes, transaminases).
A cewar wannan rahoton, matsakaicin lokacin da aka fara bayyanar cututtuka zuwa mutuwa ya kai kwanaki goma a asibiti.
Maimakon haka, marasa lafiya da ke sashen kula da kulawa mai tsanani (ICU) suna da matsakaicin lokaci tsakanin kwana bakwai a asibiti da mutuwa.
A cikin binciken farko, matsakaicin lokacin da mutum ya nuna alamun cutar da mutuwa ya kasance tsakanin kwanaki 14 da kuma tsakanin kwanaki 6 da 41.
A binciken da Hukumar Lafiya ta Kasa (NHC) ta yi a kasar Sin, adadin mutuwar ya kai kashi 2.8% na maza da kuma kashi 1.7% na maza.
Binciken ilimin lissafi (Histopathological examinations) a kan samfurori na mutuwa ya nuna lalacewar alveolar da kuma fibromyxoid na salula a cikin huhu biyu.
An lura da canje-canje na kwayar cutar kwayar cutar a cikin pneumocytes.
Hoton da aka yi na huhu ya nuna cewa yana da ciwon numfashi mai tsanani (ARDS).
A cikin mutuwar 11.8% da Hukumar Lafiya ta Kasa ta China ta ruwaito, an lura da ciwon zuciya tare da matakan rashin ƙarfi na zuciya (troponin ko bugun zuciya).
A cewar wani rahoto da aka samu a ranar Talata daga Amurka, kashi 89% na wadanda aka kwantar a asibiti suna da wasu cututtuka. Kulawa da tattalin arziki na iya ƙara yawan mutuwar marasa lafiya.
Ƙididdigar yawan mutuwar mutane suna canzawa saboda bambancin da ke faruwa a yankunan, amma kuma saboda matsalolin da ke faruwa a duniya.
Idan ba a lissafa marasa lafiya da yawa ba, za a iya ƙididdige adadin waɗanda za su mutu.
Amma, saboda yawan mutanen da suka mutu sun kasance ne daga waɗanda suka kamu da cutar kwanan nan, hakan na iya nufin cewa adadin mutanen da suka mutu ba shi da yawa.
Masu shan sigari suna da kusan kashi 1.4 na yiwuwar samun alamun cutar COVID-19 da kuma sau 2.4 na buƙatar kulawa ta gaggawa ko mutuwa idan aka kwatanta da waɗanda ba sa shan sigari. Akwai kuma tsoron da aka nuna ga waɗanda ke da wasu cututtuka.
Hukumomin asibiti na Hong Kong sun gano raguwar karfin hanta tsakanin kashi 20% zuwa 30% a wasu mutane da suka kamu da cutar kuma an yi gwajin cutar a cikin huhu.
Wannan kuma na iya haifar da ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon.
Har zuwa watan Maris na shekarar 2020, ba a san ko wasu cututtuka na cutar da aka gano suna da tasiri ga masu warkewa ba.
An gano cutar ta hanyar halayyar wasu nau'ikan kwayar cutar, amma kuma an gano masu cutar da suka warke daga COVID-19 a cikin gwajin da aka yi.
Ana ganin cewa waɗannan marasa lafiya ba za su sake kamuwa da cutar ba.
An yi imanin cewa kwayar cuta ta samo asali ne daga dabbobi kuma ta shiga cikin mutane ta hanyar kwararar ruwa.
Ba a san ainihin asalin cutar ba, amma a watan Disamba na shekarar 2019 cutar ta ta'allaka ne ga mutane.
Binciken da aka yi kan mutane 41 da aka fara tabbatar da cutar COVID-19, wanda aka buga a watan Janairun 2020 a cikin mujallar The Lancet, ya nuna cewa alamun farko sun bayyana ne a ranar 1 ga Disamba, 2019.
Bayanan hukuma na WHO sun ce bayyanar cututtuka ta farko ta bayyana ne a ranar 8 ga Disamba, 2019.
Ana amfani da ma'auni da yawa don a tantance yawan mutuwa.
Wannan adadin ya bambanta daga yanki zuwa yanki kuma ya dogara da yawan gwajin, ingancin magani, maganin da ake samu, tsawon lokacin da cutar ta fara, da sauran abubuwan da suka shafi mutane kamar shekaru, wanda ya dogara da yanayin lafiyarsu gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambobin gaggawa na ICD-10 na cutar U07.1 ga waɗanda suka mutu daga cutar SARS-CoV-2 da aka tabbatar a gwaji da kuma U07.2 waɗanda suka mutu sakamakon gwajin COVID-19 ba tare da gwajin gwaji ba don tabbatar da cutar SARS-CoV-2.
A cewar kididdigar Jami'ar Johns Hopkins, yawan mutuwar mutane a duniya ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga watan Afrilu na shekarar 2020.
Sauran matakan sun hada da yawan mutuwar marasa lafiya (CFR), wanda ke nuna yawan adadin mutanen da suka kamu da cutar, da kuma yawan masu kamuwa da cutar (IFR), wanda ke nuna yawan mutanen da suka kamu da cutar (wanda aka gwada kuma aka sake gwadawa) kuma suka mutu saboda cutar.
Wannan lissafin ba ya dogara da lokaci kuma yana bin mutane daga wani nau'i na cutar daga lokacin da suka kamu da cutar zuwa ƙarshen su (sake warkewa ko mutuwa).
Ko da yake ba dukan mutane da suka kamu da cutar ba ne suke da kwayar cutar, amma mutum da ke da kwayar cutar zai iya ba mu bayanai game da yawan mutanen da suka kamu da cutar.
A Italiya, inda cutar ta fi yaɗuwa, ƙaramar ƙauyen Castiglione d'Adda, mutane 4,600 suka mutu.
A Gangelt, cutar ta bazu a lokacin bikin Carnival, inda ta shafi matasa, inda mutane da yawa suka mutu kuma ba duk wanda ya mutu daga COVID-19 aka tabbatar da cewa ya mutu ba.
Bugu da ƙari, asibitocin Jamus ba za su yi alhakin marasa lafiya ba.
A Netherlands, kashi uku cikin ɗari na mutane suna da rigakafin cutar, kamar yadda aka lura a cikin masu ba da jini.
An tabbatar da mutuwar COVID-19 a kashi 69 (kashi 0.004% na yawan jama'a).
Rashin lafiyar da ke tattare da cutar da kuma yawan mutuwar mutane sun bambanta ga maza da mata.
A ƙasar Sin da Italiya, an gano cewa yawan mutanen da suke mutuwa maza ne.
Yawan haɗarin da ke faruwa a tsakanin maza yana tsakanin shekara 50 zuwa 50, kuma tsakanin maza da mata yana tsakanin shekara 90.
A ƙasar Sin, adadin mutanen da suke mutuwa ya kai kashi 2.8 cikin ɗari na maza, da kuma kashi 1.7 cikin ɗari na mata.
Ba a san ainihin dalilin da ya sa ake da bambanci tsakanin mata da maza ba, amma za a iya ganin cewa hali da kuma kwayoyin halitta suna da tasiri.
Bambancin jinsi bisa ga yawan shan taba, mata masu shan taba da yawa da maza masu fama da cututtuka kamar su ciwon daji a cikin shekaru fiye da mata na iya haifar da yawan mutuwar maza.
A Turai, kashi 57% na masu kamuwa da cutar maza ne kuma kashi 72% na waɗanda suka mutu daga COVID-19 maza ne.
Har zuwa watan Afrilu 2020, gwamnatin Amurka ba ta bin diddigin bayanan jinsi a cikin masu cutar COVID-19 ba.
Bincike ya nuna cewa cututtukan ƙwayoyin cuta kamar Ebola, HIV, mura da SARS suna shafar maza da mata daban.
Yawancin likitoci, musamman ma mata, sun fi saurin kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga watan Fabrairun 2020 cewa sunan hukumar na cutar zai zama "COVID-19".
Babban Daraktan WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO yana wakiltar corona, VI don kwayar cutar, D don cutar, da 19 lokacin da aka fara gano cutar: 31 ga Disamba, 2019.
An zaɓi sunan don kaucewa yin magana game da kowane wuri (misali China), nau'in dabbobi ko rukuni na mutane, bisa ga ƙa'idodin duniya don kauce wa nuna bambanci. An kira kwayar cutar da ke haifar da COVID-19 da cutar coronavirus 2 mai saurin numfashi (SARS-CoV-2).
WHO ta kuma yi amfani da "kwayar COVID-19" da "kwayar cutar da ke da alhakin COVID-19" a cikin sadarwa da jama'a.
Dukkanin su, ana kiran cutar ta "coronavirus".
A lokacin da aka fara gano cutar a Wuhan, China, an kira kwayar cutar da cutar "coronavirus" da "Wuhan coronavirus".
A watan Janairun 2020, WHO ta amince da cutar numfashi mai saurin 2019-nCov da 2019-nCoV a matsayin sunaye na lokaci don a kira su cutar da cutar bayan shawarwarin 2015 na hana amfani da wuraren watsawa na cututtuka da ƙwayoyin cuta.
An fitar da sunayen hukuma na COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu 2020.
Saboda ƙarancin iyawar samar da kayayyaki na yau da kullun, wasu masana'antun suna samar da kayan aikin kiwon lafiya kamar su swabs na hanci da sassan kayan aikin numfashi.
Alal misali, sa'ad da asibiti a Italiya ya bukaci bawul na na'urar numfashi, amma ba a kawo shi a kan lokaci ba, wani kamfani a ƙasar ya soma ƙera bawul guda 100 a dare ɗaya.
Bayan barkewar cutar COVID-19, an fara samun jita-jita, labaran karya game da asalin cutar, girmanta, rigakafinta da maganin ta da kuma wasu bayanai game da cutar da suka bazu a duk fadin yanar gizo cikin kankanin lokaci.
Mutane suna iya yaɗa wannan cuta ga dabbobi.
Binciken bai sami bayanai game da kamuwa da kwayar cutar a aladu, aladu, da kaji ba.
Babu magani ko rigakafin cutar da aka tabbatar.
Binciken duniya kan allurar rigakafin COVID-19 ana gudanar da shi ta hanyar hukumomin gwamnati, kungiyoyin bincike, da masu binciken kwayar cutar.
A watan Maris, WHO ta kaddamar da wani tsari mai suna "TESTING IN AVAILA" don tantance ko maganin da ake da shi a yanzu ya fi inganci.
Babu maganin rigakafi amma hukumomi da dama suna kokarin gano wanda zai taimaka.
Ana amfani da binciken farko na SARS-CoV saboda SARS-CoV da SARS-CoV-2 duk suna amfani da mai karɓar ACE2 don shiga cikin kwayar cutar mutum.
Akwai nau'o'in rigakafi guda uku da ake bincike a kansu.
Da farko, masu bincike suna ƙoƙari su yi maganin da zai kawar da cutar.
Yin amfani da kwayar cutar, ko tana raye ko a raye, yana nufin samar da rigakafin kamuwa da cutar COVID-19.
Wani zaɓi, allurar rigakafi mai suna subunit vaccines, wannan tsari yana nufin samar da rigakafi wanda zai sa kwayar cutar ta hana kamuwa da kwayar cutar.
A cikin SARS-CoV-2, binciken ya mai da hankali kan furotin S-spike wanda ke taimakawa kwayar cutar ta shiga cikin mai karɓar enzyme na ACE2.
Hanya ta uku ita ce rigakafin nucleic acid (DNA ko RNA vaccines, sabuwar hanyar samar da rigakafi).
Alluran rigakafin da aka gwada daga waɗannan hanyoyin za su buƙaci gwaji don tabbatar da amincin su da kuma ingantaccen magani. A ranar 16 ga Maris, 2020, an fara gwajin farko na asibiti tare da masu ba da gudummawa huɗu a Seattle.
Magungunan rigakafi sun ƙunshi kwayar halitta mara lahani da aka kwafa daga kwayar cutar. An bayyana cewa inganta tsarin garkuwar jiki na iya zama ƙalubale wajen samar da allurar rigakafin SARS-COV-2, amma wannan ba gaskiya bane.
Ya zuwa watan Afrilu na 2020, an gudanar da gwaje-gwaje na asibiti sama da 300.
Gwaje-gwaje bakwai sun bincika magungunan da aka riga aka amince da su don maganin zazzabin cizon sauro, ciki har da gwaje-gwaje huɗu na hydroxychloroquine ko chloroquine.
Magungunan rigakafin cutar da ake amfani da su wajen magance cututtuka na daban sun kasance babban ɓangare na binciken kasar Sin, tare da gwajin kashi na III na remdesivir tara a ƙasashe da dama yayin da aka fitar da rahotanni a ƙarshen Afrilu.
An fara gwajin gwaji na gwaji don samar da allurar rigakafin COVID-19 da kuma yiwuwar magani a watan Afrilu na 2020. Ana nazarin magungunan rigakafi da yawa don magance COVID-19, gami da, remdesivir, chloroquine da hydroxychloroquine, lopinavir/ritonavir da lopinavir/ritonavir tare da interferon beta.
A watan Maris na shekarar 2020, akwai wasu bayanai da ba a tabbatar da su ba cewa maganin remdesivir yana da amfani.
An samu karuwa a cikin marasa lafiya da ake yi wa maganin remdesivir mai amfani da tausayi.
Ana gudanar da gwajin gwaji na mataki na III a Amurka, China da Italiya. An gwada Chloroquine, wanda aka yi amfani da shi don maganin zazzabin cizon sauro, a China a watan Fabrairun 2020, tare da wasu sakamakon farko.
Maimakon haka, an nemi a yi nazari a kan batun.
Jami'an kiwon lafiya a Koriya da China sun goyi bayan amfani da chloroquine.
Amma, duk da cewa Cibiyar Kula da Kwayoyin cuta ta Wuhan, ta ba da shawarar shan kashi ɗaya a rana na gram ɗaya, ta yi gargadin cewa yawan shan wannan kashi yana da haɗari kuma yana iya kashe mutum.
A ranar 28 ga watan Maris na 2020, FDA ta ba da izinin gaggawa ta amince da amfani da hydroxychloroquine da chloroquine bisa shawarar likitoci da ke kula da marasa lafiya na COVID-19.
Binciken ya nuna cewa ana bukatar karin allurai na ribavirin don hana SARS-CoV-2 a vitro.
An ba da shawarar yin nazarin Nitazoxanide a cikin kwayoyin halitta bayan da aka nuna rashin ƙarfi a cikin SARS-CoV-2. Sakamakon binciken ya nuna cewa farkon haɓakar furotin na farko na transmembrane protease serine 2 (TMPRSS2) yana da mahimmanci don shigar da SARS-CoV-2 ta hanyar haɗuwa da mai karɓar ACE2.
Binciken chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba suna da lahani da yawa waɗanda suka hana likitoci yarda da amfani da waɗannan magungunan ba tare da ƙarin bincike ba. Oseltamivir baya hana SARS-CoV-2 a cikin vitro kuma ba a san amfanin COVID-19 ba.
Cytokine storm na iya zama mummunan rauni yayin da COVID-19 ke yaduwa.
Akwai tabbacin cewa hydroxychloroquine na iya samun kaddarorin anti-cytokine storm. Tocilizumab an sanya shi cikin jerin da Hukumar Lafiya ta China ta yi bayan gudanar da bincike kadan.
Yana cikin matakin gwaji na matakin 2 na Italiya bayan gano alamun cutar a cikin mutane.
Yanzu an haɗa shi da gwajin jini na jini na serum ferritin don gano guguwar cytokine, kuma yana da niyyar kawar da irin wannan abu, wanda ake tsammanin zai kashe wasu marasa lafiya.
FDA ta amince da maganin mai karɓar mai karɓar Interleukin-6 bisa ga binciken da ya gabata don magance cutar cutar cytokine mai hana steroid ta hanyar wani abu, maganin CAR T cell a cikin 2017.
Ya zuwa yanzu, babu tabbaci mai ƙarfi cewa maganin maganin maganin CRS.
Ana ganin sauya tsarin rigakafin cutar da aka yi wa allurar rigakafin cutar ta hanyar yin amfani da maganin rigakafin cutar COVID-19 da aka yi wa mutanen da suka kamu da cutar.
An gwada wannan hanyar a kan SARS amma sakamakon bai zama na ƙarshe ba.
Anaesthesia wani magani ne wanda ke amfani da maganin rigakafi wanda ya shafi cutar SARS-CoV-2.
Sauran hanyoyin, kamar su maganin rigakafi da ke dogara da ƙwayoyin cuta da kuma/ko phagocytosis, suna yiwuwa.
Ana kuma ci gaba da yin amfani da wasu hanyoyin da za a iya amfani da su wajen magance cututtukan da ke hana yaduwar cuta, kamar su maganin rigakafi na monoclonal.
Za a iya ƙara maganin da ake kira convalescent serum, wanda ke ɗauke da jinin da aka yi amfani da shi a kan marasa lafiya da suka warke kuma yana ɗauke da ƙwayoyin cuta da ke hana kamuwa da cutar.
Cutar Coronavirus, wani rukuni na alamun da ke da alaƙa
Li Wenliang, likita a asibitin Wuhan, daga baya ya kamu da cutar COVID-19 kuma ya mutu bayan sanar da cutar.
